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FOREWORDS 
 
‘WHAT DO YOU THINK ABOUT THIS BOOK?’, ‘NO, WHAT DO YOU THINK?’ 
 
PROFESSOR IRUKA N. OKEKE  
IBADAN, NIGERIA, AUTHOR OF ‘DIVINING WITHOUT SEEDS THE CASE FOR STRENGTHENING LABORATORY MEDICINE IN 
AFRICA’ (2011) 
 
I have spent most of my scientific career working trans-continentally between West Africa and 
the US and Europe as both an African and a Northern researcher.  I have so many times been 
surprised, shocked and even stumped by the plethora of ethical challenges that emerge 
when individuals from vastly different backgrounds, with uneven but limited access to 
resources, study African life, death and disease.   Several excellent resources for ethical 
reflection and training exist but too few address situations that are specific to Africa.  Of those 
that do, most are too extensive or too specialized to be accessible to biological and clinical 
scientists.  This single volume fills these critical gaps.  By assembling this collection of thought-
provoking case studies, the authors have skillfully constructed a resource that can be used in 
its entirety, or in a modular fashion, to guide thought and discussions around ethical issues of 
varying complexity.  This book will become indispensable to individuals that work on, or 
engage with, experiments that are performed in or on Africa but which may be fully or partly 
conceived, conducted or interpreted elsewhere on the globe.   
In the many case studies, the authors fearlessly point out misconceptions of Africans that 
predominate in the West, as well as African misconceptions of Euro-Americans.  They illustrate 
that power is often tied to economics but that other resources can be similarly empowering.  
They prod researchers to think about and air inequalities associated with resource distribution, 
institutional support, compensation and career advancement of different actors within 
collaborations.  This is not a manual for ‘solving’ ethical problems.  Perhaps one of the most 
important lessons the book will teach those who seek to answer biological questions or solve 
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clinical problems is that while ethical challenges should be identified, acknowledged and 
even mitigated against, many cannot easily be fixed. 
Multiple case studies in this workbook go beyond sketching out well-known ethical quandaries 
to force readers or discussants to think beyond internationally agreed-upon strategies for 
addressing some issues.  The growing literature on ‘global health’ research ethics overly 
focuses on patient or volunteer participant issues.  While this book also leans heavily in favor of 
clinical trial scenarios, it extends the patient exploitation discourse to the professional, personal 
and institutional relationships among scientists from different backgrounds.  Thus, in addition to 
medical researchers, this book will be of use to ecological, psychological and archeological 
researchers, indeed anyone who is engaged in so-called collaborative inquiry in Africa.   
Each case is accompanied by a set of questions to guide discussions, helpful facilitator’s notes 
and suggestions for further reading.  The discussion tools and the thoughtful optional 
academic background section will be indispensable to biomedical research leaders who are, 
in general, not professional ethicists but need to formulate discussion questions and guide 
others to think about them.  The mix of ‘grassroots’ and ‘managerial’ examples means that  
African and Western researchers can refer again and again to case studies as they advance 
or change roles in biomedical research.  This resource should also be used by those that do 
not necessarily engage in transnational research but who study or reflect on its outcomes.  
Such individuals will include those conducting systematic reviews of the biomedical literature, 
teaching in ‘global health’ curricula, working in African health and educational institutions, or 
making decisions about research funding and publication. 
 
PROFESSOR NELSON K. SEWANKAMBO  
MBCHB, MSC, M.MED, FRCP, DOCTOR OF LAWS, HONORIS CAUSA, PRINCIPAL OF MAKERERE UNIVERSITY COLLEGE 
OF HEALTH SCIENCES, UGANDA 
Many books on ethics are out there but this volume occupies a very special place. It is a great 
teaching and learning resource that is a must read and will be appealing to a large and 
varied audience: students who are training in health research, junior and senior indigenous 
and foreign researchers who engage or plan to engage in health research in Africa or in 
similar environments around the world, research administrators and managers, members of 
community advisory boards, research participants and the enlightened community members 
who wish to learn more about research ethics. It is easy to read and provides a bridge for 
moving from ethics regulations and rules to the realities and challenges of practicing ethics in 
the field.  When I started reading it I could not stop and had to push aside many other 
commitments I had to do. 
This new volume brings fresh thinking and emphasis in the field of relational ethics, from a 
social science perspective and grounded in fictionalised case studies from Africa.  It relates 
very well to real life challenging field experiences encountered in research in Africa and yet it 
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challenges one’s thinking and promotes critical reflection. The cases cited are loaded with 
intriguing questions that the busy researcher or the less initiated individuals may just brush over 
and miss the real messages embedded in the case.  As you scratch deeper you soon realise 
the richness of the cases and cannot help but to share these with peers and students or those 
in your research team.  
Every passing year new ethics challenges emerge that remind us of the need to keep thinking 
and reflecting on these challenges because the field is not static. Books like this one 
originating in cases from Africa will in due course enable African researchers to play a more 
active and less passive role in debates on priority ethics issues that affect them and thus bring 
an African voice and experiences to inform these debates. In so doing they will contribute 
more meaningfully to advancing the field. 
 
SIR BRIAN GREENWOOD  
CBE, FRS, FMEDSCI, PROFESSOR OF CLINICAL TROPICAL MEDICINE, LONDON SCHOOL OF HYGIENE AND TROPICAL 
MEDICINE, UK 
Clear general principles have been established to guide the ethical conduct of clinical 
research wherever this is conducted, but these may not help when detailed, practical 
decisions on what to do have to be made.  This is especially the case in low income countries 
where there are many day-to-day challenges facing those who consider volunteering for 
inclusion in a research project. In such situations, should volunteers be paid for inclusion in a 
study and, if so, how much; should medical care be provided just to the volunteer or also to 
their family; how much autonomy should a woman have to make a decision about 
volunteering herself or her children for inclusion in a trial; how can confidentiality between 
volunteers and staff living in close contact with them in their community be maintained?  
Frequently, there is no correct answer to such questions but, nevertheless, decisions have to be 
made. These are often guided by the prior experience of a senior member of the research 
team who knows the community well, but such a person may not be available and there are 
few other sources of help for researchers experiencing some of these challenges for the first 
time. This book aims to fill this gap and does so very successfully. Using a series of case studies, 
accompanied by evocative paintings by Johnson Ondiek, the authors provide examples of 
some of the common problems met by researchers working in low income settings and use 
these as the basis for discussion groups.  In many cases, the correct course of action to follow is 
not obvious and the questions posed should elicit a lively debate. 
 It is clear that the case examples have been chosen by authors with extensive practical 
experience of dealing with the kind of problems faced every day by researchers in the 
developing world and they immediately strike a chord with the writer based on his own 
experience of conducting research in Africa. The book aims to raise awareness among mid-
career researchers and students of some of the ethical challenges of conducting research in 
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low income settings but reading these case stories may also cause more senior researchers to 
ponder on some of the decisions that they may be required to make.  This is an important and 
original contribution to a neglected area that will be of value to many concerned with 
conducting clinical trials in poorly resourced communities whilst at the same time trying their 
best to maintain the highest standards of research ethics.      
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PREFACE 
Conducting good, ethical global health research is now more 
important than ever. Increased global mobility and connectivity 
mean that in today’s world there is no such thing as ‘local health’. 
How we experience the effects of disease may be shaped by our 
particular social and political-economic circumstances, but the 
sick in one part of the world and the healthy in another are 
connected through economics, politics, media, and imagination, 
as well as by the infectiousness of disease. Global health research 
carried out through transnational collaboration is one crucial way 
in which people from far-flung geographic regions relate to each 
other. Good global health research, and the relationships it 
creates, therefore, concerns us all.  
This book is a collection of fictionalized case studies of everyday 
ethical dilemmas and challenges often encountered in the 
process of conducting global health research in Africa where the 
effects of global, political and economic inequality are 
particularly evident. Our aim is to create a training tool which can 
begin to fill the gap between research ethics guidelines and their 
implementation ‘on the ground’. The case studies, therefore, 
focus on everyday or ‘relational’ ethics: ethical actions and ideas 
that emerge through relations with others in context, rather than 
in universal principles or abstract regulations. 
The fictional case studies are based on stories and experiences 
collected by a group of anthropologists who have worked with 
leading transnational medical research organizations across 
Africa over the past decade. The stories have been anonymised, 
combined with each other, and substantially altered in order to 
provide ‘stumbling stones’ to start discussions, without naming real 
places or situations.  
As a collection, these stories offer a flexible resource for training 
across a variety of contexts, such as medical research 
organizations, universities, collaborative sites, and NGOs. We 
hope they will encourage global health researchers to think – and 
talk – about their everyday experiences and practices, and 
about ethics, in a new light.
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FINDING YOUR WAY AROUND THE 
BOOK 
 
The first part of this book is a short introduction to relational ethics, 
followed by a collection of 42 training case studies for global health 
researchers. We have divided the collection into four sections, each with a 
brief introduction to the section theme. Each section focuses on the 
different types of relationships that characterize the practice of global 
health research: 
 1. Researcher - participant relationships 
 2. Community and family relationships 
 3. Institutional relationships 
              4. Staff relationships 
 
Each training case study comprises: 
a. An introductory sheet for the training facilitator 
     This includes a learning objective, keywords, and a commentary on the core ethical 
dilemmas that the story addresses. 
b. A group handout  
     This includes the story, an illustration, questions to prompt discussion and suggestions for 
further reading. Many of the case studies also include ideas for group activities. 
A full list of case studies indexed by learning objective and keyword is provided at the end of 
the book. 
 
The collection of case studies is followed by guidance on how to use the training case studies. 
We provide detailed advice on group use using the case Helping hand as an example; a 
template form to help facilitators prepare for a training session; and a list of additional 
resources such as key journals and websites. We also discuss insights from our own experiences 
of piloting the case studies with different groups in Africa and Europe.  
The second part of this book provides a more in-depth discussion of the key perspectives 
informing our approach, an analysis of the context of transnational medical research in Africa, 
and an outline of what we believe anthropology and the social sciences can offer. 
JUDY WONDERED 
WHERE TO START 
      
 
11 
 
TRAINING CASE STUDY SECTIONS 
1. RESEARCHER-PARTICIPANT RELATIONSHIPS 
This collection of training case studies concerns issues arising out of direct interactions 
between researchers and study participants. The stories mainly focus on questions of ‘good 
clinical practice’ such as informed consent, coercion and participants’ understanding of study 
protocols, but also include a consideration of both personal moralities and relationships. They 
include, for example, accounts of friendship between researchers and participants, as well as 
exploring how research staff introduce themselves, develop ongoing rapport, and balance 
their personal and professional identities. Some of the case studies explore particularly difficult 
issues relating to structural inequalities and working with poor populations such as how to deal 
with participants’ hunger and post-research responsibilities for participants’ welfare.  
 
2. COMMUNITY AND FAMILY RELATIONSHIPS 
This collection focuses on what is commonly known as ‘community engagement’. It includes 
stories about rumours, the challenges of working with community advisory boards, and 
‘therapeutic misconception’, where research activities are confused with treatment 
programmes. It also includes stories about the role of gender and family relationships in 
research participation. In contrast with Section 1, the relationships in this section are to do with 
kinship and community, and lie outside the immediacy of personal interactions between a 
research participant and a researcher.  
 
3. INSTITUTIONAL RELATIONSHIPS 
This collection covers collaborative relationships between governments, ministries of health, 
health facilities, research funders, and researchers. The stories deal with the various mandates, 
responsibilities and aims of different institutions, their unequal access to resources and 
expertise, and the relative importance of local experience and global scientific scope. 
Misunderstandings and tensions can arise between these groups of people who may have 
different aims, limitations and responsibilities. Many stories in this section invite discussion on the 
wider relationships between and across countries involved in global health research.  
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4. STAFF RELATIONSHIPS 
This collection explores the kind of workplace relations characteristic of transnational 
collaboration. It includes stories of scientific co-operation between researchers from different 
institutions and backgrounds, as well as between different organizational levels and 
hierarchies; tensions that arise from unequal access to education, resources and decision-
making; accusations of nepotism and corruption; experiences and perceptions of ‘culture 
clash’; and simple misunderstandings.
INTRODUCTION       
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INTRODUCTION 
REGULATORY VERSUS RELATIONAL ETHICS 
Global health research is not just about blood samples, 
laboratory technologies, data capture and translating 
evidence into health policy. It is about people. More 
specifically it is about relationships between people. It is the 
relationships between funders, government staff, local and 
international scientists, fieldworkers, research participants and 
communities, which facilitate the conduct of essential health 
research. A concern with ‘relational ethics’, simply put, means 
thinking carefully about these relationships.  
It also means thinking beyond and outside of the wealth 
of regulations which have sprung up in the field of 
transnational medical research. Relational ethics are the 
complex and spontaneous momentary pursuit of morally 
right actions in personal interactions with other humans. 
They are guided not so much by formal rules as by 
individual and social conscience, and by particular 
overlapping identities and relationships. Good clinical 
practice guidelines will tell you what you need to include in 
a participant information sheet for a research study. But they 
won’t help you think through what to do, for example, if members 
of your team are labelled ‘Satanists’ by the community, if a 
participant says her child is hungry during a research 
appointment, or if one colleague makes a derogatory comment 
about another because of their gender, faith or ethnicity. 
Guidelines and regulations do not account for the ‘messiness’ of 
everyday encounters involved in global research practices. 
 
 
 
 
 RESEARCH IS ABOUT PEOPLE 
RESEARCH IS ABOUT RELATIONSHIPS 
SATANISTS AT WORK 
INTRODUCTION       
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ANTHROPOLOGY AND RELATIONAL ETHICS 
Anthropologists, on the other hand, have made the messiness of life their subject of enquiry. 
Anthropology is the study of human behaviour and human 
relationships. Anthropologists learn about this by spending 
long periods of time living in, and observing, different 
communities around the world. In our case, these were the 
communities of people involved in medical research in 
Africa.  
For the past decade we have been involved in, and 
conducted studies on, transnational medical research in 
different parts of Africa, in many 
cases at long-established, large-scale research sites. Our aim 
is to explore how medical research works in practice, and 
what ideas and hopes actors pursue through their work in 
their relations with others.  
To collect data on ‘relational ethics’, we shadowed 
fieldworkers, sat in on senior staff meetings, and lived in the 
homes of research participants. We paid close attention to 
mundane practices and tacit knowledge, as well as hidden 
tensions, subtle cues, and complex moralities. We did this 
over long periods of time so that we could understand individual encounters and incidents in 
their wider contexts. At the same time, we also engaged ourselves in research collaborations, 
sought our informants’ consent, underwent ethical review and faced ethical dilemmas – much 
in the same way as our colleagues in the medical sciences do. We tried to learn from the 
ethical reflections that arose from our own research too and, needless to say, we more often 
than not failed to achieve definite, satisfactory solutions to the challenges that, ultimately, 
stem from the unjust distribution of wealth between the world’s peoples, as well as between 
academic and scholarly institutions. 
During this process, we gathered many stories – some we were part of, others we followed as 
they unfolded, or were about told by colleagues. These stories have been fictionalized for the 
training case studies, but they are not hypothetical. They represent live encounters between 
researchers, participants and communities, and they show that ethics in medical research is 
complex and fluid, involving more than regulations and rules. Personal, cultural, professional, 
and community moralities and perspectives are all brought into play in specific contexts and 
situations.  
 
RESEARCHING RESEARCH 
ANTHROPOLOGY: LEARNING BY BEING 
WITH PEOPLE THROUGH ALL ASPECTS OF 
THEIR LIVES 
INTRODUCTION       
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RELATIONAL ETHICS AND INEQUALITY IN AFRICA 
Reflecting on relational ethics is important in any medical 
research context, but particularly crucial in Africa where 
global health research invariably involves major economic 
and political inequalities. The vast majority of health research 
conducted in Africa involves partnerships between countries, 
populations, institutions and staff from the global ‘North’ (the 
former European colonial powers and their North American 
successors), and their counterparts in the global ‘South’ 
(roughly speaking the formerly colonized areas of the globe). 
This means medical research in Africa operates across huge differentials in power, resources, 
and knowledge. Both the current reality of these differences, and historical memories of 
colonial relationships and post-colonial attempts at redress, affect how people involved in 
research today relate to each other. We found that these differences were an underlying 
theme to many of the ethical dilemmas we describe in this teaching resource. With this in mind 
we encourage both facilitators and training participants to read and engage with the 
material presented in the second half of this book which explores the current and historical 
context of transnational medical research and ethics in Africa in more depth. 
Such things are often hard to talk about. Being explicit about inequality – and its many small 
practical effects – can be embarrassing, even humiliating. It can also highlight irresolvable 
differences in opinion, and therefore seem futile. This is 
why this workbook uses stories, rather than real cases. It is 
our hope that discussing the stories will give global health 
researchers the opportunity to think about how they 
manage dilemmas and uncomfortable research 
encounters across power divides.  
Our aim is to create a training tool which can begin to fill 
the gap between ethics guidelines and their 
implementation. The stories are designed to encourage 
practical thinking within constrained conditions, in order to 
improve the   immediate conduct of medical research. But, at the same time we aim to raise 
awareness of the underlying, more challenging, issue of global inequality and how it affects 
global health research. The case studies are set up to encourage ethical deliberations on the 
stories to move between three distinct arenas of debate and action: debate over individual 
choices and behaviour, debate over institutional practices, and debate over wider ‘structural’ 
issues. An awareness of all three of these ‘levels’ operating in global medical research is, in our 
view, essential for all involved to move forward with a wider and more empowered 
understanding of ethical dilemmas.  
 INEQUALITIES ARE SOMETIMES 
HIGHLY VISIBLE IN RESEARCH 
PATIENTS NOTICED THE SUBTLE 
DIFFERENCE BETWEEN THE GOVERNMENT 
CLINIC AND THE RESEARCH CLINIC 
PART ONE: TRAINING CASE STUDIES       
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PART ONE: 
TRAINING CASE STUDIES 
 
 
‘THINKING ABOUT THESE THINGS WAS NOT GOING TO BE EASY’, THOUGHT ALOUIS.
RESEARCHER-PARTICIPANT RELATIONSHIPS                    Case studies 1-15 
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RESEARCHER-PARTICIPANT 
RELATIONSHIPS 
 
TRAINING CASE STUDIES 
 
 
EVERYONE WAS WONDERING: WHO WAS CARO’S SMARTLY DRESSED 'FRIEND' WITH THE BIG CAR…? 
 
RESEARCHER-PARTICIPANT RELATIONSHIPS                    Case studies 1-15 
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RESEARCHER- 
PARTICIPANT RELATIONSHIPS 
CASE STUDIES 
 
How can we best categorize the relationship between researcher and participant? One is 
paid; the other is not, yet is not a customer or receiving a 
service. One seems more powerful, yet cannot function 
without the other; he or she cannot proceed in the 
relationship without the other’s explicit consent. They are 
not friends, yet often share intimate details – albeit one-
sided – about their lives. Their relationship is at once highly 
technical and sometimes deeply human. Furthermore, it is 
one which, while at first glance – in the moment of 
drawing blood or obtaining consent – seems to be a 
relationship between two individuals, in reality stands for 
relationships between whole populations, countries, 
governments and 
institutions.  
                                       The stories in this section 
concern this unique relationship. They explore 
standard ethical concerns such as the informed 
consent process, coercion, and transparency. They 
also explore less commonly talked about issues such 
as friendship and kin-like relationships between 
researchers and participants, as well as the emotional struggle researchers sometimes deal 
with when faced with the conditions of abject poverty experienced by some participants. The 
stories look at relational ethical dilemmas, such as when research clinicians faced with sick 
participants are forced to decide whether to be foremost researchers, or clinicians. 
 
FURTHER READING 
Special Issue: Fieldworkers at the 
interface between research 
institutions and local 
communities. Developing World 
Bioethics 13(1) 
COLLECTING INFORMATION, 
CONNECTING WITH PEOPLE 
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FIELDWORK AND 
FRIENDSHIP: 
WORKING IN YOUR OWN 
COMMUNITY 
FACILITATOR’S NOTES 
This story focuses on the blurred lines between fieldwork and 
friendship when researchers are employed in their own 
communities.  
Many research organizations rely heavily on the unique expertise 
of local community interviewers (also called ‘villager reporters’, 
‘community health workers’, etc.), who are valued for their local 
understanding and their ability to negotiate both individual and 
collective consent. However, the personal position of such a 
worker is delicate, as they may feel pressure to represent the 
interests of both the research organization and the trial 
participants. Many conflicts and misunderstandings between 
organizations and their target communities are related to 
competition for limited employment in an already challenging 
economic environment. Paid interviewers often have to deal 
with resentment of their own economic good fortune, at the 
same time as working to encourage community members to 
participate in projects for free. Local staff may also be working 
directly with research participants who are friends or relatives, 
which adds extra pressure. How do they handle this? 
This case study is designed both to encourage staff members in 
similar situations to express their personal challenges, and to help 
senior staff better understand these challenges. As such, care 
needs to be taken when setting the ground rules for this 
discussion. The facilitator needs to think carefully about the 
possible consequences of encouraging staff to open up about 
this topic. Many research organizations have strict rules 
governing conduct between researchers and participants. Will 
LEARNING 
OBJECTIVE 
To consider the 
challenges of 
working for 
research 
programmes in 
one’s own 
community, 
especially when 
competing for 
limited 
employment 
opportunities, and 
to identify possible 
solutions 
 
 
 
 
KEYWORDS 
Informed consent 
Community-
based fieldworkers 
Friendship 
Employment issues 
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there be any consequences for staff if you encourage them to speak freely? The range of the 
discussion should be made clear at the beginning and this may involve extra preparation to 
create a ‘safe space’. For example, if possible it would be helpful to be able to assure 
participants that there will be no disciplinary action if they discuss personal experiences that 
may have violated regulatory ethics. If this is not possible, we recommend you steer the 
discussion carefully away from areas where disclosure could lead to staff being disciplined 
later. The final discussion should include a discussion and comparison of different types of 
ethics – regulatory, and relational or individual. 
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FIELDWORK AND FRIENDSHIP:  
WORKING IN YOUR OWN COMMUNITY 
 
 
 
THE TENSION WAS PALPABLE AS JENNY READ MAGGIE THE CONSENT FORM 
THE STORY  
enny is a community interviewer for a transnational research organization, and is 
employed on a casual contract to work in her own marital village, where she has a long 
history of community work. As well as casual work for the research organization, she 
provides voluntary home-based care for people living with HIV/AIDS. She is also the secretary 
of a local network of women’s self-help groups, and a church teacher. She has helped the 
research station on a number of projects over the past ten years, and has gone on numerous 
training courses.  
At the moment, Jenny is working on a project looking at the feasibility of distributing condoms 
to women door-to-door. Her role is to visit women in their homes, explain the study to them 
and obtain their informed consent. Today she visits Maggie, a younger woman living with her 
husband and child. Maggie is a teacher working in a nearby school so Jenny visits her on the 
weekend when she knows she will be in. Jenny and Maggie have known each other for a long 
J
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time. Before Maggie trained to be a teacher, Jenny organized for her to assist her as a village 
reporter on a research project. But, after that project finished, Maggie was not asked to assist 
again. Jenny says that this was because Maggie ‘didn’t know the right way to talk to people’.  
When Jenny arrives at Maggie’s home she is greeted cordially and invited to sit. After 
exchanging greetings and some local news, Jenny starts to explain the new study to Maggie. 
Soon, however, the atmosphere becomes a little awkward. Jenny stumbles over her words 
when reading the form and Maggie corrects her disdainfully. Maggie’s husband arrives when 
they are still going through the consent form, and stays to listen. When they get to the end, 
Jenny asks Maggie if she is happy to be visited and given the condoms every month. Maggie 
says loudly, ‘No, I do not consent. It is my right. Look here, it says I can say no. You need to say 
that it is my right to say no. Say that first.’ 
Jenny is a bit taken aback at Maggie’s tone, but agrees that of course Maggie can say no. 
She looks for her pen. ‘Look,’ says Maggie, ‘this lady is not prepared, where is her pen?’ 
Maggie’s husband is clearly uncomfortable. He asks Jenny to tell him what the research is 
about. But before Jenny can answer, Maggie tells him, ‘Why are you asking her? I know what it 
is about.’ Maggie and her husband start to bicker, and now Jenny is uncomfortable. She tells 
Maggie she will come back later for the consent form and leaves quickly. 
Walking away, Jenny is clearly upset. A researcher accompanying her on the visit asks her 
what went wrong. ‘I don’t know,’ replies Jenny, ‘we used to be such good friends, and now 
look at the way she talks to me. She has become so arrogant since she became a teacher. I 
won’t be able to do good work in that home again. Last month, she promised me she would 
take her child to the clinic for that vaccine study. She kept saying she was going to and then 
she didn’t. In the end I arranged for a motorbike to take them. Then she left me to pay for it!’  
‘Do you think it was because I was there?’ the researcher asks. ‘Perhaps,’ Jenny replies. ‘I 
don’t know. I think she is also having some problems with her husband. He has been staying 
away a lot. I did hear he might be getting a second wife.’ 
QUESTIONS 
 There might be several reasons for the awkwardness that has developed between 
Jenny and Maggie. What might these be? 
 Do you think Jenny’s employers should know about what has happened? Why (or why 
not) might it matter to them?  
 What should Jenny do, if anything? 
 What should the research organization do, if anything? 
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GROUP ACTIVITY  
Divide into two groups. Drawing on their own experience, the first group brainstorms the 
ethical dilemmas and possible tensions somebody like Jenny may face. Again drawing on 
their own experience, the second group explores the benefits of working within your own 
community, like Jenny does. Are there situations where fieldworkers can actually avoid ethical 
challenges, or act more ethically, because of their unique position and knowledge of their 
own community?  
Then the two groups present their points to each other. Do the benefits outweigh the 
challenges? 
FURTHER READING 
Chantler, T., Otewa, F. et al. (2013) Ethical challenges that arise at the community interface of 
health research: village reporters’ experiences in Western Kenya. Developing World Bioethics 
13(1), 30–37.  
Kamuya, D.M., Theobald, S.J. et al. (2013) Evolving friendships and shifting ethical dilemmas: 
fieldworkers’ experiences in a short term community based study in Kenya. Developing World 
Bioethics 13(1), 1–9.  
Simon, C. and Mosavel, M. (2010) Community members as recruiters of human subjects: 
ethical considerations. American Journal of Bioethics 10(3), 3–11. 
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SOAP AND 
PERSUASION:  
RECRUITING AND CARING FOR 
PARTICIPANTS 
FACILITATOR’S NOTES 
This case study is about the way a study recruiter relates to 
and interacts with potential participants, and raises the 
question of whether his interactions are ethical. It is a useful 
scenario to use to encourage discussion about the challenges 
fieldworkers encounter, and how these can be managed 
ethically. The case study prompts broader questions about 
benefits, inducements, coercion, and the distinction between 
research activities and meeting participants’ basic public 
health needs.  In this story a government public health worker 
is seconded to a research project, raising issues around 
different work experiences and goals. This case study can, 
therefore, also be used to make connections to themes arising 
in the Institutional Relationships group of case studies. 
You may not be able to cover all of this ground in your session, 
so in directing the discussion, it may be useful to think about 
who your training participants are, what questions engage 
them most in their work, and what changes they may be in a 
position to make. This does not mean that you should not 
touch upon all these questions, but you may want to decide 
on what you will focus on in most depth. 
LEARNING 
OBJECTIVE 
To recognise that 
the balance 
between 
professional 
involvement and 
personal 
relationships is both 
a practical and a 
moral challenge for 
staff who interact 
directly with 
research 
participants, and to 
consider various 
possible views of the 
role of medical 
research in 
communities 
 
KEYWORDS 
Informed consent  
Inducements 
Government 
Poverty 
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SOAP AND PERSUASION: 
RECRUITING AND CARING FOR PARTICIPANTS 
 
 MAMA JANE WATCHED AS THE RESEARCHERS REMOVED ALL HER THINGS 
THE STORY 
 research study looking at the cost-effectiveness of indoor residual house spraying (IRS) 
is taking place in Malawi. The study is being carried out by a Danish university in 
collaboration with a Malawian research institute. The study involves spraying 1,000 
houses over a few days, every six months. The researchers have asked local government 
public health officials for assistance with this, so four public health officials are seconded to the 
study on a temporary basis to help with the spraying, and with obtaining consent from the 
household heads. 
David, one of these public health officials, has a huge amount of experience in community 
public health work. He is highly respected, and known locally as ‘Pastor-Doctor’ because he 
also preaches in one of the nearby Pentecostal churches. He is close to retirement age; 
several of the local researchers on the study received their first training in public health work 
from him, before getting jobs in more lucrative international research. 
Soon it is time for the third and final round of spraying, and the study is going well. Relations 
with the community are good and consent rates are high, particularly among the homes 
A
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visited by the public health officials, who are seen as ‘community experts’ by the researchers. 
For this last round, David is unable to visit one of the houses he has visited before so a local 
female researcher, Bilah, goes instead.  
There have never been any reported problems with spraying this home, which belongs to an 
elderly widow known as Mama Jane. However, this time Bilah reports back that Mama Jane 
has refused to give her consent for her house to be sprayed. ‘She doesn’t like the research,’ 
she tells the study coordinator. ‘She doesn’t want me moving her things outside the house 
where people can see them. And she says she wants the soap that the Pastor-Doctor always 
brings before he sprays her house. 
David is called in for a meeting. The study coordinator accuses him of ‘bribing’ Mama Jane to 
take part, saying that his actions have invalidated the informed consent process. David is 
really angry. ‘How can I “bribe” my grandmother?’ he retorts. ‘This widow has no one to take 
care of her. Did you not see the way her house was? How her things were so dirty? If I don’t 
give her soap, who will?’ The study coordinator tells David that, as a researcher, this isn’t his 
concern. His role in this case should only be to obtain informed consent before spraying, which 
means that Mama Jane has to understand the research and freely agree. ‘Ha!’ replies David. 
‘What does that mean? She believes that malaria is caused by the rain. Are you telling me 
that because of this we should let her house go unsprayed, and let her become sick? IRS is not 
only about research. It’s about public health!’ 
The study coordinator and David reach an impasse. David threatens to pull out of the study. 
The study coordinator is concerned about the effect this will have on community relations. He 
is also concerned about just how much soap has been circulating in the study area.  
QUESTIONS 
 What do you think are the key issues in this story? 
 What do you think about researchers asking public health professionals to undertake 
recruitment for them? What are the consequences of this for recruitment practice? 
 What do you think David means when he says ‘How can I “bribe” my grandmother?’ 
What other ‘kinship’ relationships seem to be at play among David, the researchers, the 
coordinator, and the community?  
 What could be the consequences for the project if David leaves the study? 
 Do you think that participants in this study should receive some form of reimbursement? 
If no, why not, and if yes, what should this be? 
 What do you think about David’s commentary on the public health aspect of the IRS? 
Do you agree? What challenges – and benefits – does this idea pose for researchers?  
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FURTHER READING 
Chantler, T., Otewa, F. et al. (2013) Ethical challenges that arise at the community interface of 
health research: village reporters’ experiences in Western Kenya. Developing World Bioethics 
13(1), 30–37.  
Geissler, P.W., Kelly, A., Imoukhuede B., Pool, R. (2008) ‘He is now like a brother, I can even give 
him some blood’ – relational ethics and material exchanges in a malaria vaccine ‘trial 
community’ in The Gambia. Social Science and Medicine 67(5), 696–707.  
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GEL AND/OR 
CONDOMS: 
SAFETY IN A MICROBICIDE TRIAL 
 
FACILITATOR’S NOTES 
This story is about participants’ understanding of the risks 
involved in research. It focuses on a woman taking part in a 
microbicide trial who appears to have understood the study 
information, but still chooses to use the gel in a way which 
puts her at risk of HIV infection. The aim of this case study is to 
encourage deeper reflection on how we interpret 
participants’ understanding of the information we provide, 
and the extent of our responsibility to reduce the risks 
participants are exposed to – especially when they could be 
seen as ‘vulnerable’ in some way.  
When thinking about informed consent and participants’ 
understanding of risks, this study invites us to look beyond 
asking simply whether participants understand the basic facts. 
It is clear that the woman in this story understands the 
information she is given. However, despite the advice of the 
researchers, she takes a calculated risk, based partly on 
economic necessity and partly on her understanding of the 
context of the project. The question is whether she is more at 
risk of catching HIV as a result of taking part in the research, 
and, if so, what the responsibility – and ability – of the 
researchers might be to address this.
LEARNING 
OBJECTIVE 
To move beyond a 
simplistic 
understanding of 
informed consent (in 
terms of simple 
comprehension of 
facts), and to reflect 
on the extent of 
researchers’ 
responsibility 
towards reducing 
risks for vulnerable 
participants 
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Informed consent  
Safety 
Understanding risk 
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GEL AND/OR CONDOMS: 
SAFETY IN A MICROBICIDE TRIAL 
 
 
‘EXCELLENT!’ SAID LUCY, ‘NOW I CAN THROW AWAY THESE CONDOMS' 
THE STORY 
ucy is taking part in a trial to see if using a microbicide gel protects women in 
occupations with a high risk of HIV infection. Lucy is widowed and runs a makeshift bar 
behind her house. She brews local alcohol which she serves to a mainly male clientele. 
She does not consider herself a commercial sex worker, but sometimes for a little extra tip or a 
gift she does have sex with a few of her regular customers.  
Lucy has been given information about the trial and the gel on a number of occasions: when 
the researchers first visited her bar to tell her about the trial; at a second visit to enroll her 
formally into the study; and every month when she comes to the research clinic for a study 
visit. Each time she is told that ‘because we don’t yet know whether the gel works, you must 
still use a condom. Proper use of a condom is the most effective form of HIV prevention.’ Each 
time, Lucy is given the same information sheet to read, accompanied by a cartoon about the 
trial. And each time she is asked a series of questions by the staff to check she has understood 
the message. Lucy passes this test every time.  
L
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However, towards the end of the study a social scientist comes to do some in-depth interviews 
with some of the women about their experiences of the trial. Lucy is selected to participate. In 
her interview she tells the social scientist that she understands that the gel may not work, or 
that she may be using a placebo gel. She tells her that ‘“placebo” means fake’. But, she also 
tells the social scientist that she has been trying out the gel without using a condom because 
she wants ‘to see if it works’. When the social scientist probes a bit deeper to understand what 
Lucy means, she says ‘Well, if I use a condom, how will I know if the gel works? It will be the 
condom working, not the gel!’ The social scientist asks her if she is not worried about HIV 
infection. Lucy tells her that the researchers must be already quite confident that the gel 
worked, otherwise they wouldn’t be bothering to do the trial.  
When Lucy is asked what she likes about the gel, she tells the social scientist that ‘It has been 
helpful for me, because when I use the gel instead of a condom my boyfriends give me 
something extra.’  
The social scientists report their findings back to the study researchers. The researchers are 
frustrated. ‘What can we do,’ they wonder, ‘to stop someone like Lucy putting herself at risk? 
We thought she understood.’  
‘Well,’ says the Principal Investigator, ‘at least this shows us that effective microbicides are 
really needed.’ 
QUESTIONS 
 What are key ethical issues at stake in this situation? 
 Do you understand Lucy’s decision?  
 What do you think is the extent of researchers’ responsibility to reduce the risk of HIV 
infection when offering participants an experimental HIV prevention tool? How could 
researchers assess their own efforts at this? 
 Has participation in the study increased Lucy’s risk of contracting HIV or other sexually 
transmitted infections?  
 Is there anything else the study team could do to help Lucy use condoms? Is this their 
job? 
 What do you make of the Principal Investigator’s response? 
REFLECTIONS ON YOUR OWN EXPERIENCE 
Can you think of similar situations from your experience? How did you ensure participants were 
at minimal risk of harm? Did things ever work out unexpectedly, despite your best efforts? 
Looking back now, what might you have done differently? 
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ACTIVITIES 
1. Split up into two groups, and devise an information sheet or activity to explain the 
importance of condom use for each sex act in a study similar to the one described 
above. Then, take in turns to use your information sheet/activity to inform the other 
group about your project. What potential issues that affect safety are not covered by 
the information? What situations can the group being informed imagine where they 
would not follow the advice being given? How can you best talk through these issues 
with the participants? 
2. In 2013, the Vaginal and Oral Interventions to Control the Epidemic (Voice) trial, a multi-
sited study in South Africa, Ugandan and Zimbabwean hit the global news headlines 
when researchers revealed that blood tests showed that many participants had lied 
about their adherence to the products being tested. The study aimed to test whether a 
daily anti-retroviral pill or once-a-day vaginal gel would protect at-risk women from 
contracting HIV.  The women were blamed in the global press for deliberate deception 
and for participating in the research only for “stipends”. This led to a debate about the 
morality of clinical trials. A group of anthropologists conducted some interviews with the 
South African participants to explore the meaning of the lie from the perspectives of the 
women themselves. Read a summary of their findings here: 
https://theconversation.com/what-drove-women-to-lie-in-an-hiv-clinical-trial-in-
southern-africa-51143 and discuss the implications in your group for designing future 
trials. In what way is what happened in the VOICE study different to Lucy’s story above? 
In what way is it similar?                    
FURTHER READING 
Beskow, L.M. and McCall, J. (Eds). Informed Consent. Rethinking clinical trials: a living textbook 
of pragmatic clinical trials. NIH Health Care Systems Research Collaboratory. Available at: 
http://sites.duke.edu/rethinkingclinicaltrials/informed-consent-in-pragmatic-clinical-trials 
(accessed 25 October 2015).  
Corneli, A.L. et al. (2012) Improving participant understanding of informed consent in an HIV-
prevention clinical trial: a comparison of methods. Aids and Behaviour 16(2), 412–421. 
Cooper, M. (2013) Double exposure – sex workers, biomedical prevention trials, and the dual 
logic of global public health. S & F Online 11(3), 1–11. 
Kingori, P. (2015) When the science fails and the ethics works: ‘Fail-safe’ ethics in the FEM-PrEP 
study. Anthropology and Medicine Epub 2015 Oct 20, 1-17 
Moodley, K. (2007) Microbicide research in developing countries: have we given the ethical 
concerns due consideration? BMC Medical Ethics2007 Sep 19, 8:10.  
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Stadler, J., et al. (2015) Adherence and the Lie in a HIV Prevention Clinical Trial. Medical 
Anthropology: 1-14.                                                                                                                                                     
Vallely, A. et al. (2010) How informed is consent in vulnerable populations? Experience using a 
continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. 
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FRIENDS LIKE HOW?:  
GETTING PERSONALLY INVOLVED 
WITH PARTICIPANTS 
FACILITATOR’S NOTES 
The story in this case study is about a friendship that develops 
between an expatriate social researcher and a research 
participant. It deals with questions of boundaries in research 
relationships, and with confidentiality and trust. The different 
backgrounds of the two individuals in this relationship are 
striking, but similar situations can occur with local researchers 
and study participants. You might want to point this out in your 
discussions, and talk about whether this raises similar or 
different challenges.  
The question of friendship and ongoing connections can 
become particularly important at the end of a study, when 
research staff have to tell participants that they will no longer 
be visiting them or seeing them at clinic. In situations where 
participants are in evident need, or are socially isolated, this 
can be very difficult, and some staff might choose to remain in 
contact with certain participants. It would be good to think 
about the consequences of this, and also to consider the role 
of culture, and the fact that some participants might live in the 
same neighbourhood as research staff.  
The other key theme this case study touches on is 
confidentiality, both in terms of disclosing how the two people 
meet, and how the relationship helps the researcher collect 
‘rich’ data for the study. How should the researcher manage 
this ethically? Should she leave her friend out of her write-up of 
the research, or just try to ensure she understands that some of 
her experiences will be included in the research? These are 
important questions which need to be considered carefully, 
bearing in mind that different research disciplines use different 
approaches to data collection
LEARNING 
OBJECTIVE 
To explore personal 
closeness and 
boundaries in 
research 
relationships, 
especially at the 
end of trials 
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FRIENDS LIKE HOW?: 
GETTING PERSONALLY INVOLVED WITH 
PARTICIPANTS 
 
 
AS JANE SWITCHED ON THE RECORDER, SALLY HANDED HER A CHICKEN. 
THE STORY 
ane, an overseas social scientist, is attached to a clinical study of HIV positive men and 
women taking place in an African city. As part of her research she conducts in-depth 
interviews with some participants and accompanies them on clinic visits. One of these 
participants is Sally. Jane spends a long time interviewing Sally in Jane’s own home, as there is 
nowhere else Sally feels comfortable talking about her HIV status. During their second interview 
Sally asks Jane if they could ‘become friends’. Jane is a little cautious about being asked such 
a direct question; she wants to know exactly what Sally means, and asks, ‘Friends like how?’ 
Sally replies, ‘Friends who talk to each other.’ In their next few interviews Sally shares a lot with 
Jane. She tells her about the difficulties she has with her husband, who refuses to talk about his 
own HIV status and will not go for a test.  
J
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A few weeks later, Jane hears that Sally’s CD4 count has dropped and she needs to start 
treatment. Jane knows that this will be upsetting for Sally, because she has talked a lot about 
the fact she was proud she was not on treatment. Jane knows it will be a shock. She also 
knows from her interviews with Sally that Sally reacts to shock with initial silence. In one of the 
clinical study meetings, Jane hears the staff saying that they are worried that Sally will not 
come to the clinic for the treatment ‘because of stigma from her husband’ and that it is quite 
an urgent situation. Jane does not know what to do. She feels sure that Sally intends to 
participate, but is just taking a day to recover from the shock. She considers calling Sally to 
encourage her, but feels she should not repeat what she has heard about Sally in the clinical 
study meeting. She also feels that she cannot tell the clinical study staff about what she knows 
about Sally’s character from the in-depth interviews, as this would be breaking Sally’s 
confidentiality. So she waits a few days, all the time quite worried about Sally.  
Then Sally herself sends Jane a text message. She just says she has had a big shock and is 
feeling lost. She does not give any more details. She asks Jane if she would be able to 
accompany her to the clinic ‘as a friend’. Jane agrees. Jane and Sally arrive early at the 
clinic. Jane brings a thermos of tea which they share while Sally talks about what has 
happened. When she found out she needed to start treatment, she told her husband, who 
already knew her status, but he just walked away and has said nothing more about the issue 
since then. She says she called Jane because she needed ‘moral support’ to attend the clinic.  
Sally asks Jane to come in to see the doctor with her. Jane thinks about reminding Sally that 
she is also a researcher, and so would be observing with ‘two hats on’, but it does not feel like 
this is the right moment. Instead, she quickly makes sure that the doctor is happy for her to 
accompany Sally.  
The doctor talks to both Jane and Sally, saying they should speak in English for Jane. Jane finds 
herself thinking ‘English would be better for my research!’ But then mentally rebukes herself, 
and tells them to use whichever language they prefer. She pretends she can understand the 
local language better than she actually can, and wishes she had a tape-recorder to translate 
later. Jane also accompanies Sally to have her blood taken and to see the pharmacist. 
Because of the language issue, Jane isn’t entirely clear what happens in all these sessions. 
Afterwards, Sally tells Jane that she cannot imagine how she could have even entered the 
clinic alone, as she was still in shock. For the rest of the study, which is nearing its end, the study 
staff refer to Sally as ‘Jane’s friend’. Sometimes they tell Jane things about Sally and her 
treatment that Sally herself does not discuss with her. Jane feels very awkward about this and 
does not want to get caught in the middle. While staff praise her for supporting Sally, Jane 
feels conflicted because although her main motivation is to be helpful, she has also gathered 
a lot of data for her research from the experience. She is still not clear if Sally understands this 
aspect of their relationship. 
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After the study ends, Sally takes courage and goes to register at the HIV Care and Support 
Centre by herself. Several years later, Jane and Sally are still very good friends; they have met 
each other’s families, slept in each other’s houses, and attended funerals and weddings 
together. Sally is very private about her HIV status. She tells people who ask how she knows 
Jane that they met as ‘pen-friends’. But she doesn’t tell Jane this, so when asked by Sally’s 
father-in-law, Jane says ‘we met just around on the streets’. 
QUESTIONS 
 How would you describe what happened here? What are the key ethical issues? 
 Why do you think Jane was initially cautious when Sally asked to be friends?  
 Why do you think Sally called Jane in particular to go with her to the clinic? 
 Do you think Jane did the right thing? For whom? Could she have done some things 
differently? Do you think there could have been any problematic consequences from 
this situation? For whom? Sally? Jane? The clinical study? 
 Do you think this was a one-off unique situation for either Jane or Sally?  
 Do you think Jane’s research suffered or benefited from what happened?  
 What part do ‘rapport’ and ‘relationships’ play in your own work? 
REFLECTION ON YOUR OWN EXPERIENCE 
Can you think of any similar situations from your experience? How did you deal with them? 
Looking back now, what could you have done differently? 
ACTIVITY 
Split into small groups and think about the nature of relationships in social research, and how 
to manage the boundaries between friendship and acquaintance. List the advantages and 
disadvantages of Jane’s agreeing to befriend Sally, and think about what might have 
happened if she had explained that she could not be her friend due to her relationship with 
her as a researcher. Discuss and then vote on whether Jane should describe in her research 
what she has learned from her relationship with Sally. 
FURTHER READING 
Madiega, P.A., Jones, G. et al. (2013). ‘She's my sister-In-law, my visitor, my friend’ – challenges 
of staff identity in home follow-up in an HIV trial in Western Kenya. Developing World Bioethics 
13(1), 21–29
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READABILITY AND 
SWEET TALK: 
TRANSLATION AND 
COMPREHENSION OF STUDY 
DOCUMENTS 
FACILITATOR’S NOTES 
This case study is about the translation and comprehension of 
study information, and it also raises questions about how such 
information should be delivered – for example, during the 
consent process should fieldworkers be able to use their own 
words to illustrate particular points? This story could be useful 
during the run-up to a new project, when study documents are 
being prepared and decisions are being made about 
recruiting participants.  
There are two main areas for discussion here: the first is about 
the translation process, and the second is about how 
information is exchanged between research staff and 
participants. It would be good to think carefully about what is 
meant by ‘sweetening’ the words on the consent form, and 
how this might be different from using colloquial terms to 
illustrate certain points. Questions of trust and protocol 
between the Principal Investigator and the staff also emerge.
LEARNING 
OBJECTIVE 
To think more widely 
about the translation 
of study documents, 
considering local 
variations in 
language, the 
different ways 
participants interpret 
terms and facts, and 
the role of social 
relations in the 
information process 
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Documents 
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READABILITY AND SWEET TALK: 
TRANSLATION AND COMPREHENSION OF STUDY 
DOCUMENTS 
 
 
 THE P.I LOOKED AT THE TRANSLATED CONSENT FORMS IN DESPAIR 
THE STORY 
he Institutional Review Board in this African country requires consent forms to be rated for 
their ‘readability’ using the Flesch-Kincaid grading system. The Flesch-Kincaid system uses 
word and sentence length to assess readability. After achieving an appropriate rating, 
the English forms are translated and back-translated to and from local languages, by staff 
who consider themselves fluent. This country has a large number of tribes, each with their own 
‘mother-tongue’. The linguistic situation is complicated further by the existence of local sub-
tribes and clans, who speak variants of the tribal languages.  
Despite achieving high readability scores in her consent forms in English, the British Principal 
Investigator of a TB study encounters endless problems when they are translated. She initially 
T 
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asks two native speakers to do separate translations: the study coordinator, who grew up in a 
city, and a younger fieldworker who grew up in the rural area where the study will take place. 
The translations they produce look quite different. Despite speaking the same local language, 
they disagree about certain words, as well as how to translate English words for which there is 
no straightforward equivalent. After some discussion, several other staff members are drafted 
in to help, and a working consensus is reached. The final translated consent form contains 
some English words, and is considerably longer than the English original. The Principal 
Investigator worries whether it will still have an acceptable ‘readability’ grade if the Flesch-
Kincaid formula were applied, but as there is no equivalent system for testing readability in the 
local languages, she decides to proceed.  
However, when the consent forms are used in the field she discovers that her problems are not 
over. The forms are used by fieldworkers who are, mostly, one or more generations older than 
the staff who translated the forms. They were instructed to read the forms aloud to 
participants, but in practice some of them stumble over the words, and the participants do 
not always appear to be reading along with them. The fieldworkers often follow the text with 
their fingers, and seem to repeat many of the sentences again after getting to the end of 
them. It seems to take a long, awkward time for the fieldworkers to read out the form, and the 
participants usually do not have any questions about the study at the end. This suggests that 
they have not really understood.  
Sometimes, however, the fieldworker would abandon the form after a short time and talk 
casually about the study with the participant. The participants seem to ask more questions in 
these cases. The fieldworkers’ off-the-cuff descriptions of the study seem to be different from 
the formal written descriptions. For example, fieldworkers are asked to say they are looking for 
pregnant women to include in a sub-study. But instead, they tend to say that they would be 
looking out for ‘any women whose skin had become very beautiful and smooth recently’.  
When asked about their experiences using the form, the fieldworkers say that the forms were 
good and made sense. But when they are probed a bit further, it emerges that both the 
fieldworkers and participants are not used to reading in their local language. Those that can 
read and write tend to do so in English. The Principal Investigator asks if it would be better to 
use forms written in English. ‘No,’ the fieldworkers reply, ‘most participants do not really 
understand English.’  
‘What about making the sentences shorter?’ she asks. ‘Would that help?’ ‘Well,’ they reply, 
‘mother-tongue is different from English; the meaning is not in the sentences but in the whole 
thing. You have to get to the end to know what the beginning means.’ 
Despite the difficulties with reading the form aloud, the Principal Investigator cautions the 
fieldworkers against abandoning the form and using their own words to describe the study. ‘It 
is important that all the participants hear the same messages,’ she says. ‘When they sign that 
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form, they are signing to say that they have heard all of it.’ The fieldworkers reply: ‘But 
sometimes we need to sweeten the words of the form. Otherwise people will say we are 
disrespectful. You can’t say some of it just like that. You need to take the participants slowly.’ 
‘So what should we do?’ wonders the Principal Investigator. 
QUESTIONS 
 How would you measure the Flesch-Kincaid grade of this case study? 
 What do you think grading systems can measure? What can’t they measure? 
 Is the readability of a form the same as participants being able to comprehend a 
study?  
 There are several different issues about the use of consent forms signposted here. Can 
you disentangle and list them?  
 The study coordinator and the young fieldworker produce different translations of the 
form. Can you think of several reasons why? 
 Why does the finalized translation not always work in the field? 
 Why do you think the fieldworkers don’t ask directly about pregnancy? 
 What do you think the older fieldworkers meant by ‘sweetening’ the words of the form?  
 What does this case tell you about the nature of language? Can you think of different 
ways you use one language, in different contexts?  
 How do you think the Principal Investigator feels, about her relationship with her staff 
and the ethics of the study? If you were her, what would you do next?  
 Are there alternative ways of getting informed consent to using written forms? 
ACTIVITY 
Divide into groups, and, if you are in a group where people speak several languages, try to 
translate the following paragraph and compare notes. Where do you find differences or 
challenges? Even if you do not speak any other languages, do you think any parts may be 
problematic? What solutions can you come up with? 
 
We invite you to take part in a study. The study is conducted by EMRC/HTW. This study is 
investigating the current prevalence of TB among the general population in your area. 
We also want to know the prevalence of TB among pregnant women. As part of this 
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study fieldworkers will be visiting people in their homes and collecting sputum samples 
from all willing household members over the age of 18. The fieldworkers will also offer 
female participants over the age of 18 pregnancy tests. The information below will help 
you decide whether you are happy to participate in the study. 
FURTHER READING 
Kithinji, C. and Kass, N.E. (2010) Assessing the readability of non-English-language consent 
forms: the case of Kiswahili for research conducted in Kenya.IRB: Ethics & Human Research32 
(4), 10–15.  
Mack, N., Ramirez, C.B., Friedland, B., and Nnko, S. (2013) Lost in translation: assessing 
effectiveness of focus group questioning techniques to develop improved translation of 
terminology used in HIV prevention clinical trials. PLoS One 8(9): e73799. 
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WE DON’T PAY:  
‘BUS FARES’ AND OTHER GIFTS IN 
RESEARCH 
FACILITATOR’S NOTES 
Research participants usually receive reimbursement for their 
transport costs to research clinics. Often this is provided as a 
fixed amount rather than on provision of a receipt. From the 
perspective of research protocols, transport reimbursement is 
just that – reimbursement for transport. But it might have a 
different meaning for research participants. This story asks why, 
and whether it matters. 
The story describes a woman participating in a diabetes care 
study, who despite being in poor health wants to walk to the 
clinic in order to keep her transport money. This poses a 
challenge to the research staff, who feel responsible for 
participant welfare as well as abiding to standard operating 
procedures. 
Invite your group to think about practical solutions to this 
dilemma. However, you could also extend the discussion to 
reflect on how you think research participants really view their 
involvement. It is clear that the research participant in this story 
sees the transport reimbursement as a direct benefit of 
participation. Normally she receives it as fixed amount which is 
the same as all other participants, regardless of where they live 
in relation to the clinic or how they travel there. She may have 
come to depend on this money for expenses like food. This 
time, however, her worsening condition means that the 
research team bring her to the clinic. Suddenly the transport 
reimbursement she has previously viewed as a direct cash 
benefit becomes money that has to be explicitly used for 
transport. 
For research participants living in challenging social and 
economic conditions, the relatively small amounts offered as 
LEARNING 
OBJECTIVE 
To reflect on the 
meaning and value 
of monetary 
payments in 
research among 
poor populations 
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Inducements 
Informed consent 
Personal morality 
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transport reimbursement are comparable to daily wages obtained through casual labour. 
Does this mean it equates to payment for participation? What are the implications of this in 
terms of informed consent? Does it really matter if potential participants conceive of this 
money as a direct benefit? Do you think that this could compromise the research? 
This case study touches on the differences between ‘rules’ and ‘practice’. You may want to 
take steps to avoid participants getting into any trouble later for views or experiences they 
describe, such as asking if the group is willing to maintain confidentiality after the session.
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WE DON’T PAY: 
‘BUS FARES’ AND OTHER GIFTS IN RESEARCH 
 
 
THE PARTICIPANTS HAD DIFFERENT IDEAS ABOUT WHAT TO DO WITH THEIR BUS FARE MONEY 
THE STORY 
argaretha is a middle-aged market trader who is participating in a diabetes trial, 
which aims to improve the management of her condition. She usually walks to the 
research clinic to attend her scheduled visits. One day, however, one of her legs is 
more painful than usual, so she contacts the research team and asks for the study vehicle to 
take her from the market to the research clinic. The research vehicle is not going in that 
direction, so a fieldworker accompanies her to the clinic by taxi.
After examining her and dressing a wound on her leg, the clinician gives Margaretha a follow-
up appointment for the next day, and arranges for her to be collected from the market. 
Margaretha then goes to the clinic secretary and asks for her usual ‘reimbursement’ 
(approximately US$4). The secretary, who has just paid for the taxi, tells her that because she 
was brought to the clinic by taxi she will not receive this reimbursement today. Margaretha is 
taken aback, and responds that in that case she does not want a taxi or project vehicle to 
collect her on the following day. Looking down at the dressing on her painful leg, Margaretha 
sighs and says, ‘Well, I will just have to walk.’
M
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After Margaretha has left the clinic, the secretary goes to see the study coordinator. Feeling 
bad about refusing the payment, she asks him what she should do. The study coordinator is 
equally bewildered. The rules concerning transport reimbursement are clear, and although 
everybody knows that most participants walk to the clinic, it also seems wrong to reimburse 
somebody whose transport has been paid for by the study. ‘But,’ says the secretary, ‘isn’t it 
wrong to make somebody with a poorly leg walk, especially when that person is your patient?’  
A young clinician passes by and throws in an ironic off-hand remark that: ‘She waited long 
enough here before being seen, so isn’t she entitled to be paid?’  
Upon hearing this, the study coordinator points out that, according to good clinical practice, 
payments are a form of coercion. ‘We can only reimburse participants for travel expenses, 
nothing else.’  
The coordinator telephones the expatriate study PI and she advises that since this is a one off, 
we should just be kind and pay. The secretary, thinking of her bookkeeping asks the 
coordinator: ‘So what shall I call that payment?’  
‘Transport reimbursement,’ responds her boss, smiling.  
QUESTIONS 
 What is Margaretha’s understanding of ‘transport reimbursement’? 
 What is the ethical basis of the secretary’s argument?  
 What do you make of all the other people’s views? What ethical beliefs do they 
express? 
 
 How is the disagreement resolved, and what role do professional hierarchies play in 
this? 
REFLECTION ON YOUR OWN EXPERIENCES 
 Can you think of situations in a professional research context, where terms like ‘transport 
reimbursement’ is used even though it ‘isn’t really like that’? 
 
 Can you find other examples, from your experience, where solutions had to be found in 
practice, rather than through rules? 
 
 Can you think of other situations where senior people resolve dilemmas faced by junior 
staff through executive decisions, rather than ‘by the book’? Who can and should take 
such decisions? What does this mean for more junior staff? 
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 What is your experience with modifying or infringing such rules, on a personal level and 
in relation to your professional responsibilities?  
 
 Can you think of similar situations from your experience – situations in which different 
positions and experiences, and different understandings of ethics and morality, 
appeared equally legitimate but hard to reconcile? How did you deal with them? 
Looking back now, what could you have done differently? 
 
ACTIVITY 
Split up into two groups, one group making an argument for reimbursing the participant and 
the other against. After presenting your opposing arguments to each other, try to find an 
appropriate solution that will work in practice. 
FURTHER READING
Grant, R.W. and Sugarman, J. (2004) Ethics in human subjects research: do incentives matter? 
Journal of Medicine and Philosophy 29(6), 717–738. 
Molyneux, S., Mulupi, S., Mbaabu, L., and Marsh, V. (2012) Benefits and payments for research 
participants: experiences and views from a research centre on the Kenyan coast. BMC 
Medical Ethics 2012 Jun 22, 13:13  
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YOUR FRIEND HAS 
NICE CLOTHES:  
CONFIDENTIALITY AND STAFF 
IDENTITY IN HIV HOME FOLLOW-UP 
FACILITATOR’S NOTES 
This case study is about challenges around confidentiality 
which can occur when following up with research 
participants. It talks about how fieldworkers introduce 
themselves, how they deal with underlying common 
assumptions and rumours about research, and how they 
develop relationships and express solidarity with study 
participants.  
When considering the fieldworker’s decision to hide her true 
identity, and the consequences of this or of telling the truth, 
participants in your group should consider how one’s identity 
as a research worker is associated with many different things: 
income, project resources, medical expertise, HIV, blood 
taking (and associated rumours), etc. Some of these could 
affect people’s responses to the fieldworker; others might 
have effects for the research participant and her relations. 
It also raises questions about how research resources are used, 
by comparing the amount spent on tracing a participant with 
how this money could have helped this participant meet her 
child’s basic needs. This question might seem pointless, since 
researchers cannot ignore their responsibility to follow up trial 
participants. But at the same time it is important to consider 
how money is spent in research, where savings could be 
made, and whether these could be directed into support 
funds for participants in need. This may help address some of 
the problems fieldworkers face in encountering participants in 
evident need.  
LEARNING 
OBJECTIVE 
To raise awareness 
of potential 
challenges – 
especially regarding 
confidentiality –
when conducting 
home visits with HIV 
positive participants, 
and to discuss the 
role and personal 
involvement of 
research staff in 
relation to 
participants 
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The main focus of this case study, however, is the relationship between fieldworkers and 
participants – specifically the different identities a fieldworker may adopt in order to establish 
contact, protect participants’ confidentiality, and ensure that they complete the study. It 
offers the opportunity to discuss these challenges with research staff, allowing them to voice 
similar problems they may face in their work. This could then lead to thinking about ways 
research staff can be better supported in carrying out their role.  
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YOUR FRIEND HAS NICE CLOTHES: 
CONFIDENTIALITY AND STAFF IDENTITY IN HIV HOME 
FOLLOW-UP 
 
 EVERYONE WAS WONDERING WHO WAS CARO’S SMARTLY DRESSED 'FRIEND' WITH THE BIG CAR… 
THE STORY 
aro is a young woman and mother, made homeless after her husband rejected her 
and their baby when he found out that she was HIV positive. Caro has nowhere to go 
and keeps moving, like many of her fellow research participants on a vaginal 
microbicide trial. She cannot afford to rent a place of her own; her parents do not want her to 
return home; and she is also not welcome in her younger sister’s marital home. For the time 
being, she rents a one-room semi-permanent house in a slum area and tries to set up a 
business selling snacks. Caro has not visited the research clinic for a while and her study visit is 
overdue. 
This is when Maureen gets on the case; her task is to follow-up on lost participants. Caro has no 
telephone so Maureen has spent two days tracking her through neighbours at her previous 
address. When asking about Caro’s whereabouts in a poor area, several young men start 
pestering Maureen, on account of her beautiful hair style and clothing. One of the neighbours 
asks her directly whether the girl she was looking for, Caro, had AIDS. 
C 
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Happy that she has come with the project Land Rover and the male driver, Maureen sets off 
towards the opposite side of town, where one of the neighbours claims that Caro lives now. 
After a lot of discussion, one of the neighbouring women agrees to travel with her and show 
her the place. When approaching this large and infamous slum, this lady tells Maureen they 
had better walk, as there is no road to the place. Reluctantly, the driver lets them go, but as 
they walk he tries to negotiate a way to stay nearby. 
The path is muddy and dirty, people look at her dress, and Maureen worries about her 
handbag. Her guide offers her a plastic bag to hide it from view. Finally they find the place, a 
small courtyard surrounded by single rooms, in front of each several people and children. 
Maureen introduces herself and her puzzled guide as Caro’s friends from Church fellowship, 
coming to pray together. Someone goes to fetch Caro from the shops, where she sells chips, 
but he returns without her, claiming that he did not find her. When Maureen wants to leave 
again, she finds the Land Rover in front of the compound. Driving off, she spots Caro on the 
street. They communicate silently with facial gestures and Maureen realises that Caro is afraid 
of all the questions her neighbours will have about Maureen’s presence here. 
In low voices, they talk through the car window. Maureen asks general questions about Caro’s 
health, but as Caro refuses to come with her, she cannot examine or weigh her, check her 
coital diary, or restock her microbicides to check treatment adherence. The forms she brought 
remain incomplete.  
The research team has spent about US$35 on petrol (apart from salaries and allowances for 
Maureen and the driver) – about the same as Caro’s profit from her chips business. In order to 
encourage Caro to come to the clinic, Maureen gives her money for the bus the next day. 
From her own pocket she adds some small banknote ‘for the children’. Caro hides both in her 
bra, conscious of the onlookers around her.  
QUESTIONS  
 Why is Maureen not introducing herself as a research worker on a microbicide study? 
Should she have done so? 
 
 If she told the truth, what might the implications be for herself, for the research 
participant, and for the research itself, in the short and long term? 
 
 What do you think the local people, the lady who helps Maureen, and Caro’s relatives 
think about who she is? 
 
 What are the advantages and disadvantages of full openness about one’s identity in 
the field? 
 
 What problems might arise from not revealing one’s true identity and purpose? 
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 What do you think about the use of money in the case study – the resources spent to 
track Caro, and the personal money that Maureen gives Caro? Is the former an 
appropriate use of resources, and what does the latter represent?  
 
REFLECTION ON YOUR OWN EXPERIENCES 
 In your own research setting, what are the guidelines for fieldworkers when moving 
around in the field or conducting home visits? Do you think these could be improved 
upon, and if so, how? 
 
 For your organization, how do local people unrelated to the research project respond 
to staff? 
FURTHER READING 
Kamuya, D., Marsh, V., and Molyneux, S. (2011) What we learned about voluntariness and 
consent: incorporating ‘background situations’ and understanding into analyses. The 
American Journal of Bioethics 11(8), 31-33. PubMed PMID: 21806436. 
Madiega, P.A., Jones, G. et al. (2013). ‘She's my sister-In-law, my visitor, my friend’ – challenges 
of staff identity in home follow-up in an HIV trial in Western Kenya. Developing World Bioethics 
13(1), 21–29. 
Simon, C. and Mosavel, M. (2010) Community members as recruiters of human subjects: 
ethical considerations. American Journal of Bioethics 10(3), 3–11.
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TRUTH AND LIES:  
DOING FIELDWORK IN YOUR OWN 
COMMUNITY 
FACILITATOR’S NOTES 
This case study urges us to think carefully about the nuances 
involved in working as a community-based fieldworker for a 
research organization. Local assistants are generally highly 
valued by research organizations because of their insider 
knowledge, cultural understanding and ability to help 
researchers gain access and build trust with community 
members. However, their position as community intermediaries 
requires them to negotiate complicated issues related to 
confidentiality and community expectations. In the story 
below a local fieldworker gains some information which could 
jeopardize a trial participant’s ongoing access to free care. 
Given her privileged understanding of the situation as a friend 
and neighbour, she is reluctant to expose the family in 
question.  
This is just one example of some of the dilemmas community-
based field assistants can experience as a result of their dual 
allegiance to their home communities and their employers. 
Another is spoken and unspoken expectations for material 
assistance (given their association with a ‘wealthy’ 
organization). An additional issue, although it is not really 
specifically touched on in the story, is that some community 
members may not feel able to share sensitive information with 
a fieldworker whom they know very well. For example, they 
may not want to tell someone who goes to the same church 
as them that their underage daughter is pregnant. It is 
important that these nuances are thought through carefully 
both to support fieldworkers and to ensure that research data 
is valid and research participants are protected.  
In this case, it would be good to get training participants to 
think about whether and how the trial participant’s life could 
LEARNING 
OBJECTIVE 
To consider the 
challenges and 
dilemmas 
community-based 
field assistants can 
experience as a 
result of their dual 
allegiance to their 
home communities 
and their employers, 
and discuss how 
these could be 
better addressed 
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have been saved. For example, if better follow-up referral processes were in place, would the 
child’s mother, the grandmother, and the fieldworker have been happier to inform the 
research study about the change in circumstances? In the absence of universal high 
standards of care, healthcare insurance, or other forms of financial support, there will not be 
any easy solutions to some of these dilemmas. However, we believe that it is important to bring 
these dilemmas into the open, in order to share experiences, offer support, and start thinking 
about how they could be addressed.  
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TRUTH AND LIES: 
DOING FIELDWORK IN YOUR OWN COMMUNITY 
 
AS SUSAN COMFORTED JUDY’S DAUGHTER SHE WONDERED IF SHE SHOULD HAVE ACTED DIFFERENTLY… 
THE STORY 
usan is a community fieldworker for a long-term demographic surveillance project. She 
works in the village where she has lived since she got married, and is employed on a 
casual basis to help the demographers keep track of births, deaths and migration. She is 
regarded as an expert on village relationships by the research organization and is employed 
for her detailed knowledge of these matters. There is another study ongoing in the area which 
provides a degree of free healthcare for its participants. It is related to, but not part of, the 
demographic surveillance project, and Susan does not work on it.  
Whilst on one of her regular walk-arounds of the village to check for new births and deaths, 
Susan meets an old friend, Judy. Judy used to work on the demographic surveillance with 
Susan a long time ago when the project was being set up. She has a daughter who has a 
tempestuous relationship with her husband and has been living with her for the last few years. 
Judy’s daughter has a young son who has been sickly from birth and has often benefited from 
the free treatment provided by the second study.  
Judy tells Susan that she is very worried about her daughter, because she has decided to 
move back to her husband’s home under pressure from her in-laws. The home is outside the 
S 
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catchment area of the study and this will mean that Judy’s grandson will no longer benefit 
from the free treatment.  
A few weeks later Susan is surprised to see Judy’s daughter and grandson at the local study 
hospital. Judy’s grandson is seriously ill and has been admitted, but there is some confusion 
about who will pay the bill. The researchers suspect that Judy’s daughter has left home. They 
ask Susan for confirmation. Susan knows that Judy and her daughter don’t have the resources 
to pay the bill and she is not 100 per cent sure that Judy’s daughter has really left home, given 
the tempestuous relationship she has with her husband. She tells the researchers she ‘thinks’ 
Judy’s daughter still resides in the village. Later, Susan talks to Judy about it and Judy tells her 
that she is just ‘keeping quiet’ when the researchers ask about changes in who lives in her 
home. After all, who knows how long her daughter will stay with her husband this time? 
Susan does not work on the free treatment study and is unsure what to do. Judy is a good 
friend and she is concerned she will lose her trust if she tells the researchers her daughter has 
moved out. Susan is also concerned about Judy’s grandson’s welfare. She knows Judy’s 
daughter’s husband and considers him a ‘bad’ man who will not look after them well. She 
decides to think about the issue for a while.  
A few weeks later Susan hears from Judy that her grandson is sick again, but that her son-in-
law is refusing to take him to the nearest hospital because he can get free treatment in the 
study hospital. But Judy’s daughter doesn’t have money to pay the fare to take him to her 
mother’s village. Judy asks Susan to lend her the money, which she does. But by this time, her 
grandson is dangerously dehydrated. He is admitted to the study hospital for over a week but 
sadly does not recover.  
Susan attends the funeral, which is held at Judy’s home. Judy’s daughter and her husband 
have separated for good this time.  
QUESTIONS 
 What are the challenges identified here, for both Susan and the study?  
 
 What do you think Susan could have done differently? Do you think the outcome would 
have been the same? 
 
 In these kinds of circumstances, what are the advantages and disadvantages of 
working in the place you live, from the worker’s and employer’s perspective? How 
about from the perspective of local people in the community – in what ways does it 
help, and in what ways does it get in the way to have your friends employed as 
fieldworkers? 
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 Do you think that Judy’s grandson should have remained eligible for study benefits 
even though he had moved out of catchment? Please explain your reasons either way.  
 
 Why do you think Judy asks Sarah to lend her some money? Could this have anything to 
do with her work, or is it just a neighbourly request?  
 
 What bigger issues shape this story? What are the background challenges which 
contribute to the death of the little boy? 
 
REFLECTION ON YOUR OWN EXPERIENCE: 
Have you experienced or witnessed similar scenarios in the course of your work? If yes, how did 
you, or others, manage these kinds of issues?  
FURTHER READING 
Chantler, T., Otewa, F. et al. (2013) Ethical challenges that arise at the community interface of 
health research: village reporters’ experiences in Western Kenya. Developing World Bioethics 
13(1), 30–37.  
Kamuya, D.M., Theobald, S.J. et al. (2013) Evolving friendships and shifting ethical dilemmas: 
fieldworkers’ experiences in a short term community based study in Kenya. Developing World 
Bioethics 13(1), 1–9.  
Simon, C. and Mosavel, M. (2010) Community members as recruiters of human subjects: 
ethical considerations. American Journal of Bioethics 10(3), 3–11. 
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I COULD BE A SEX 
WORKER:  
MEANINGS OF EXCLUSION AND 
INCLUSION CRITERIA TO 
PARTICIPANTS 
FACILITATOR’S NOTES 
Sometimes researchers complain about participants being 
dishonest or lying in order to ‘greedily’ get into trials, and 
participants’ motives are labelled as ‘good’ or ‘bad’. However, 
the poor quality of public healthcare available in some places 
and the wider context of global health inequality make it difficult 
to pass judgment on participants’ attempts to obtain treatment. 
Inclusion criteria for trials matter to researchers from the point of 
view of funding and scientific rigour, but for participants, they 
can be a matter of life or death. 
This case study asks training groups to put themselves in the 
shoes of a participant who is keen to get onto a project. 
Whatever their final verdict on her actions, hopefully discussing 
the case will help them to understand her. You may want to 
emphasize how confusing the various options for care might 
seem to participants, and how they often need to become 
adept at representing themselves and their condition in order to 
navigate this complex landscape. The story is about accessing 
post-trial care, but from a patient’s point of view, this is not 
particularly important. The same issues could arise around 
recruitment to a research project. 
The story also points towards several wider issues which your 
group may like to reflect upon: what is ‘fair’ in the context of 
global health inequality; specific cultural attitudes towards what 
counts as ‘sex work’; and the potential dynamics between 
researchers and study participants. 
LEARNING 
OBJECTIVE 
To reflect on 
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I COULD BE A SEX WORKER:  
MEANINGS OF EXCLUSION AND INCLUSION 
CRITERIA TO PARTICIPANTS 
 
 MAUREEN THOUGHT, 'OK, IF I GET MYSELF SOME TIGHTER CLOTHES I COULD BE A SEX WORKER...' 
THE STORY 
n this busy African city there are several large transnational medical research organizations, 
and many NGOs providing a range of care and treatment services for people living with 
HIV/AIDS. 
Maureen is an HIV positive woman who has just exited a research study looking at the 
progression of HIV and Hepatitis B co-infections. During her time in the study she received her 
HIV care and treatment at a study clinic. She felt she received excellent care, as well as 
having her transport to the clinic reimbursed. She also enjoyed being a member of an active 
self-help group, and attending several training sessions for which she received certificates. 
Before exiting the study Maureen and the other participants are advised to think carefully 
about where they would like to receive their care and treatment post-research. 
Maureen has done her research well on the options available to her. She has visited the 
various clinics and spoken to other research participants who have already exited the study. 
She decides that the best place for her is a clinic run by a Swedish organization which caters 
specifically for commercial sex workers. One of the friends she made during her time in the 
I
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study, a sex worker in a local bar, has told her that if she ‘gets a spot’ in the clinic she’ll 
continue to get her transport reimbursed, and that there may be employment opportunities 
there for her as a peer educator. The only problem is that Maureen has not considered herself 
to be a sex worker before now. She has had a number of boyfriends and concurrent 
relationships, but actual money has not changed hands. Her sex worker friend tells her this 
shouldn’t matter. She advises her to say that she is a sex worker with a number of ‘long-term 
clients’ or ‘sugar daddies’, rather than short-term engagements. She also tells her to say that 
one of her boyfriends (or ‘clients’) pays the monthly rent on her house. This, she advises, will 
help her qualify.  
Maureen goes for an interview at the sex workers’ clinic. She wears a little more make-up than 
usual and copies the dressing style of her friend. Her friend gives her a ‘peer referral’ to the 
clinic as well. Maureen is accepted at the clinic and also joins the self-help group. A few 
months later, Maureen applies for, and gets, one of the highly sought-after peer educator 
positions. Her certificates and training from the former study, as well as her ambition and 
commitment, have impressed the interviewers.  
 
QUESTIONS 
 
 What do you think about what Maureen does? Why does she do it? What do you think 
the consequences might be for Maureen, and for the organization? 
 
 Why do you think the Swedish organization is only open to ‘sex workers’? Do you think 
this is important from the point of view of people living with HIV/AIDS? 
 
 Do you think it is important to Maureen that the first organization she receives care from 
is a research project and the second an NGO? 
 
 Do you think Maureen will make a good HIV peer educator? 
 
 Can you think of anything that could help avoid this type of situation? 
 
 If you were a member of staff in the Swedish organization and you found out that 
Maureen does not think of herself as a sex worker, what would you do? 
 
 Is it always clear what ‘sex work’ is? 
 
 Is this situation also applicable to participation in research studies?  
 
 What do you think this story tells us about how the presence of overseas organizations 
may be interacting with local culture?  
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 What could you say about the wider issues behind this situation? Do you think the 
overseas organizations are doing a good job?  
 
 ‘Sex work’ suggests making a living from your body. Do you think this story can tell us 
anything about the interaction between medical organizations and research 
participants?  
 
REFLECTIONS ON YOUR OWN EXPERIENCE 
 Have you ever been in a situation like this where boundaries have been blurred (either 
as a member of staff, or changing the way you represent yourself to get something you 
need)? How did you approach the situation? What happened? 
 
 Have you experienced similar situations in recruiting research participants for studies?  
 
FURTHER READING 
Aellah, G. and Geissler, P.W (2016) Seeking exposure: conversions of scientific knowledge in an 
African City: The Journal of Modern African Studies 54(3) pp 389-417 
Geissler, P.W. (2013) Stuck in ruins, or up and coming? The shifting geography of urban public 
health research in Kisumu, Kenya. Africa: Journal of the International African Institute 83, 539–
560. 
Prince, R. (2012) HIV and the moral economy of survival in an East African city. Medical 
Anthropology Quarterly 26(4), 534–556. 
Simon, C. and Mosavel, M. (2010) Community members as recruiters of human subjects: 
ethical considerations. American Journal of Bioethics 10(3) 3–11. 
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THEY JUST COME AND 
ASK QUESTIONS:  
PARTICIPANTS’ UNDERSTANDINGS 
OF THE PURPOSE OF RESEARCH 
FACILITATOR’S NOTES 
This case study invites us to consider challenges which can 
arise from the involvement of households in long-term 
demographic surveillance systems. Such systems represent an 
invaluable resource for researchers conducting studies which 
aim to assess the effectiveness of new healthcare 
interventions. In the long term, this research may also have 
direct benefits for household members who provide 
demographic information. However, the value of this research 
can seem less evident to them in the short term, and, as we 
read in this story, some of the questions which are asked as 
part of surveillance activities can give rise to misplaced hopes 
or expectations for material help.  
The aim of the story is to serve as a catalyst for discussions 
about consent processes in this type of research, and ways of 
addressing misunderstandings about the purpose of 
demographic surveillance. In terms of consent, it is important 
to think about the way households are organized with 
reference to cultural norms. In the rural community portrayed 
here it is usual for newly married women to live with their 
husbands in a larger compound, which can include several 
houses. The owner of the compound is the father-in-law, and 
so he is the decision-maker when it comes to who is welcome 
in the compound. He must consent for the fieldworkers to visit 
his compound before any of the other compound members 
are approached. However, given the long-term nature of the 
demographic surveillance activities a case could be made for 
renewing this consent on an annual basis.  
LEARNING 
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In addition, there is a need to ensure that all household members are given information about 
the purpose of collecting demographic data and any possible benefits. Encourage your 
training participants to think about ways this could be achieved, and how they would explain 
the purpose of the demographic surveillance system and the reasons for including questions 
about household assets. You could also ask participants to consider why community members 
may find it difficult to distinguish between research and development organizations, and how 
this misconception could be addressed. If you are based at a research centre which is 
involved in demographic surveillance, try to find out more about how this works before the 
session. It would also be a good idea to review the types of questions asked during fieldwork, 
and to think about how these might be viewed by community members.  
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THEY JUST COME AND ASK 
QUESTIONS:  
PARTICIPANTS’ UNDERSTANDINGS OF THE PURPOSE 
OF RESEARCH 
 
 
'MY HUT IS GOING TO BE AMAZING!' THOUGHT JESSIE. 'I WONDER WHEN HE’LL BRING ALL THESE NEW THINGS?' 
THE STORY 
 demographic surveillance system has been functioning in a rural area for many years. 
Every three months, fieldworkers visit homes and compounds in the area and ask 
household members about who has moved in and out, and whether there have been 
any births or deaths. Sometimes they ask about possessions owned by household members 
including bicycles, cows, televisions and thermos flasks. The homes were originally included 
into the system after consent had been obtained from the head of each household, who 
provided permission on behalf of all the other household members. Many years on the 
community has become very used to both the fieldworkers and the questions.  
A
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Jessie recently moved into the area after marrying the son of one of the household heads. The 
next time the fieldworker visits, Jessie is the only person at home. The fieldworker, Jim, arrives by 
bicycle. This is the 15th household he has visited today and he has many more to visit. Jim 
introduces himself briefly and starts asking Jessie his questions on behalf of the whole 
household. Jessie’s husband told her something like this would happen so she is not surprised. 
When Jim starts asking her about number of bicycles they have, she answers none, although 
this isn’t true. She does not show it, but in her heart she is quite excited. She thinks that perhaps 
this is a non-governmental organization doing a survey of things that are needed in their 
household, and hopes they might bring them next time. She has heard that there are lots of 
NGOs operating in this area.  
When Jessie’s husband gets home she tells him all about it. He tells her, no, they never bring 
those things. ‘Oh,’ says Jessie, ‘then why are they asking the questions?’  
‘Hmm,’ says her husband. ‘I’m not sure.’ 
QUESTIONS  
 Why do you think the head of the household was the one who was asked to provide 
consent on behalf of all the residents? 
 
 Why do you think Jessie kept quiet, even if she was excited?  
 
 Why do you think Jim did not explain the purpose of the research to her?  
 
 Why do you think Jessie thought the fieldworker might come back with some things for 
the home?  
 
 What does all this tell us about how participants and researchers view each other, even 
though it is not really discussed? 
 
 Why do you think Jessie’s husband could not answer her questions? What does this tell 
us about the ethical position of the project? 
 
 What do you think the consequences of this misunderstanding could be? Is it a big 
deal? 
 
 How well could you answer Jessie’s question?  
 
 Do you think it is possible or desirable to keep re-consenting? What are some of the 
drawbacks?  
 
 What strategies could be put in place to help this situation?  
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REFLECTION ON YOUR OWN EXPERIENCES 
 What other situations does this remind you of? 
 
 Is this different from therapeutic misconception? What are the similarities and 
differences? 
 
 This case study shows that it is important to understand local structures of authority, 
respect and consenting when doing research, but that this can also be challenging for 
achieving individual consent and understanding. What other examples of this do you 
have from your own work?  
FURTHER READING 
Carrel, M. and Rennie, S. (2008) Demographic and health surveillance: longitudinal ethical 
considerations. Bulletin of the World Health Organization 86(8), 612–616.  
Mondain, N. (2010) Exploring respondents’ understanding and perceptions of demographic 
surveillance systems in Western Africa: methodological and ethical issues. African Population 
Studies 24(3), 149–165. 
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RESPONSIBILITY FOR 
WHAT AND WHOM?:  
END-OF-TRIAL AND LONG-TERM 
HEALTHCARE 
FACILITATOR’S NOTES 
This case study is about researchers’ responsibilities towards 
study participants beyond the end of a trial. Three main issues 
are likely to arise in discussions: researchers’ general 
responsibility for follow-up after the end of trial; their 
responsibility for follow-up when access to appropriate 
treatment is poor in the public health system; and the legal 
and ethical responsibility of both researchers and their 
sponsors to follow up participants whose health is placed at 
risk as a result of the trial. Before you use this case study you 
may want to check up on the legal requirements for research 
in your setting, and think about how these are applied in the 
studies conducted at your site.  
In the questions at the end of this case study, certain terms are 
used which you might need to unpack for your students. 
‘Legal liability’ would mean researchers’ responsibility for any 
negative effects of the trial, which can be proven formally to 
arise directly from patients’ participation. Both ‘personal’ and 
‘institutional’ responsibility can be linked to legal liability 
(national or international), but can also be thought of as being 
independent of direct causation. They arise through long-term 
engagement with the participants, and are also influenced by 
the availability of resources that could help in a specific 
situation.  
‘Feasibility’, ‘justice’ and ‘equity’, on the other hand, are 
‘macro’ concepts which require students to consider the 
wider context of the research. Exploring these ideals might 
lead students to suggest that, given how much it would cost to 
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OBJECTIVE 
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follow-up all participants in the trial, these resources would be better used for wider public 
health aims, benefiting a larger population. This case study then points to a discussion about 
the role of rich international research organizations within poor countries, and the relationship 
between scientific and political engagement. 
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RESPONSIBILITY FOR WHAT AND 
WHOM?:  
END-OF-TRIAL AND LONG-TERM HEALTHCARE 
 
 ‘SO….YOUR RESEARCH PROJECT WANTS ME TO DO WHAT?!’ 
THE STORY 
 trial of a new drug regime for the treatment of Hepatitis B enrols men and women with 
chronic infections. The drugs are tested and approved internationally, but are not 
usually given as routine treatment in this African country due to their cost and the 
unreliability of supplies. In the study, the drugs are given for one year. Participants are then 
‘exited’ from the research and referred to local hospitals for continued monitoring.  
When they are referred on, participants are given a letter containing information on their 
health status and recommendations on how their infections should be monitored. The letters 
all state that it would be good for the participants to be kept on the trial drug regime for 
longer, if local resources allow. Aware that this may be difficult, the researchers make 
recommendations about carefully considered alternative treatments, and provide a contact 
number for the new doctors to call to discuss this further. Researchers advise the participants 
to try to find treatment at a larger hospital in the nearby city, which has specialist Hepatitis B 
care and good links with the research organization.  
A
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However, many of the participants prefer to seek treatment in the small clinics near their home 
villages, due to transport costs and their familiarity with the staff. Now that they are no longer 
receiving transport allowances through the study, many participants cannot afford a long trip. 
When the participants take their letters to the smaller clinics, some of the resident clinical 
officers there are unable to interpret the information. Some of the clinicians admit this, but 
others tell the ex-participants that they are unhappy at ‘being told what to do’ by foreign 
scientists ‘who don’t know this place’. Sometimes the clinicians at the small centres contact 
the trial clinicians and are given further advice. One of them even uses the opportunity to visit 
the research centre to update his knowledge. 
Hepatitis B care is still under development in this region and not all clinics have access to the 
latest drugs and tests. Although, officially, relevant drugs should be available in local clinics, 
this is not usually the case. A widely publicized report by an international NGO draws attention 
to this problem. Some of the ex-participants’ cases are then resolved through personal 
interventions by the research clinicians, who know whom to call at the national drug 
procurement programme to get them to send adequate supplies to a particular centre. 
The researchers soon realize that it would be good to continue to monitor what happens to 
the trial participants over the coming years, and they apply for funding from their organization 
to help them maintain contact. They start to find that a few of the participants have 
developed resistance to the drugs, and theorize this is because of the interruption in their 
treatment when they leave the study. 
However, finding all the participants after the end of the trial and communicating with them is 
not always easy or cheap. Most of them have had only primary school education, sometimes 
unfinished; some of them are single mothers; hardly any has regular work or employment; few 
have a permanent residence. As a result of economic and social insecurity, many move 
between different urban locations, their parents’ and other relatives’ rural homes, or their 
marital homes. Such moves either require regular transport back to their local clinic, which few 
can afford, or transfer the patients from one clinic to another, requiring lots of paperwork, the 
involvement of new doctors, and time lost in trial periods. 
The case of these participants creates debates among doctors, scientists and managers 
involved in the trial. Some feel that the study should have continued to provide drugs directly 
to the smaller centres for those participants whom they felt would benefit. Others argue that 
the participants’ Hepatitis B infections will not be properly monitored in the smaller clinics. 
Many of the researchers feel concerned about the fate of the participants they have become 
close to over the course of the trial. 
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QUESTIONS 
 If you were a researcher on this study, how do you think you would feel? Do you think 
your feelings should be reflected in the policy of the organization? 
 
 What role do each of the issues below play in this case? Who is responsible for 
implementing each of them? 
 
1. Legal-medical liability (under local or international law)  
2. Personal and institutional responsibility and morality 
3. Concerns with feasibility and equity 
 
 What would post-trial plans look like if the researchers prioritized: 
 
1. Obligations/responsibilities on the individual level? 
2. Justice/feasibility, for everybody or at the population level? 
3. Liability, legal obligation, or economic risk at the managerial level? 
 
 What different perspectives do you think different people might have on this issue? You 
might want to consider the possible views of participants, workers in the local 
healthcare facilities, people working at the national drug procurement programme, 
research fieldworkers/nurses, study coordinators, scientists, funding bodies, and in-
country government officials (local and national)? 
 
 Do you think calls for the highest possible standards of care and continued responsibility 
are justified? What is the impact of such demands on individual research projects?  
REFLECTION ON YOUR OWN EXPERIENCES 
 What happens to research participants in your work when they leave a study and are 
referred to public hospitals? What has this meant for you, personally? 
 
 What limitations are implied by your organization about its responsibility for further care? 
 
 What do you think your organization could do to support local healthcare? For 
example, does it provide clear and up-to-date information on drugs and future 
treatment options available? Does it engage with the practicalities of this – how much it 
might cost, and how it might support local clinics to follow the recommendations? 
FURTHER READING 
de Cenival, M. (2008) L'éthique de la recherche ou la liberté d'en sortir [Ethics of research : the 
freedom to withdraw].  Bulletin of the Exotic Pathology Society 101(2), 98–101. 
Shaffer, D. N. et al. (2006) Equitable treatment for HIV/AIDS clinical trial participants: A focus 
group study of patients, clinician researchers, and administrators in Western Kenya. Journal of 
Medical Ethics 32.1: 55–60. 
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HUNGER IS NOT OUR 
MANDATE: 
DEALING WITH POVERTY AMONG 
RESEARCH PARTICIPANTS 
FACILITATOR’S NOTES 
This story is about how far people conducting scientific 
research among poor populations decide whether to allow 
poverty – and more specifically hunger – to come under the 
remit of their activities. Here, in a research project involving 
children and their parents from a poor area, participants and 
staff do not talk about the fact that many of the children are 
hungry, and many of the parents worry about not finding food 
for them. The absence of discussion about the subject is striking 
because the subject of the research is nutrition and weight.  
The story sheds light on a question that appears in many similar 
situations: how can one, as a research worker, relate to the 
poverty of the people one meets through research? While the 
researchers here are clearly concerned about nutrition – it is 
the rationale for their research – it is harder to consider how this 
affects them personally. The question is what responsibilities 
arise from the encounter between relatively privileged 
researchers, and research participants with essential needs?  
Various questions may emerge. Does economic inequality 
have anything to do with the research? Or is it a private 
matter, separate from science? If so, how do researchers 
reconcile private experiences and responsibilities with their 
professional roles? How does this sit with ethics rules about non-
inducement, and scientific standards of objective research? 
Or should research take on a wider responsibility when 
engaging people who lack essentials such as food or 
medicine? If so, how, and funded by whom? What are the 
limits to this responsibility? Who decides, and how? 
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HUNGER IS NOT OUR MANDATE: 
DEALING WITH POVERTY AMONG RESEARCH 
PARTICIPANTS 
 
'NO. TODAY WE DID NOT EAT ICE-CREAM.' 
THE STORY 
or a study on gastrointestinal infections and weight gain, primary school children from an 
urban slum are recruited and asked to visit a clinic regularly with their caregivers. They 
are also invited to visit the clinic in the case of any illness and provided with free 
treatment. Apart from this, staff are cautioned by supervisors not to provide any ‘material 
incentives’ to research participants, because such gestures could potentially infringe ethical 
regulations. 
Part of the regular appointments is a ‘food frequency’ questionnaire, filled out after weighing 
the children and taking measurements. The questionnaire asks how regularly and in which 
quantities the children eat particular foods. The five-page list of foods is taken from a standard 
nutritional assessment tool, and ranges from maize to ice-cream, from cabbage to yoghurt. 
The survey is completed by a ‘24-hour recall diet’ recording, which asks children about the 
food and drink they have consumed in the past day. It assumes children have had three 
F
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regular meals and up to four intermediate snacks. Although the children are supposed to 
answer the questions, the accompanying caregivers usually help with the task. 
When answering the questionnaire, the children occasionally ask questions about foods 
mentioned in the questionnaire which they don’t know. Otherwise, they do their best to 
answer all the questions put to them by the nutritional counsellor truthfully. They do not 
mention the obvious difference between the range of foods mentioned in the questions 
(which are sometimes expensive), or the way the questionnaire assumes they have regular 
meals (plus snacks!), and their own everyday realities. Their answers usually include very few 
basic foods, and frequently skipped meals.  
However, while the participants are waiting outside for their appointments, unattended by 
staff, they speak with each other about this. Sometimes they joke about the questions the 
counsellors ask, which are so far from their lived realities: ‘How can she ask me whether I eat 
ice cream and bread?!’ 
This gap is not addressed by the research staff either, although from the regular home visits 
and from simply living in the same city they are familiar with slum residents’ economic situation. 
Sometimes, when talking privately and among trusted colleagues, they express sympathy with 
participants’ misery, and they commonly give small amounts of their own money or bring food 
or old clothes on home visits for participants who are obviously needy.  
One word in particular that does not appear anywhere in the questionnaire is ‘hunger’. Only 
very rarely, one of the children’s parents mentions that finding the means to feed children is a 
challenge, and asks for support. Usually this happens not in the clinic but during home visits, 
when staff and participants establish more personal relationships. (The children’s parents are, 
of course, aware that the staff earn good salaries.) Staff never discuss participants’ requests, 
nor their own responses, in formal meetings, or when talking to their supervisors. 
When asked why hunger is nowhere on the questionnaire, the clinic staff are quick to point out 
that ‘this would be embarrassing for the women’. The Principal Investigator of a breastfeeding 
study which is taking place in the same area, however, answers more fully: ‘Hunger is a 
background reality for everybody here; poverty forms the backdrop of all our research here. 
But it is outside the remit of the research project. Hunger is a matter of development aid 
programmes, and not of scientific institutions; it is not our mandate. I cannot fund measures 
against hunger through my research budget.’  
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QUESTIONS  
 Why is the participants’ hunger not directly spoken about in the meetings at the clinic 
between staff and participants? Why can it be discussed when research staff visit 
participants, or when either participants or research staff are ‘among themselves’? 
 
 Why did the supervisor advise research staff not to give participants food or money? 
Discuss the various possible consequences of doing this. Do you think it worth the risk? 
 
 If hunger were mentioned more explicitly, who would be embarrassed and why?  
 
 The overseas Principal Investigator gives different reasons from the clinic staff about why 
hunger is not mentioned. What do you think of her explanation? Do you think she cares 
about people on the project? From what she says, what can we understand about her 
beliefs and culture?  
 
 What do you think about the fact that it is local staff who end up paying money and 
giving clothes to the participants, not the project itself or the overseas staff? In what 
ways is this fair or right, and in what ways not? 
 
 What do you think are the potential advantages and disadvantages of talking more 
about hunger and poverty? 
 
 What else could this research organization do to support its staff?  
REFLECTION ON YOUR OWN EXPERIENCES 
 How is poverty, especially that of research participants, discussed in your research 
setting? 
 
 When are words like ‘poverty’ or ‘hunger’ – terms that describe gross inequalities or 
actual economic misery – used in your research setting? How do they feature in 
publications and minutes of research meetings? What does this tell us? 
 
 When, and with whom, can one talk about these issues in your organization, and with 
whom would one avoid these subjects? Why? 
 
 Are there subjects which people (at any level) joke about in your organization, but 
which aren’t mentioned in other places? Do you think anything could or should be 
done about these issues?  
FURTHER READING 
Kalofonos, I.A. (2010) ‘All I eat is ARVs’: the paradox of AIDS treatment interventions in Central 
Mozambique. Medical Anthropology Quarterly 24(3), 363–380. 
Prince, R. (2012) HIV and the moral economy of survival in an East African city. Medical 
Anthropology Quarterly 26(4), 534–556. 
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THEY JUST WANT TO 
SIGN QUICKLY:  
DIFFERENT INTERPRETATIONS OF 
INFORMED CONSENT 
FACILITATOR’S NOTES 
This case study is about different understandings of the 
informed consent process and the documents associated with 
it. Here, four different approaches to informed consent within 
a study open up multiple overlapping interpretations of what it 
may mean.  
You can use this case study as a springboard for discussion, 
looking at who holds each view – participants, fieldworkers, 
research designers, external commentators, etc. Each of these 
‘groups’ is not necessarily a single unit; people within them 
may hold multiple overlapping or conflicting perspectives. In 
trying to unpick these interpretations, you may need to 
encourage your group to look at all of them as equally valid, 
rather than factually ‘correct’ or ‘wrong’. A medical-legal 
model of consent, or a scientific one, after all, is just another 
cultural view. 
Some of the understandings described here may include 
viewing the consent process and documents as: 
o An entry-point to cash and healthcare benefits 
o A way to address social injustice  
o A way to avoid unethical and abusive practices 
o An agreement between researchers and study 
participants, involving mutual obligations and 
entitlements 
o An absolute principle which, once included in any form, 
guarantees sound scientific data 
o A starting-point for interpretation about what is ‘fair’ 
LEARNING 
OBJECTIVE 
To understand 
different 
interpretations of the 
informed consent 
process among 
researchers, social 
scientists, and 
participants, and to 
reflect on how to 
deal with 
withdrawals, silent 
refusals, and 
avoidance ethically 
 
 
 
 
 
 
KEYWORDS 
Inducements 
Informed consent 
Documents 
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o A way of recognising the autonomy of individuals to make decisions  
o A highly social practice, in which powerful authorities recruit newcomers into the 
project via a ritual induction ceremony 
o A document conveying status and prestige 
Before using this case study, think carefully about how it relates to current views and practice 
in your organization, how it might challenge them, and how to protect those taking part in 
your discussion. You may want to take steps such as asking if the group wants to declare the 
meeting a confidential and ‘safe’ space to discuss this important principle. 
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THEY JUST WANT TO SIGN QUICKLY:  
DIFFERENT INTERPRETATIONS OF INFORMED 
CONSENT 
 
THE PARTICIPANTS FOUND EVERYTHING ELSE MORE INTERESTING THAN THE CONSENT FORMS. 
THE STORIES 
OLUNTARY OR INDUCED CONSENT?  
Guideline 7 of the Council for International Organizations of Medical Sciences (CIOMS) 
states that ‘Subjects may be reimbursed for lost earnings, travel costs and other 
expenses incurred in taking part in a study; they may also receive free medical services […] 
The payments should not be so large, however, or the medical services so extensive as to 
induce prospective subjects to consent to participate in the research against their better 
judgment (“undue inducement”).’  
A three-year sexual health research project involving 1000 participants is taking place in a city 
slum in Chad. All participants must sign a consent form on enrolment to the study. The consent 
form states that: ‘Medical care for common medical problems will be given to you and your 
immediate family at the study clinic at no cost while you are in the study’. Later on in the 
consent form it states: ‘Participation in this study is voluntary. You are not obliged to 
participate in this study, and even if you agree to participate today, you can change your 
mind later. If you do so, you will not have disadvantage from this.’ 
V
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CONSENT AS DOCUMENT OR RITUAL?  
Fieldworkers from the city slum project feel that the research participants ‘do not take consent 
seriously at all’. They report that during the study’s ‘information and consent’ sessions, people 
appear bored when the forms are read out to them; others glance at them but do not seem 
to pay much attention when doing so. Fieldworkers comment that ‘most of them just want to 
sign the papers quickly and proceed to the clinic’. 
Concerned by this trend, the trial managers ask a social scientist to investigate participants’ 
perspectives on informed consent. The social scientist is somewhat puzzled to find that while 
participants do indeed appear unconcerned with the information provided in the consent 
process, many of them keep their signed consent forms for a long time, even beyond the end 
of the trial. They store them with other legal documents, contracts and certificates. One 
person even framed her consent form and hung it on the wall in her living room. 
WITHDRAWING CONSENT – PRINCIPLE VERSUS PRACTICE 
The commentary to CIOMS Guideline 7 guideline states, under ‘Withdrawal from a study’, that 
‘A subject who withdraws from research for reasons related to the study, such as 
unacceptable side effects of a study drug, or who is withdrawn on health grounds, should be 
paid or recompensed as if full participation had taken place. A subject who withdraws for any 
other reason should be paid in proportion to the amount of participation. An investigator who 
must remove a subject from the study for willful noncompliance is entitled to withhold part or 
all of the payment.’ 
Under a section on ‘Withdrawing from the Study,’ the consent form for the city slum project 
states that ‘If you withdraw later, you will not suffer any negative consequences’. 
As part of this study, as well as routinely taking blood for testing, frequent penile swabs are 
taken from male participants. Many of the men find the experience uncomfortable and 
embarrassing. Once these start, numerous participants who have signed consent forms deny 
field staff access to their homes, or do not show up for their scheduled monthly clinic visits. But 
a minority of these people continue to seek care and medication from the trial clinic at times 
of illness. Others still bring their children to the clinic, although they themselves are not 
complying with study procedures. 
The wave of non-compliance and withdrawal threatens the validity of the overall study, and 
leads to discussions among trial managers, scientists and staff about possible solutions. One 
nurse reports that, in a different study, he refused to provide care to families of participants 
who had withdrawn or were no longer complying. Some of his colleagues wonder whether this 
is right. ‘Is it really the children’s fault if the father refuses? Shouldn’t we continue to provide 
treatment for the children at least?’ The study coordinator interjects: ‘I can see your point, but 
if we provided treatment for everybody, even if they refused the swabs, then who would 
choose to participate in the trial?’ 
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The discussion soon moves on to possible solutions. So few of the participants are actually 
returning to the trial clinic after their first swab that the study staff decide that free healthcare 
is no longer going to work as an incentive for people to take part.  
 
CONSENT AS EXCHANGE?  
The social scientist involved in the city slum project visits some of non-compliant participants at 
home, to ask why they have not been attending scheduled visits. She visits the home of a 
participant who has not brought any family members to the clinic for routine treatment either. 
When she asks why the family no longer access the clinic’s superior healthcare services, the 
participant’s wife replies: ‘How can you break an agreement and yet you want to continue to 
be paid? Can you offend your host and still want to eat his food? If you are part of research, 
you have to give your blood.’ 
QUESTIONS  
 Why do you think people appear bored when signing the consent form? 
  
 Who do you think is not taking consent seriously?  
 
 What do you think the meaning of signatures on contracts might be in a community 
where many people can’t read? Why do you think study participants keep their 
consent forms? 
 
 The study design suggests that consent is something freely given by an empowered 
person. Do you think this is how everyone on the project views it? What other views are 
there? 
 
 What different understandings are present among research staff and trial participants, 
and in the guidelines and the consent form, about trial-related healthcare provision?  
 
 Do you think trial-related healthcare is ‘undue inducement’? 
 
 What would you do if you were the staff, deciding whether to provide healthcare to 
non-compliant participants and their families? Why? 
 
 Who do you think should interpret how much people should be ‘paid’ who withdraw? 
How might this work if there is no money, just trial-related healthcare? 
 
 What might you do differently if you were working on this project, to minimize the 
problems of withdrawal? 
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REFLECTION ON YOUR OWN EXPERIENCES 
 What is the practice where you work concerning non-compliant participants or 
withdrawals: do they receive continued free healthcare? Are there other benefits that 
they continue or do not continue to access? 
 
 Have the reasons for this ever been discussed on your project? If not, why do you think 
that such debates do not commonly take place? 
 
 How ‘free’ do you think participants are in medical research projects which target poor 
populations? In what ways do you think people express any freedom? 
ACTIVITY 
Form two groups. One prepares arguments in favour of continued care for non-compliant 
participants; the other assembles arguments for discontinuation of care. Make sure you 
include both practical arguments as well as ethical considerations. 
FURTHER READING 
Council for International Organizations of Medical Sciences (2002) CIOMS Guidelines. 
Available at: http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm  
(accessed 25 October 2015). 
Leach, M. and Fairhead, J. (2011) Being 'with Medical Research Council': infant care and the 
social meanings of cohort membership in Gambia's plural therapeutic landscapes. In: Geissler, 
W. and Molyneaux, C. (eds.) Evidence, Ethos and Experiment: The Anthropology and History of 
Medical Research in Africa. Berghahn Books, Oxford, UK, pp. 77–98. 
Molyneux, C. S., Peshu, N. et al. (2004) Understanding of informed consent in a low-income 
setting: three case studies from the Kenyan coast. Social Science & Medicine 59(12), 2547–
2559. 
O’Neill, O. (2003) Some limits of informed consent. Journal of Medical Ethics 29, 4–7.  
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MARTHA’S DILEMMA:  
FOREIGN MEDICAL RESEARCH AS 
PUBLIC GOOD OR EXPLOITATION? 
 
FACILITATOR’S NOTES 
This story focuses on how medical research organizations may 
work to improve life and health in the future, but on the path 
towards realising this, they may not be contributing very much 
to people’s lives and health in the here and now. This story asks 
you to put yourselves in the shoes of a research participant 
and consider her viewpoint. Even though participants in 
research projects may benefit from better care than in the 
public health system, this is only temporary and can create its 
own problems. Research organizations may be seen as both 
contributing to the public good, and at the same time building 
their privileged position on the very inequalities that they claim 
to alleviate.  This case study aims to open up discussion on 
both the ethical and practical aspects of this paradox.
LEARNING 
OBJECTIVE 
To recognise how 
and why 
participants may 
feel conflicted 
about the value of 
foreign-funded 
medical research, 
and that these 
differing views can 
co-exist and create 
dilemmas. 
 
 
 
 
KEYWORDS 
Inducements 
Standards of care 
Poverty 
North-South 
relationships 
Long-term 
engagement 
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MARTHA’S DILEMMA:  
FOREIGN MEDICAL RESEARCH AS PUBLIC GOOD 
OR EXPLOITATION? 
 
 
 A RESEARCH CLASS SYSTEM 
THE STORY 
artha is a well-educated woman in her early thirties. Some years back she had a 
formal job, but lost it because her company went bankrupt. Since then she has tried 
to run a small business as well as volunteering at a public health clinic, where she is 
much appreciated because of her skills and enthusiasm. 
When pregnant with her third child, Martha gets involved with an internationally funded 
medical research project, which focuses on preventing mother-to-child HIV transmission via 
breastfeeding. This is not an easy decision for her. She thinks to herself: ‘I don’t like these 
researchers. Why are they testing us? Why aren’t they doing it in their country? Is it because 
we are poor, or what?’ She finds it hard to trust the motivations of the researchers. 
At the same time, she understands that she will get first-rate care and advice regarding her 
child and her own health as long as she is involved with the project, which she would 
M
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otherwise not be able to afford. She joins the research, and appreciates the knowledge she 
gains and the care that she and her infant receive.  
After the project ends, Martha receives ongoing care at a public health clinic. Although she is 
always treated with respect at this free clinic, there are obvious differences between the 
resources available here and at the research project. She is quite upset about this difference. 
‘How can the researchers just come here and use us just because we are poor?’ she thinks. 
‘It’s an insult how their Principal Investigators get promotions because of us. They should not 
get an advantage out of our poverty. They are even contributing to it by giving us a little 
something in transport reimbursement, just to keep us quiet. They probably say behind our 
backs, “Africans are weak, just give them a bit of money and they’ll do whatever you want.” I 
don’t know how the government permits them to come and do this work!’ 
Martha is unsure about whether to join the next research project when it opens for recruitment. 
She knows that certain research projects have to be carried out in Africa, because the 
particular conditions that the research aims to tackle are comparatively rare in Europe and 
the United States. Still, she finds it very odd that foreign-funded research organizations operate 
as almost independent entities in the overall healthcare system. She also feels that, although 
the medicines and treatments on trial are meant to benefit people like herself in the future, 
rich research organizations recruiting poor local people should do something further to 
improve their situation right away. 
QUESTIONS  
 Can you summarize Martha’s ideas about foreign-funded medical research? What are 
the questions that are most important to her?  
 
 What ideals do Martha’s concerns express? Are these reasonable? 
 
 Try listing the factors that would make Martha feel better about participating in the 
research. If Martha could see into the future, what would she hope to see coming out 
of the project?  
 
 How about you? How much do you think research organizations should worry about 
improving people’s lives and health here and now, as they carry out their exploration of 
how to improve the future?  
 
 What about the past? What role do you think it plays when people are trying to 
understand present-day research? 
 
 What practical problems might arise for the project, if concerns like Martha’s are not 
addressed? 
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 Can you think of realistic ways in which a research project could try to draw links 
between present work, and the way it will be remembered in the future? 
REFLECTION ON YOUR OWN EXPERIENCES 
 Have you come across similar conflicting views of foreign-funded medical research? If 
so, how has your organization responded? 
ACTIVITY 
Split into groups of four to six people, depending on the size of your workshop, and discuss one 
of Martha’s main areas of concern. Try to decide who is responsible for the problem, how it 
could be addressed, and how you could judge the outcome.  
FURTHER READING 
Crane, J.T. (2013) Scrambling for Africa: AIDS, expertise, and the rise of American global health 
science. Cornell University Press, Ithaca, New York. 
Kingori, P. (2015) The ‘empty choice’: A sociological examination of choosing medical 
research participation in resource-limited sub-Saharan Africa. Current Sociology 63(5), 763–
778. 
Petryna, A. (2007) Clinical trials offshored: on private sector science and public 
health. BioSocieties 2(1), 21–40. 
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ROUTINE HEALTHCARE: 
WHOSE OBLIGATION? 
FACILITATOR’S NOTES 
Clinical trials often provide free basic medical care for their 
participants. This is considered a benefit of participation, but 
also enables researchers to get the best possible data for their 
research. This story asks researchers to think about the full 
implications of providing ‘routine’ medical care for their 
participants. What are the limits of this provision? What do you 
do when the study can’t, or won’t, provide treatment for 
certain conditions, and your participants are unable to access 
it for themselves? Whose concern is the general health of 
research participants?  
The story asks students to brainstorm best practice solutions to 
these kinds of situation. But it also invites them to think more 
widely and deeply about the underlying structures that create 
them. For example, one of the nurses in this story suggests that 
a participant is vulnerable, and thus unable to give reasonably 
informed consent, due to his poverty as well as his condition. 
Yet if this were true, who would be eligible to participate? 
Some critics do, in fact, argue that medical research is not 
ethical when it provides facilities that the national healthcare 
system does not. What does your group think about this?  
In your discussion, you may want to ensure that you both 
touch on this wider debate, and also consider the elements of 
this specific case which make it difficult for the doctor in the 
story. Stigma and personal relationships also play a role. What 
similar experiences have your students had with research 
participants? How do their organizations support them through 
these dilemmas, or what solutions have they found? 
 
 
LEARNING 
OBJECTIVE 
To discuss best 
practice when 
providing routine 
medical care for trial 
participants, and to 
consider the limits of 
‘informed’ consent 
 
 
 
 
 
 
 
 
 
KEYWORDS 
Research versus 
care 
 
Poverty 
 
Standards of care 
 
Clinical responsibility 
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ROUTINE HEALTHCARE: 
WHOSE OBLIGATION? 
 
 ‘WHAT CAN WE DO ABOUT THIS "AFFLICTION OF THE MOON"?' 
THE STORY 
wosa, a cook, decides to participate in a meningitis-related clinical trial, and is 
screened and enroled in it. He is required to live in the study area for two years, to 
follow a number of strict study procedures, and to make frequent visits to the clinic. 
Nwosa proves himself to be a very diligent participant. He always attends scheduled visits, and 
turns up unannounced for extra visits when sick.  
During one of these extra visits one of the study doctors, Jane, begins to suspect that Nwosa 
has a serious medical condition which requires attention. She finds herself in a dilemma, and is 
unsure how best to assist him. She shares her suspicions about his condition with a senior 
colleague, but not with Nwosa, who is anyway treated for something else on this visit. Jane’s 
colleague provides little guidance so she decides to just stick to the study and try to forget 
about her concerns for Nwosa’s health beyond this. 
However, during one of his next study visits Jane notices something unusual on his body: it looks 
like he has been burnt. She is curious, and asks him about it. Nwosa explains that he always 
falls down when the moon is up. He can’t remember how he got burned, but thinks it was 
around that time. Jane’s suspicion is confirmed: Nwosa, she now believes, has epilepsy. But it is 
N
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not a condition she is experienced in. She does know that sufferers are often stigmatized in 
their community, and she is also aware that there is only one public specialist in the province, 
who is very difficult to see because he runs a busy and expensive private practice.  
After this Jane decides to share her concerns at a team meeting. One of the nurses asks 
whether she has spoken to the Principal Investigator; as a study participant Nwosa is entitled to 
free routine medical care, so shouldn’t this include treatment for epilepsy? ‘I think it is your 
obligation as a doctor and as a researcher to make sure he gets treatment for his condition!’ 
she says.  
Jane replies that she has shared the issue with a senior colleague, but they were not helpful. 
But Nwosa’s illness keeps bothering her. She says, ‘Maybe I should find out what treatments 
and services are available at the local hospital.’ 
One of community interviewers asks Jane if there are any procedures in place to help staff 
decide what medical conditions qualify for ‘routine care’. And what are the procedures for 
linking participants to outside care when services can’t be provided by the study clinic? Jane 
cannot answer this question and promises to follow up on the issue.  
The same community interviewer then adds, ‘Nwosa is a vulnerable participant. He earns less 
than a dollar a day. He’s extremely poor. He’s only in the study because he knows he can 
come for those frequent sick visits. Should he even be in this study? How can he give informed 
consent?’ ‘Hmm,’ says another doctor. ‘If we categorize Nwosa as “vulnerable”, then we 
should probably do the same with all our participants. Who will be left to participate?’ 
‘But that’s a totally different question! Poverty and epilepsy are not connected!’ another 
member of staff responds. The meeting ends without any proper conclusions about how to 
assist the participant. The discussion about a specific case seems to have opened up a much 
wider uncertainty.  
Time passes and Nwosa’s next study visit comes around. This time, Jane finds he has more 
serious burns as a result of falling in the kitchen during his ‘affliction of the moon’.  
QUESTIONS 
 Why do you think Jane does not share her suspicions with Nwosa? 
 
 Why do you think she talks about his case in the team meeting? Why do you think it is a 
nurse who raises the question of Nwosa’s general vulnerability? And why do you think 
the senior colleague was not very interested in the case? 
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 Why do you think Jane’s specific question about what she should do leads to a wider 
discussion about involving poor people in medical research? What does this suggest 
about how the staff feel about their work in general? 
 Do you think the senior colleague is supporting front-line staff enough? What might 
happen within the organization if nothing is done? What else could the organization 
do? 
 
 What do you predict will happen to Nwosa if nothing is done? Why do you think 
decisions about his care are being postponed? 
 
 What solutions for Nwosa’s case can you come up with? What is the ideal solution? 
What is the most realistic solution? 
 
 Do you agree with the community interviewer’s classification of Nwosa as a ‘vulnerable’ 
participant? What factors do you think might be at play here? Should poor people be 
allowed to participate in trials, and if so, what measures should be put in place to 
ensure their consent is ‘informed’? 
REFLECTIONS ON YOUR OWN EXPERIENCES 
 Does your study team have procedures and guidelines in place to help decide what 
qualifies as the free medical care you will offer to participants? How about referring 
participants on to other services? If so, what do you think about these documents? 
Could they be improved? 
 
 Can you think of ‘special’ cases in your experience where you or a colleague has gone 
to extra lengths to provide extra medical care for a particular participant? Discuss these 
with the group and consider the ethics of this. 
 
 How do you think an organization like Jane’s can support its staff, in the face of working 
against widespread suffering (financial or medical)?  
FURTHER READING 
Mfutso-Bengo, J., Ndebele, P. et al (2008) Why do individuals agree to enrol in clinical trials? A 
qualitative study of health research participation in Blantyre, Malawai. Malawai Medical 
Journal 20. 37 - 41. 
Whyte, S. R. (2014) Therapeutic research in low-income countries: studying trial communities. 
Archives of Disease in Childhood 99(11) 1029 -1032. 
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COMMUNITY AND FAMILY 
RELATIONSHIPS 
TRAINING CASE STUDIES 
 
 
FRED FELT A LITTLE UNWELCOME WHEN HE CAME TO "CONSENT" GEORGE’S WIFE TO THE NEW STUDY…
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COMMUNITY AND FAMILY 
RELATIONSHIPS 
CASE STUDIES 
 
‘Community engagement’ is an increasingly important 
priority for research organizations and funders. Colonial 
medical research in Africa assumed a paternalistic, 
dogmatic role for researchers (both overseas and 
national), with 
communities cast 
as passive bodies 
to be studied and 
healed, in 
comparison with 
the more 
consultative role 
aimed for today. The concept of ‘informed consent’, let 
alone ‘community consent’, did not exist. 
Today global health researchers are exploring different 
permutations of community consultation and 
engagement. Some research stations set up community 
advisory boards or groups of elected representatives 
from different groups within communities. Others hold 
open community meetings to discuss, explain, and 
disseminate their research. Sometimes community 
members are invited to tour research stations, interview 
new researchers, and comment directly on protocols in 
their early stages.  
Underlying these community engagement activities – and our collection of community 
relationships stories – are questions like: how do we best engage, work with and communicate 
our intentions and findings to different communities? How much involvement in research 
agenda setting and planning should – and can – communities actually have? Who ‘owns’ 
research? And what kind of meaningful understanding can there be between scientists and 
local communities, when the two groups sometimes see and experience the world differently? 
FURTHER READING 
Geissler, P.W. and Pool, R. (2006) 
Editorial: Popular concerns about 
medical research projects in sub-
Saharan Africa – a critical voice in 
debates about medical research 
ethics. Tropical Medicine & 
International Health 11(7), 975–
982.  
Angweniyi, V. et al. (2014) 
Complex realities: community 
engagement for a paediatric 
randomized controlled malaria 
vaccine trial in Kilifi, Kenya. Trials 
15, 65.  
Aellah, G. and Geissler, P.W (2016) 
Seeking Exposure: conversions of 
scientific knowledge in an African 
city. Journal of Modern African 
Studies. 
A COMMUNITY ENGAGEMENT MEETING 
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An important aspect of community engagement involves understanding the ways power and 
authority operate in particular communities. Who has the authority to make decisions about 
research participation? To whom do individuals look to guide them? Religious leaders? Clan 
leaders? Opinion leaders? Local government? In many African contexts, decision-making is 
not necessarily done at an individual level. In response some research projects obtain consent 
for research participation from community leaders or household heads. What are the 
ramifications for this mode of consent for research and research ethics? What role does 
gender play in decision-making? 
Another major concern in the relationship between researchers and communities is the 
destructive power of rumours about medical research. Rumours about blood and organ 
stealing, about birth control as a form of sterilization (including the association of bed-nets with 
infertility), and about the deliberate spreading of disease (for example through vaccines or 
holes in condoms) are common in sub-Saharan Africa. Rumours can have devastating effects 
on the success of projects and cause considerable anxiety for researchers. We agree that 
rumours need to be taken seriously and we have included several case studies on rumours 
here.  
Our stories on rumour have the same underlying message: it is not particularly helpful to think 
about rumours in contrast to truth. Looking at rumours in this way makes them easy to dismiss 
as due to insufficient knowledge, or a lack of education or ‘enlightened’ modern thinking. 
However, as every researcher knows, simply increasing knowledge about the aims and 
practices of research in a community does not always lead to a reduction in rumour. This is 
because to understand rumours we need to look at them in the context of social relations, 
which are produced and changed by medical research. It is much more productive to think 
about rumour as a tool people use to express more nebulous anxieties about socio-economic 
conditions, and we need to take these anxieties seriously. Several of the case studies in this 
section explore this in more detail.  
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EVERYBODY’S 
CORRUPT: 
UNDERSTANDING SUSPICION IN 
MEDICAL RESEARCH 
FACILITATOR’S NOTES 
This case is about a misunderstanding which arises when 
Community Advisory Board (CAB) members are paid their 
regular travel reimbursement in a different way after a 
meeting. CAB members suspect that the research staff are 
pocketing extra cash, and are not surprised by this, because 
they view corruption as common in all walks of life. In fact, 
what happened was not corruption but an administrative 
change which was not communicated effectively. 
What is interesting about this case study is that when CAB 
members become aware of a change in routine procedures, 
they immediately suspect foul play. Prevailing corruption 
across different sectors of society feeds these suspicions, and 
instead of asking for an explanation, CAB members feel 
disappointed but not surprised. This case shows that 
sometimes the administrative requirements of research (in this 
case, to do with providing appropriate information according 
to set budgets) can be misinterpreted ‘in the field’ as 
reflecting something sinister, based on prior experiences of 
corruption. In your discussions you could focus on how these 
kinds of misinterpretations could be prevented, and also think 
about diverse understandings of travel reimbursements/sitting 
allowances.  
You can also use this story as a jumping-off point to address 
more general issues of corruption in research which your group 
may have experienced. This story is about perceptions of 
corruption. But this could lead to a more general discussion of 
what corruption is. Encourage the group to discuss different 
LEARNING 
OBJECTIVE 
To reflect on 
situations where 
simple administrative 
practices in research 
may lead to 
suspicion in the 
community 
 
 
 
 
 
 
 
KEYWORDS 
Corruption 
Community 
engagement 
Money 
Rumour 
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understandings of what corruption means, what forms ‘real’ corruption might take, who might 
be involved, the challenges involved in speaking about it, and what practices might offer the 
most effective safeguards in your specific research settings. 
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EVERYBODY’S CORRUPT: 
UNDERSTANDING SUSPICION IN MEDICAL 
RESEARCH 
 
 
‘THREE PROJECTS, BUT ONLY ONE LUNCH?!' COMMUNITY MEMBERS SUSPECT CORRUPTION 
THE STORY 
 large research station operating across several locations has established several 
Community Advisory Boards (CABs) to serve as community links and to test ideas for 
new studies. Today, one of the rural CABs is meeting to learn about three new studies. 
The 30 members sit in a meeting hall in the middle of their rural community, and three study 
coordinators give overviews of their proposed research using PowerPoint presentations. It’s a 
very long morning, after which they all have lunch.  
CAB members are usually given the equivalent of US$ 15 in cash per meeting, as 
compensation for their time and travel expenses. This is usually called ‘transport 
reimbursement’ or ‘seating allowance’. To receive this allowance, they have to sign a 
designated sheet. Before ending the meeting, one of the study coordinators quickly explains 
that the three studies are related to each other, hence they decided to present at one 
meeting to save the busy CAB members having to come back three times. He tells them that 
because there are three studies represented today, they will divide the CAB into three groups 
A
COMMUNITY AND FAMILY RELATIONSHIPS                                       HANDOUT Everybody’s corrupt 16 
 
95 
 
for signing. He calls out their names and tells them which study coordinator they should go and 
see to sign for their allowance. There is a rumble of discontent amongst the group. This is a 
change from the normal routine. Why, they wonder, isn’t everyone signing the same piece of 
paper? One of the CAB members notices that there are lots of blank lines under the ten 
names assigned to one of the studies.  
During lunch the CAB members sit separately from the study coordinators. The members’ 
conversation is all about this issue. They decide that the study coordinators must be corrupt. 
They speculate that each study was given money for the CAB meeting, but that the study 
coordinators got together and decided to only pay them the regular US$15 and pocket the 
rest, rather than pay them US$15 three times at three different meetings. That’s what the blank 
lines are for – they are going to fill in fake names later. The study coordinators’ bosses will never 
know what happened. The CAB members are annoyed, but not overly outraged. They don’t 
tell the study coordinators their concerns directly. They are used to corruption; it’s a normal 
occurrence. And anyway, they think the research organization is much less corrupt than the 
government. 
QUESTIONS  
 Can you untangle what is happening here? What are the key ethical issues? 
 What specific factors do you think led to this situation? 
 How is the time given by CAB members to fulfil their role valued by study coordinator 
and CAB members? Are there any notable differences in perspective? Why do you 
think this might be? 
 What do you think about the way the study coordinators are administering the transport 
reimbursement on this occasion? How transparent were they being and what could 
they have done differently to avoid misunderstanding? 
 Do you think the study coordinators and the CAB members share the same idea about 
what the transport reimbursement/sitting allowance money is for? Do you think it might 
represent something symbolic to CAB members? If so, and it seems that coordinators 
are stealing some of this money, what symbolic message might this send?  
 What could have been done differently? 
 What do you think the consequences of this situation might be? Is it ‘just one of those 
things’ which no one needs to worry too much about, or do you think it might have 
long-term consequences for this study or for future research?  
THINKING ABOUT CORRUPTION MORE WIDELY 
 What, in your opinion, is corruption? Are there other words and concepts related to it in 
your setting? 
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 What different forms can corruption (as the group has defined it) take in medical 
research?  
 
 Who can be corrupt?  
GROUP ACTIVITY 
 Divide into small groups to discuss specific examples of ways in which 1-3 of the 
categories of people below could participate in research-related corruption, and 
report your discussions back to the others. For each category, provide a specific 
example and think about the motivation behind the person’s actions. How might the 
corrupt person view their activities? Would they consider themselves corrupt? If not, why 
not?  
 
x Field-station Director 
x Overseas Principal Investigator 
x Study Coordinator 
x Drug company representative  
x Laboratory scientist 
x Auditor 
x Ethics Review Board member 
x Community fieldworker  
x Study pharmacist 
x Community Advisory Board member  
x Government minister 
x Human Resource manager 
x Administrator 
x Accountant/financial manager  
x Ministry of Health staff 
x Public hospital doctor 
x Local government official 
x Research participant 
 
 What are some of the challenges in both recognizing and dealing with corruption? 
 
 What practices could be put in place to help reduce corruption? 
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REFLECTION ON YOUR OWN EXPERIENCES 
 Can you think of any similar situations to the one described in the story from your 
experience? How did you deal with them? Looking back now, what could you have 
done differently? 
 Have you experienced any issues around corruption related to research activities? 
What kinds of corruption are there? How were they handled? What could have been 
done differently?  
FURTHER READING 
Newman, S.D., Andrews, J.O., Magwood, G.S. et al. (2011) Community advisory boards in 
community-based participatory research: a synthesis of best processes. Preventing Chronic 
Disease 8(3), A70.  
Strauss, R.P., Sengupta, S., Quinn, S.C., Goeppinger, J., Spaulding, C., Kegeles, S.M., and Millett, 
G. (2001) The role of community advisory boards: involving communities in the informed 
consent process. American Journal of Public Health 91, 1938–1943.
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BAD PRESS:  
THE ORIGINS AND IMPACT OF 
‘BLOOD STEALING’ RUMOURS  
FACILITATOR’S NOTES 
Stories and rumours about ‘blood stealing’ are found all over 
sub-Saharan Africa, and most researchers will encounter them 
at some point. This case study invites us to think critically about 
the origins of rumours about medical research. They can be a 
way to express dissatisfaction about broader issues, such as 
staff resentment and anger over inequality. It is important to 
recognise that concerns about blood have literal and 
symbolic meanings. People can be anxious about the amount 
of blood taken, and the pain involved, but the ‘gift’ of a highly 
valued substance also raises questions about fairness and 
exploitation. In this story, ‘blood rumours’ emerge as a way of 
expressing underlying complaints about access to jobs. 
Rumours can also reflect social relationships. In this story, both 
the rumour itself, and the way the rumour ends up being 
reported in a newspaper, tell us something about different 
kinds of relationships. In discussions, you could encourage your 
students to think about what the rumour and how it is reported 
can teach us about the relationships between community 
members on the one hand, and both their leaders and the 
research station on the other. You may also want to discuss 
the role of the media, and think about how research 
programmes can work with media representatives.  
Addressing rumours is not straightforward. It is not just a matter 
of trying to convince people that the facts of the rumour are 
wrong. The rumour itself may express deeper concerns about 
internationally funded medical research, how it operates, and 
what it aims to achieve, and mirror historical relationships 
between the country where the research is taking place and 
the countries of the international researchers.
LEARNING 
OBJECTIVE 
To consider the 
origins and spread 
of rumours about 
medical research 
programmes, and to 
discuss how 
researchers could 
seek to manage 
these more 
proactively 
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BAD PRESS:  
THE ORIGINS AND IMPACT OF ‘BLOOD STEALING’ 
RUMOURS 
 
 
 ‘GOOGLING’ HIS OWN NAME WAS NO LONGER FUN… 
THE STORY 
n this particular area, international medical research has been taking place for a long time, 
mostly without trouble. The research station employs a lot of people. Their rates of pay are 
the best in the region, and everyone competes for positions. Every time new jobs are 
advertised, a few people complain about corruption and tribal favouritism. After a while, 
these grumbles usually disappear. 
This time, however, after a round of staff recruitment for a new vaccine trial, the Principal 
Investigator opens the national newspaper to find a special edition of ‘The Reporter 
Investigates’ focusing on his study. The article states that people are being experimented on 
by money-grabbing foreign researchers, who are taking advantage of their poverty to test 
new, dangerous drugs. Local ‘opinion leaders’ are quoted: ‘“Strangers regularly come to the 
villages and take our blood. They never tell us why. One widow even fainted after her blood 
was taken.”’ 
I
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The Principal Investigator is mentioned by name. Soon after putting down the newspaper his 
phone rings. It’s his boss, calling from Vancouver. She wants to know how this could have 
happened.  
The next week a corrective is published in the newspaper. In it, the director of the research 
station is quoted, explaining that the research station is run in partnership with the country’s 
government, that all research is subject to approval by an ethics review board, that 90 per 
cent of the staff are local, and that the research station has a programme to disseminate 
findings. The damage is limited. But every time the Principal Investigator Googles his own 
name, the first link is a web forum discussion entitled ‘Evil Western plot to sterilize our children’. 
QUESTIONS 
 Why do you think local opinion leaders were speaking negatively about the research? 
Do you think there might be any ‘symbolic’ truth in the story and if so, what? 
 If you were the Principal Investigator, how would you answer your Canadian boss: how 
could this have happened? 
 What are the potential long-term consequences of this media report, for the research 
programme, for the community, and for the Principal Investigator? 
 What media strategies does your research organization have in place? Do you have 
any for social media? Who deals with media enquiries?  
 Who are local opinion leaders you work with, and how should research organizations 
seek to work with them? 
REFLECTION ON YOUR OWN EXPERIENCES 
 Have you had any experience of rumours being reported on in the media? If yes, what 
happened and why do you think this happened? What did your organization try to do 
about this?  
 Think about the types of rumours that are common in the areas where you work. What 
are they about, literally and symbolically? When do they usually surface, and how do 
you try to address them?  
 How do rumours influence or affect the way you conduct research, engage with the 
local community, and recruit participants?  
ACTIVITY  
Split into small groups of four people and draft a media strategy for your research organization 
– or critically review your organization’s current strategy. Think about how opinion leaders 
should be engaged. How, by whom, and in what type of forums? Why?  
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FURTHER READING 
Mills, E. et al. (2005) Media reporting of tenofovir trials in Cambodia and Cameroon. BMC 
International Health and Human Rights 5(1), 6. 
Singh, J.A. and Mills, E.J. (2005) The abandoned trials of pre-exposure prophylaxis for HIV: what 
went wrong? PLoS Medicine 2(9): e234. 
 
Practical guides to engaging with the press can be found on Sci Dev Net 
website:  
What journalists want from scientists and why: 
http://www.scidev.net/global/communication/practical-guide/what-journalists-want-from-
scientists-and-why.html (accessed 25 October 2015) 
Explaining controversial issues to the media and the public: 
http://www.scidev.net/global/communication/practical-guide/explaining-controversial-issues-
to-the-media-and-t.html (accessed 25 October 2015) 
How do I become media savvy? http://www.scidev.net/global/communication/practical-
guide/how-do-i-become-media-savvy-.html?from=related%20articles (accessed 25 October 
2015) 
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PEOPLE WILL ALWAYS 
TALK:  
PROTECTING PARTICIPANTS FROM 
STIGMA IN AN HIV STUDY 
FACILITATOR’S NOTES 
In many parts of Africa, HIV-related stigma, is still very real, and 
in some places simply being associated with transnational 
research represents a risk of being stigmatized as HIV positive. 
This case study follows a microbicide trial and the efforts study 
staff make to limit gossip about participants’ HIV status. It asks 
how much responsibility staff can and should have to try to 
control what people are saying about participants, especially 
when participants belong to a group considered ‘at risk’.  
The case provides a powerful example of the way medical 
and social issues can become entangled. The researchers in 
the story put in a lot of effort to protect their participants. 
However, we invite you to think about how effective their 
solution really was, or whether it could have had other 
negative consequences. You may want to explore other 
possible approaches, for example, sharing information about 
the study with the general public to emphasize that it focuses 
on women who do not (yet) have HIV. Going further, the case 
raises the question if researchers’ efforts to protect their 
participants could be contributing to stigma. You might also 
want to discuss whether the changing nature of the HIV 
epidemic altered the way people view HIV? If yes, does this 
mean we can/should change the way we think about stigma 
in relation to medical research? You may be able to draw links 
with ethical arguments made for opt-out or provider-initiated 
HIV testing, which have suggested that giving HIV testing a 
special status of ‘voluntary’ has actually contributed to stigma 
(see further reading). 
LEARNING 
OBJECTIVE 
To reflect on some 
of the social and 
economic problems 
associated with 
researching HIV 
among ‘at risk’ 
communities, and to 
consider how far 
and in what ways 
researchers on this 
type of project are 
responsible for 
addressing these 
issues 
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Rumour 
Confidentiality 
Home visits 
Stigma 
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PEOPLE WILL ALWAYS TALK: 
PROTECTING PARTICIPANTS FROM STIGMA IN AN 
HIV STUDY 
 
 
JACINTA WORRIED THAT HER CUSTOMERS WOULD THINK SHE HAD HIV IF SHE PARTICIPATED IN THE STUDY 
THE STORY 
acinta works in a bar. One night she is approached at work by a smartly dressed lady 
who hands her a leaflet about a study, and invites her to attend a meeting the next day 
in a community hall to find out more. Jacinta has heard from other girls that research 
studies are a good way to get free healthcare, so she goes along.  
At the meeting, the study coordinator, Dr Agava, explains the project to the 20 women who 
have gathered. She tells them that the trial aims to find out whether a microbicide gel will 
protect women from HIV infection, and that researchers are looking for HIV negative women 
to take part. Participants will be asked to use the gel every time they have sex, and to attend 
the local government HIV clinic regularly, where study doctors working alongside government 
medical personnel will test them for HIV and other STIs. The doctors will also distribute more gel 
and administer questionnaires about participants’ sexual behaviour. If participants miss 
J
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appointments, they may receive follow-up visits at home. They will also receive money for their 
transport and time, as well as free healthcare throughout the 12-month study.  
Most of the women are enthusiastic. Jacinta likes the idea of the gel; if it works, it will be 
helpful, as most of her boyfriends don’t want to use condoms. But she is worried about visiting 
the HIV clinic regularly. The study coordinator asks the women for their thoughts about the 
study. Jacinta puts up her hand and says: ‘The problem is that this is a small city. If people see 
me going to the clinic every month, they will talk. Everyone will think I have HIV. Then people 
will gossip about me. It will give me stress.’  
Dr Agava asks the women for suggestions about how to solve this problem. Jacinta proposes 
they hold the clinic in a secret place. One of the other women suggests using one of the 
rooms in a local guesthouse. ‘People will just think we have “business” there,’ she says. ‘People 
already think that I am a parking lady [prostitute]. Better that than them thinking that I have 
HIV’.  
As a result of this discussion, the researchers set up a ‘clinic’ for women to visit in several 
guesthouses on different days of the week. They are careful not to talk about this widely in the 
community, and the guesthouses continue to provide services for customers on the other days 
of the week. Everyday activities, such as small markets and food stalls, continue in front of the 
guesthouses during clinics. 
One day Jacinta is asked to work on her allotted clinic day, so misses her appointment. The 
next day one of the study staff visits her house. Jacinta has shown the researchers where she 
lives. David, one of the field staff, comes in the study vehicle, with its institutional logo on the 
side. Jacinta lives in a large compound with lots of small apartments, and his driver parks the 
vehicle inside the gate because, in this neighbourhood, he doesn’t want to risk leaving it 
outside.  
David is worried about the home visit, fearing that after this Jacinta might not want to 
continue with the study. He apologizes to Jacinta for bringing the vehicle. ‘But,’ he tells her, ‘I 
can’t take your samples back to our lab on public transport, so I couldn’t come in secret. I 
hope this visit doesn’t cause problems for you with your neighbours.’  
He is surprised when Jacinta replies, nonchalantly, ‘Oh, don’t worry about that. People will 
always talk. People already whisper, “Oh, you know that lady in the bar? She’s in that study for 
ladies who are sick.” But just ignore them. If you don’t listen to people like that they will talk for 
two or three days then they will stop. And if they talk loudly I just tell them they are ignorant 
and wrong.’  
‘Oh, OK, that’s good,’ says David, thinking, ‘Huh, this is a strong lady.’ 
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QUESTIONS 
 What are key ethical issues at stake in this situation? Do you think participants are being 
oversensitive about their ‘reputations’? What else do you think might be behind 
Jacinta’s ‘stress’? 
 What responsibility do you think the study coordinator has to ensure that participants 
are not exposed to stigma? What responsibility do the women themselves have?  
 Why might Jacinta have been so relaxed about David’s visit? Were you surprised at her 
response? Even if researchers do their very best to protect participants, how far do you 
think they really can control how their work is perceived? 
 What do you think about the decision to run clinics in the guesthouses instead of at the 
hospital? Could this have compromised the women’s reputations in other ways? 
(Remember that the government clinic is known to provide HIV testing, as well as 
treatment.) Could there be other consequences to removing the clinics from the 
government clinics, in terms of the relationship between the researchers and the 
government? 
 How else could the field staff have tried to mitigate rumours?  
 What underlying messages about HIV might the focus on secrecy have sent out to the 
women, and to the wider community?  
REFLECTION ON YOUR OWN EXPERIENCES 
 Can you think of similar situations from your experience where you may have tried, and 
struggled, to engage with the ways your work has been perceived?  
 Looking back at this, do you have any ideas of what could you have done differently? 
FURTHER READING 
April, M. (2010) Rethinking HIV exceptionalism: the ethics of opt-out HIV testing in sub-Saharan 
Africa. Bulletin of the World Health Organization 88, 703–708. DOI: 10.2471/BLT.09.073049 
Available at:  http://www.who.int/bulletin/volumes/88/9/09-073049/en/ (accessed 25 October 
2015). 
Stangl, A.L. and Grossoman, C.I. (Eds.) (2013) Global action to reduce HIV stigma and 
discrimination. Journal of the International Aids Society, Volume 16, Supplement 2. Available 
at: http://www.jiasociety.org/index.php/jias/issue/view/1464 (accessed 25 October 2015). 
Includes webinar.
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LOST IN TRANSLATION:  
PUBLIC COMMUNICATION AND 
POWER RELATIONS 
FACILITATOR’S NOTES 
This case is about community engagement in research – 
specifically, initial community entry. It aims to help think 
through the role, remit and constitution of representative 
public bodies in health research. The story describes what 
happens when a research team goes about setting up a 
community advisory board (CAB): the team’s disagreements 
become evident in public meetings, there are questions over 
how representative the CAB is likely to be, and governmental 
administrative leaders are keen to secure leadership within it. 
The case draws attention to the critical importance of internal 
work relationships, communication, and trust among research 
staff, and also the need for a unified, coherent approach in 
order to establish good relationships with the local community. 
It also invites reflection on the role of gender relations and 
power in this process. 
In your discussions about the story, please note that getting this 
kind of community entry right can be very difficult. Conditions 
are never perfect. Some issues to draw out might include the 
fact that, while community members clearly valued the trial 
coordinator’s presence, it would probably have been better if 
she had allowed the community relations officer to deliver the 
agreed message in the local language. This would have 
facilitated comprehension and improved team dynamics. It 
would also be a good idea for these two colleagues to discuss 
who should be responsible for the coordination of the CAB. 
Then, as the CAB starts, it will also be essential to think about its 
role, and whether it will run autonomously or with support from 
the main research unit. 
LEARNING 
OBJECTIVE 
To explore best 
practices and 
challenges in 
initiating community 
entry and creating 
community advisory 
boards, and to 
reflect on the 
importance of staff 
unity when 
engaging with the 
community 
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LOST IN TRANSLATION:  
PUBLIC COMMUNICATION AND POWER 
RELATIONS 
 
WHILE THE CHILDREN DANCED FOR THE GUESTS, NOAH AND EMZARA PROVIDED THE REAL ENTERTAINMENT 
THE STORY 
t a transnational research station in central Africa, preparations are underway for an 
exciting multi-sited trial of a new HIV prevention tool. The research station has been 
chosen as one of the first sites for this hotly anticipated project, which is bringing a lot 
of funding and prestige – as well as pressure – to the station and staff. 
The trial participants will be recruited from public health facilities in a rural area, which has not 
previously been involved in any research activities. To prepare the community, the research 
team decide they need to establish a Community Advisory Board (CAB). The male, American 
trial manager, Ham, the young female African coordinator, Emzara, and the research station’s 
African community relations officer, Noah, draw up plans for this.  
They start by visiting local government officers to explain the purpose of the trial and their 
reasons for setting up a CAB. They tell the officers that they would like community members to 
nominate potential CAB members during the officers’ regular ‘barazas’ – a grassroots vehicle 
A
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for discussion of community concerns, solving disputes between neighbours, and 
communicating administrative and political measures and regulations. NGOs and other 
organizations often use barazas to introduce themselves and their projects to the community. 
The officers agree to this and they set dates for the team’s attendance.  
Before the first baraza Ham, Emzara and Noah prepare a script to explain what the trial is 
about, why they want to set up CAB, and how the nomination process will work. Emzara, the 
trial coordinator, is a young, ambitious scientist. She is from a different tribe to the community, 
and is originally from the capital city, but has been learning some of the local tribal language 
in preparation. She plans to start the presentation with an introduction in the local language, 
but will then have to revert to English, with Noah, the community liaison officer, translating. 
Noah is in his late fifties. Before this job he had a long career in mid-level government 
administration. He was also born in this area, so he can speak and understand the local 
language in its full complexity.  
On the day of the meeting Ham, Emzara and Noah set off early in a Toyota 4x4, but by the 
time they arrive at the baraza, scheduled for 11am, the government officer has assembled 
over 50 community members and the meeting is already in full swing. The government officer 
and his assistants, dressed in full uniform, stop the meeting to greet the research team at their 
vehicle and lead them to the front of the gathering, where people are sitting in a circle under 
a group of trees. Younger women, especially those with children, sit on the grass on pieces of 
cloth to protect their clothes; older women sit amongst the older men on chairs and benches 
in a half-circle behind them. Not many young men are present; fewer than ten stand, listening 
and chatting quietly among themselves, a little way away, where they have left their bicycles 
and motorbikes in the background.  
Ham, the foreign visitor, is given the only spare chair, next to the government officer at the 
front. Emzara and Noah stand next to them while the government officer introduces the three 
of them in turn. Then Emzara steps forward to greet the gathering in the local language. This 
breaks the ice and the ambience remains positive when Emzara reverts to English to 
communicate the scripted information. Emzara reads separate portions of the text and, as 
agreed, Noah translates in turn. Halfway through, Emzara notices that Noah has gone ahead 
of her in his translation. But she is not sure what he is saying. This results in some tension among 
the staff, which is not immediately visible to the gathering.  
At the end of their script, the government officer helps Emzara and Noah to explain how the 
nomination process will work. Attendees are separated into various groupings – women’s 
groups, church groups, and village elders – who are asked to come up with two names 
amongst themselves for CAB nominees from their group. After this, the nominees’ names are 
read out to the larger gathering, to resounding applause. The nominees pass their details to 
Emzara and Noah, who tell them they will be in contact to arrange a time to meet up 
individually for a separate selection process.  
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The research team have now finished what they came to the meeting to do, and want to 
leave, as it looks like the baraza could continue all day. The government officer, however, has 
other ideas. He has organized for some primary school children to give a dramatic dance 
performance on HIV to the research team. The children are dressed in their dance outfits, and 
look very disappointed when it seems the team will leave. Ham tells the group that of course 
he would love to watch the show. He motions to Emzara and Noah that they can withdraw 
and carry on with their work by the vehicle. They have lots of phone calls to make, so they 
move away from the gathering and the children begin their performance.  
Over by the vehicle, Emzara and Noah start talking about the translation issue. Emzara is upset. 
She tells Noah it is not just about usurping the predefined format, but it is also about gender. 
She thinks that, given the nature of the HIV prevention tool being trialled, young women’s 
collaboration is key, hence the lead should be taken by a woman and not a man in public 
meetings. She also suggests that she should chair the CAB, as the female African member of 
the team. Emzara and Noah are now talking quite loudly in fast English. Some members of the 
gathering have started to look over at them. Ham pretends he can’t hear them and smiles at 
the performers.  
Later that day, Noah receives a call from the chief government officer, volunteering himself as 
chair of the CAB.  
QUESTIONS  
 Why do Ham, Emzara and Noah write a script for the baraza? Was this a good idea? 
 Why do you think they decided to use both the local language and English to explain 
the proposed trial and plans for the CAB?  
 Why do you think Noah may have started to translate ahead of Emzara? 
 What can be done to promote good working relations and trust in multi-disciplinary, 
multi-ethnic, and international research teams?  
 Was the baraza the best place to launch the project? Are all members of the 
community equally involved in it, and does this matter for the CAB and the trial? 
 What do you think about the nomination process the research team chose to identify 
potential CAB members? What was good about this, and what could have been done 
better?  
 Do you think the nominees will have understood that nomination did not necessarily 
mean that they would become CAB members?  
 What do you think about Emzara’s suggestion that a female African member of the 
research team should assume responsibility for coordinating the CAB?  
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 What do you think about the government officer’s request to be chair of the CAB? How 
should the research team respond to this? Do you think the team’s behaviour at the 
baraza had a role in his suggestion? 
REFLECTION ON YOUR OWN EXPERIENCES 
 Does this case remind you of any of your own experiences? What was happening, and 
what did you do? What could you have done differently? 
 Do you have a CAB at your workplace? If so, how was this set up, and how does it 
function? Who do you think should select CAB members?  
 What role do you think CAB members should play? What is a CAB’s mandate?  
 What do you think about the relationship between researchers and CAB members?  
ACTIVITY 
Split the group up into groups of four to six, and ask them to think through how they would set 
up a community advisory board or a similar representative body. If you already have such 
bodies at your workplace, you could ask the groups to review current practice and come up 
with ideas of how they could be improved. You could get groups to:  
x critically review any existing guidelines (e.g. nomination processes, the mandate of 
community representatives, the role of the research team);  
x report on their experiences of interacting with community representatives;  
x discuss the value of such representative bodies.  
FURTHER READING  
Diallo, D.A., Doumbo, O.K., Plowe, C.V., Wellems, T.E., Emanuel, E.J., and Hurst, S.A. (2005) 
Community permission for medical research in developing countries. Clinical Infectious 
Diseases 41, 255–259. 
Marsh, V., Kamuya, D., Rowa, Y., Gikonyo, C., and Molyneux, S. (2008) Beginning community 
engagement at a busy biomedical research programme: experiences from the KEMRI 
CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Social Science and Medicine 67, 
721–733.
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HUSBAND OUT OF 
TOWN:  
GENDER RELATIONS AND 
DECISION-MAKING 
FACILITATOR’S NOTES 
This case explores how children are recruited for trials, how 
parents are involved, and the role of gender relations in this 
kind of research. In the story, a first-time mother provides 
consent for her infant to take part in a vaccine trial without 
her husband’s involvement, with unfortunate consequences. 
The case raises key questions around participants’ motivation 
for enrolment in trials; communication and comprehension 
around participation; how much time is given to participants 
to make decisions, and in what conditions; and whether and 
how consent could involve people more fairly.  
One could argue that the mother in the story should have 
been given more time to think about joining the research. She 
could have been given information materials to take home, to 
help her talk to her husband and other family members about 
the project. Her husband could have signed a form at home 
for her to take into the clinic, to show they both agree. The 
problem with this is that it places the burden of 
communication on the mother, requires the father to be 
present and willing to engage, and makes certain 
assumptions about gender relations and power. It is therefore 
important that researchers think more creatively about how 
they can engage effectively with both parents.  
Before the session it would be a good idea to review how your 
institute organizes trial recruitment and parental consent on 
behalf of minors. You might also want to check what the legal 
requirements are in your context. 
LEARNING 
OBJECTIVE 
To reflect upon the 
informed consent 
process, especially 
in relation to 
involving both 
parents of children 
involved in trials in 
decision-making 
 
 
 
 
 
 
 
KEYWORDS 
Gender  
Informed consent 
Minors consent 
Partner involvement 
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HUSBAND OUT OF TOWN: 
DECISION-MAKING AND GENDER RELATIONS 
 
 
DAVID FIRST LEARNT ABOUT THE RESEARCH PROJECT FROM HIS FRIENDS 
THE STORY 
race, a 20-year-old first-time mum, lives with her husband’s family in a village which 
has limited access to public transport. She is worried that her five-week old baby 
Nathan is not putting on weight, so she decides to take him to the health clinic in 
town to have him checked and weighed. On her 30-minute walk to the clinic she meets her 
friend Anna, whose baby is about the same age. Anna has just come from the clinic, and 
starts telling Grace all about a new project that she has just joined. She is full of praise: the 
nurses are friendly, a doctor checked her baby, and they will be vaccinating him against 
meningitis. They took great care of her baby, and even gave her some money (the equivalent 
of US$5) to help her pay for transport even though she usually walks. She is going to use the 
cash to add some meat to the stew she is preparing tonight. Grace wonders if she can join this 
project as well. Anna tells her to go to the side buildings next to the main clinic and talk to the 
nurses there.  
When Grace arrives at the clinic she sees other mothers with young children sat on benches 
outside the side buildings. She makes her way over and sits down with them. They greet her 
G
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and they all start talking about what they have heard about the project. A nurse comes out 
and gives everyone a letter to read, saying that she will go over what is written in the letter 
with them all in about five minutes. Nathan has woken up and needs to be breastfed, so 
Grace settles him while she waits for the nurse to return. She reads the first couple of 
paragraphs of the five-page letter.  
The nurse returns, sits down on a chair in front of the mothers, and explains that the main 
purpose of the project is to test whether a new meningitis vaccine works. She then starts to 
read out the letter, getting some of the mothers to take turns in reading certain sections out 
loud. She stops regularly to encourage them to ask questions and interact. It takes almost 30 
minutes to finish reading the letter, by which time Grace is getting tired and hungry. She is 
happy that she was not asked to read aloud, but feels she has not really understood 
everything the nurse explained. It seems to be some sort of aid project, and she is keen for 
Nathan to be checked by the project doctor before she goes home, so she decides to enrol 
him. The nurse asks Grace whether she needs to talk to Nathan’s father before she signs the 
consent form. Grace tells the nurse that Nathan’s father works and lives away from home 
during the week, and she can’t contact him because she has run out of mobile phone credit. 
She does not think he will mind, so she goes ahead and signs the consent form.  
The nurses then weigh Nathan, and the doctor does a full assessment. Grace is really 
impressed by the doctor, who examines the child thoroughly, undressing him and palpating his 
abdomen. She is relieved when he tells her that Nathan is in good health. She gets a bit upset 
when the nurses and doctors take a blood sample, but feels better when they give her a cup 
of tea. Over tea, the mothers share their experience with the caring staff, and appreciate their 
hospitality. Before Grace leaves she is given the transport money Anna told her about, and is 
asked to come back in a week’s time for Nathan’s first course of vaccines.  
When she arrives home Grace has to start preparing the evening meal straightaway. She 
completely forgets to tell anyone about the project. Even when her husband, David, comes 
home for the weekend, she does not remember. It is only when he has left again that she 
recalls that she meant to tell him about the project, but then she thinks to herself: ‘It is not 
worth bothering him, he relies on me to take care of little Nathan, and anyway he might just 
want me to give him the transport money.’  
A few weeks later Grace forgets one of her project appointments – it is harvest time and she 
has gone to market to sell maize. Her husband has come home to help with the harvest, and is 
at home when a project fieldworker arrives on his motorbike. The fieldworker has come to 
check whether Grace and Nathan are OK, and to remind them to come to the clinic. David is 
surprised to see a young man making his way into their compound, and asks why he has 
come. The fieldworker explains that he works for the meningitis project and needs to check up 
on Nathan. David is angry that this man seems to be on familiar terms with his wife and son, 
and chases him away. He then gets on his bike and makes his way to the local shops to talk to 
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some of his friends about it. He finds a group of men sitting together under a tree and quizzes 
them about what they know about the programme.  
They tell him that they have heard that it involves researchers testing children and sending 
their blood overseas, and that the researchers give the mothers money. David returns home 
even more concerned, and when Grace gets back from the market he demands that she 
take Nathan out of the programme straight away. Grace tries to explain what the project is 
about and how well Nathan is being looked after, but her own understanding of the research 
is limited, and David does not want to listen. He is really angry so Grace sends a message to 
the project team, explaining that Nathan will not be able to continue to participate.  
QUESTIONS 
 Is David just being ‘backward’ or a dominant man? What effect has the project had on 
his relationship with Grace? 
 How could this situation have been avoided? If Grace had been given information and 
a form home for her husband to sign, what would have been the benefits and 
disadvantages? What would this suggest about the balance of power and responsibility 
in their relationship?  
 What should the research team do when they receive Grace’s message? 
 How much time do parents need to be given before deciding about whether to enrol 
their children in research? What else might have made Grace rush into agreeing?  
 Do both parents play the same role? Do projects need to gain both parents’ consent, 
and if so, must this be done in the same way? What might this mean for project 
planning? 
 Is information and knowledge in this situation the only key to satisfactory consent?  
 Could both Grace and David’s confusion have been avoided? If yes, what do you 
think could have been done by the research staff? 
REFLECTION ON YOUR OWN EXPERIENCES 
 Have you come across similar situations? How have you dealt with them?  
ACTIVITY 
Get into groups of three to four and draft a recruitment strategy for a children’s trial, involving 
both mothers and fathers in a way that seems appropriate. Think about the legal requirements 
of consent as well as international ethical guidelines and national laws.  
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FURTHER READING 
Mathews, C., Guttmacher, S.J., Flisher, A.J., Mtshizana, Y., Hani, A., Zwarenstein, M. (2005) 
Written parental consent in school-based HIV/AIDS prevention research. American Journal of 
Public Health, 95(7), 1266–1269. 
Pace, C., Talisuna, A., Wendler, D. et al. (2005) Quality of parental consent in a Ugandan 
malaria study. American Journal of Public Health 95(7), 1184–1189. 
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CHOP YOUR MONEY!:  
CHALLENGES IN RECRUITMENT 
AND ENFORCING STUDY RULES 
FACILITATOR’S NOTES 
This case study explores the role of both community and family 
relationships in recruiting and retaining participants. Medical 
research institutions employ several strategies to recruit and 
retain trial participants, often making use of informal structures 
such as Community Advisory Boards, peer leaders, or 
community liaison personnel to try to reach their target 
community. However, despite these efforts, smooth 
relationships with participants are not guaranteed, and 
recruiting and retaining people remains a challenge. This case 
study invites us to think critically about questions related to the 
recruitment and retention of trial participants. It provides an 
example of the requirement for female participants to use 
contraception in a trial, and the impossibility of ‘enforcing’ this. 
It invites you to think about the role of male partners in 
decision-making about following study rules. 
It also raises questions over the role of reimbursements in the 
recruitment process. Attempts to control the problems could 
infringe on participants’ basic rights. The study also points to 
the underlying suspicion and cynicism with which communities 
can view trials, and the difficulties Community Advisory Board 
members face in trying to overcome this mistrust.  
None of these questions are straightforward, so you will need 
to take care in how you manage the ensuing discussions.
LEARNING 
OBJECTIVE 
To consider 
challenges in 
recruiting 
participants and 
ensuring they follow 
study rules 
 
 
 
 
 
 
 
KEYWORDS 
Informed consent 
Gender  
Money 
Recruitment 
Partner involvement 
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CHOP YOUR MONEY!:  
CHALLENGES IN RECRUITMENT AND ENFORCING 
STUDY RULES 
 
 
‘DON’T WORRY, I’LL PRACTICE ABSTINENCE DURING THE TRIAL,' SAID MARY, REJECTING THE OFFER OF 
CONTRACEPTIVES. 'UM… OK…' SAID THE DOCTOR DOUBTFULLY 
THE STORY 
 story in a major national newspaper quotes a group of scientists from the National 
AIDS Vaccine Institute, expressing their frustration with the high pregnancy rates 
among women participating in vaccine trials. All women are advised not to become 
pregnant during the trials, due to the unknown side effects of the vaccine, however in one 
study a number of women conceived children. They have apparently been coerced by their 
partners to have unprotected sex.  
All the women in the trial have had the risks explained to them, and were offered a choice of 
contraception for free. Those who became pregnant were the ones who opted for 
abstinence as their preferred method of contraception, so in the article the scientists 
recommended that abstinence should no longer be an option given to trial participants. They 
state, ‘Every effort must be made to ensure that trial participants do not get pregnant during 
the specified periods, and that they are retained until the end of the vaccine trial.’ 
A
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After reading the newspaper article, Community Advisory Board (CAB) members in the 
National Aids Vaccine institute start talking about some of the frustrations they experience in 
participant recruitment. Many of the members were trial participants themselves before joining 
the board. Researchers hoped this would help with recruitment, as they hoped that ex-
participants could allay fears among community members and use their experience to 
convince others to join the vaccine trials.  
According to CAB members, however, this is never enough to convince suspicious community 
members. ‘Any time we tell them that we have participated in a previous study, they do not 
believe us. They say we are lying,’ says one board member. Another remarks: ‘I took part in a 
trial with other community members, but they were not convinced that I was injected with the 
same vaccine as they were. They thought I was injected with a different substance.’  
When the researchers talked to the CAB members about the issue of women becoming 
pregnant during the trial, the CAB members said that perhaps these girls didn’t participate for 
the right reasons and therefore were not ‘good participants’. They pointed out that this was 
part of a bigger problem. They told the researchers that they thought many people they try to 
recruit take advantage of the process to obtain money, with no intention of ever 
participating. Some of the participants who refuse to enrol only at the final stages of the 
recruitment process tell CAB members that this is due to fear of the vaccine, yet, the CAB 
members argue, they seem very keen to complete the initial counselling and screening 
sessions to obtain the transport reimbursements for these sessions.  
One of the CAB members explains: ‘You know, in the recruitment we often recruit our friends. 
Some of them have been quite frank and told us: “We knew all along that we would not take 
part in the trials, but you guys pay lots of money for transport, and give us snacks any time we 
come. We just wanted to chop your money.” Perhaps those women who conceived were just 
thinking about chopping money and ignored the rules of the research.’ (This expression, ‘to 
chop money’, is coined from a popular African song and means ‘taking someone’s money 
without giving anything in return’.)  
‘But on the other hand,’ one of the male CAB members says, ‘we all know that pregnancy is 
an issue between men and women, not between women and researchers! Perhaps these 
ladies did not tell their husbands about the trial.’  
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QUESTIONS  
 Do you think the female trial participants ‘intended’ to get pregnant despite enrolling? 
What are the problems with this concept of ‘intention’ in this sort of case? What does 
this tell us about informed consent? 
 
 What do you think about the scientists’ suggestion that trial participants must use 
contraception methods other than abstinence to ensure that they do not get 
pregnant? What about those whose relationship status changes during a trial or before 
a trial, and who therefore decide they want to have children? What about participants 
or potential participants whose health or personal circumstances make it difficult for 
them to use contraceptive methods consistently?  
 
 Do you think there was a need to involve participants’ male partners more in the trial? 
How could this be achieved? 
 
 Given the problems of recruitment, what ethical issues emerge from the use of financial 
inducements to recruit trial participants – for the trial, and for the potential participants? 
 
 Can you think of any reasons why the friends of the CAB members, who were recruited 
to the trials, were very opportunistic about trying to ‘chop’ the money? 
 
 What do the quotes in this story tell us about the experiences of Community Advisory 
Board members? Do you think the researchers could do more to support them, and if 
so, how?  
 
REFLECTION ON YOUR OWN EXPERIENCES 
 Have you observed similar opportunism when it comes to getting a share of research 
resources – maybe even before participants take part? If, yes, what happened, and 
how did you deal with this?  
 
 What is your view about the role of CAB members or similar representatives? Should 
they be actively involved in recruitment activities?  
FURTHER READING 
Geissler, W. (2011) ‘Transport to where?’: reflections on the problem of value and time à 
propos an awkward practice in medical research.Journal of Cultural Economy4(1), 45–64. 
Painter, M.T., Kassamba, K.L. et al. (2004) Women’s reasons for not participating in follow up 
visits before starting short course antiretroviral prophylaxis for prevention of mother to child 
transmission of HIV: qualitative interview study. British Medical Journal 329 (7465), 543.
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MY HUSBAND DOESN’T 
KNOW: 
INVOLVING MALE PARTNERS IN 
MICROBICIDE RESEARCH 
FACILITATOR’S NOTES 
This case study is about a woman who decides to take part in 
a microbicide study without first telling her husband. It invites 
students to think beyond research participants as individual 
actors, and to reflect on how taking part in research may 
affect family relationships, and be affected by them. In the 
discussion you may wish to guide the group to think about 
decision-making practices in general in your community. Who 
has the power to make decisions in families? How is this 
different from the assumptions about individual decision-
making made in the standard informed consent process? 
When designing research studies, are there ways to reconcile 
different ideas about decision-making and individual 
autonomy? For example, one possible solution might be to 
provide detailed information about the research to the 
community as a whole, so that men have some general facts 
even if their partners decide not to disclose their personal 
involvement.  
The further reading provided for this case study gives a 
detailed exploration of partner dynamics in relation to 
microbicide use in Africa. It is worth reading alongside the 
case study for deeper reflection on how we conceptualize 
safe sex methods, and research into these.  
 
LEARNING 
OBJECTIVE 
To understand that 
although informed 
consent is often 
individual, 
participants have 
relationships (such 
as marriage) which 
may be affected by 
involvement in 
research. 
 
 
 
 
 
KEYWORDS 
Informed consent 
Partner involvement 
Gender  
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MY HUSBAND DOESN’T KNOW: 
INVOLVING MALE PARTNERS IN MICROBICDE 
RESEARCH 
 
 
 ‘WHERE DID YOU GET THIS THING?!’ MARYBELLE’S HUSBAND FINDS HER MICROBICIDE GEL 
THE STORY 
arybelle is taking part in a trial of a microbicide gel to see if it will protect women 
from HIV infection. She learns about the study when researchers come to the hotel 
where she is a cook. They tell her about the study and ask if she wants to participate. 
Marybelle is told that some women will receive the active gel and some will receive the 
placebo, but they won’t be told which one they had. Marybelle decides to take part in the 
study because ‘you can never tell what your husband may be doing’. She thinks the gel might 
offer her some protection from HIV infection, as her husband does not want to use condoms. 
Following consultation with women participants in a pilot study, the trial staff decide not to 
involve women’s partners in the trial in any way, except to offer to provide a referral to an STD 
clinic if desired. Women are encouraged to inform their partners about their participation in 
the trial, and about the gel, but receive no suggestions about how to do this. 
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At the time, Marybelle decides not to tell her husband about the gel at first. She isn’t sure what 
his reaction would be, and feels it might bring some problems in her marriage, so she hides the 
gel. But one day, her husband finds it. He sees it has something to do with sex, and accuses 
her of having a boyfriend; he becomes angry and violent. Marybelle tries to explain that she is 
taking part in a research study, but has difficulty explaining the details.  
On her next clinic visit she confides in her ‘follow-up’ worker, Maureen, who offers to talk to 
Marybelle’s husband. Marybelle is doubtful that her husband will come to the clinic himself, so 
Maureen visits their home to talk to him. 
During the visit, Marybelle’s husband remains very quiet. He accepts the information sheet, but 
does not ask any questions. Maureen leaves the home a bit worried that Marybelle will soon 
withdraw from the study. However, some weeks later Marybelle tells Maureen that her 
husband has read the information sheet and now ‘really likes the study’. She says: ‘He just 
needed to take his time, and understand slowly.’ 
QUESTIONS 
 Why do you think Marybelle did not tell her husband at first? 
 
 Who are the participants in this case? The women alone? The couples? Why? 
 
 What do you think about Maureen’s response to the challenge? Could anything else 
have been done? 
 
 Why did the research programme not seek husbands’ consent? What disadvantages 
could there be to asking husbands for consent? 
 
 What impact do you think husbands’ consent (or lack of consent) might have on the 
research findings? 
 
 How far do you think study staff are responsible for ensuring that male partners are 
provided with clear information about the gel? 
 
 How much and in what way should information be provided to men, to ensure 
women’s autonomy and prevent negative consequences? Do you think women and 
men need to be informed, or give consent, in the same ways? Can you think of any 
creative solutions?  
 
 Can you think of other types of project where researchers’ relationships may be 
affected by, or may affect, the study? 
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REFLECTION ON YOUR OWN EXPERIENCES 
Can you think of similar situations from your experience? How did you ensure participants were 
at minimal risk of harm? Looking back now, what could you have done differently? 
FURTHER READING 
Montgomery, C.M. et al. (2008) The role of partnership dynamics in determining the 
acceptability of condoms and microbicides. AIDS Care 20(6), 733–740.  
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OF COURSE WE SPEAK 
ENGLISH: 
COMMUNITY ENGAGEMENT AND 
DISSEMINATING INFORMATION 
FACILITATOR’S NOTES 
Community Advisory Boards (CABs) made up of local ‘opinion 
leaders’ are often a key part of community engagement 
activities. However, it is important to reflect carefully on the 
way researchers and people in the community communicate 
and relate to one another. In this story, CAB members do not 
readily comprehend the study information, yet the researchers 
are unaware of this. On a superficial level this is about the 
language used, but underlying this is a deeper issue of power. 
In the discussion you may wish to consider how the CAB 
members see the researchers, and what this might mean for 
transparency when the two groups interact.  

 
 
LEARNING 
OBJECTIVE 
To appreciate the 
challenges involved 
in communicating 
with people of 
different cultural, 
linguistic, 
educational, and 
socio-economic 
backgrounds, and 
to consider how 
these could be 
addressed in your 
context 
 
 
 
 
 
KEYWORDS 
Community 
engagement 
Dissemination 
Translation 
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OF COURSE WE SPEAK ENGLISH: 
COMMUNITY ENGAGEMENT AND DISSEMINATING 
INFORMATION 
 
 ‘UM… I HAVE A QUESTION: WHAT ON EARTH ARE YOU TALKING ABOUT?’ 
THE STORY 
 Community Advisory Board (CAB) made up of local ‘opinion leaders’ is attached to 
an international research station. The CAB members are chosen on the basis of their 
standing in different groups in the local community: women, teachers, the local 
administration, religious leaders, people living with HIV/AIDS, etc. The researchers at the station 
believe these are people who are respected by others in these groups, and are able to 
explain the research to them as well as raise any concerns or questions from these 
communities. A condition of joining the CAB is a ‘basic’ ability to read, write and speak in 
English.  
The research station operates in a part of Africa where there are several languages used: 
English, a national language, and a tribal ‘mother-tongue’. With so much variation, the 
A
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situation is made more complicated because people who appear to be speaking the same 
language might have different levels of skill and different styles. A highly educated scientist 
living in town but able to speak mother-tongue, for example, may not speak what local 
people call the ‘deep’ mother-tongue used by villagers. Equally, the English used by villagers 
might notbe thesame as the formal English used in scientific work.
 At one particular CAB meeting, several research staff present their new studies to the CAB 
members. They all use different language combinations, but their PowerPoint slides are written 
in English. One of the speakers tries to use mother-tongue, but this has to be repeated (or re-
translated) by another, more local, staff member as people can’t really understand the first 
time. The other speakers use English, parts of which are translated. Questions by CAB members 
are usually asked in English. 
The next day, a visiting social scientist – a much younger student from overseas – holds a focus 
group with the CAB members, asking them what they learnt from the meeting. Out of the four 
projects discussed, the focus group only remember one. They remember all about the disease, 
which captured their interest, but not the details of the study. They say that there were too 
many studies discussed, they weren’t given handouts, and that they were people ‘long out of 
school’, so they ‘need to be taken more slowly’.  
The English-speaking social scientist asks them if they found understanding the English difficult. 
They were indignant! ‘No, we all speak English, that’s why we were chosen!’ ‘True,’ she says, 
‘but there are lots of kinds of English. Did you understand me today, when I welcomed you to 
this discussion?’  
‘Well, no,’ they reply. ‘But Amy [the translator] explained it too.’ The social scientist is horrified. 
‘But you didn’t tell me! I talked for a long time, and you were all nodding, looking like you were 
understanding me.’ ‘Well, yes,’ they say. ‘But you were trying hard. And anyway – we speak 
English too.’ 
A discussion in English then starts up among the CAB members. The CAB Chairman rebukes 
some members for just ‘pretending’ to be ‘learned’, and suggests that these people step 
down in response to the social scientist’s comments. ‘No,’ the social scientist says, ‘I was telling 
you I think you should step up, and feel free to say if you don’t understand.’  
 QUESTIONS 
 How would you describe what happened here? What are the key ethical issues? 
 
 Why do you think knowledge of English was a requirement for the CAB? Should it be? 
 
 Was language the only factor in the CAB members’ not remembering the study facts? 
What other things might have played a role? 
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 Why do you think the CAB members were reluctant to say during the meeting itself that 
they were finding it difficult to understand? 
 
 How about the focus group – could there be different reasons for why they didn’t say 
they weren’t understanding the social scientist at the start? 
 
 What do you think about the CAB chair’s response to the problem? What could this tell 
the researchers about the community? 
 
 Does the limited comprehension of the CAB members matter? What might it mean for 
the research, both ethically, and in terms of scientific accuracy? 
 
 Moving forward, how could communication between the CAB and the researchers be 
improved? 

REFLECTION ON YOUR OWN EXPERIENCES
 Can you think of any similar situations from your experience? How did you deal with 
them? Looking back now, what could you have done differently? 
 
 This case shows that translation can be more complicated than just using a dictionary. 
Accent, local styles, idioms, turns of phrase and so on can also be crucial. What does 
this mean for the way we translate study documents like consent forms, brochures, 
etc.? 
 
COMMUNITY AND FAMILY RELATIONSHIPS                     FACTILITATOR’S NOTES Satanists or scientists? 24 
 
128 
 
SATANISTS OR 
SCIENTISTS?: 
DEALING WITH NEGATIVE 
ASSOCIATIONS 
FACILITATOR’S NOTES 
The purpose of this case study is to invite reflection on ethical 
approaches for individuals and for research organizations 
when addressing community concerns. The story relates what 
happens when a peer recruiter comes under fire through a 
new rumour about the research, and begins to have doubts 
herself. This case study points to the challenges faced by 
community engagement personnel, especially those from the 
local area, and highlights the fact that many people juggle 
several co-existing interpretations of what research is about, 
irrespective of their level of education.  
Rather than being dismissed for their factual inaccuracy, 
rumours can be understood as expressions of genuine 
concern about the means and purposes of foreign-funded 
medical research. Far from being ‘backward’, these can 
reflect very real historical ‘truths’ about encounters between 
researchers and communities in a world of unequal relations.  
LEARNING 
OBJECTIVE 
To appreciate the 
importance of 
taking rumours 
seriously as 
expressions of 
genuine concern 
about the purpose 
of medical research, 
and a starting-point 
for debate – rather 
than dismissing them 
as naïve 
misunderstandings 
which obscure 
scientific ‘truth’ 
 
 
 
KEYWORDS 
Community 
engagement 
Rumour 
Blood 
Peer educators 
Money 
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SATANISTS OR SCIENTISTS?: 
DEALING WITH NEGATIVE ASSOCIATIONS 
 
 
A WEEK IN THE LIFE OF ROSE: THE CHALLENGES OF BEING A PEER EDUCATOR 
THE STORY 
ose has worked as a VCT (Voluntary HIV Counselling and Testing) counsellor for an NGO 
for some years when she hears about a new foreign-funded, one-year research project. 
The project will be a preparation study for a clinical trial of a new product, which aims 
to protect women against HIV infection. Rose joins the preparation study as one of the first 
participants. Because she speaks so freely about HIV to the other women in the waiting room, 
the staff invite her to become a peer educator on the project, and she accepts.  
Rose considers herself lucky and takes her new job very seriously. She speaks about HIV and 
the project both in the research clinic and in her neighbourhood, recruiting many women for 
the study. The job does not come without its problems. People say that she must have HIV – 
otherwise, why does she like to speak about it so much? She’s used to such rumours from her 
previous job, and she knows how and when to address them.  
R
COMMUNITY AND FAMILY RELATIONSHIPS                                          HANDOUT Satanists or scientists? 24 
 
130 
 
But Rose is less prepared for another rumour that begins to circulate after a while, suggesting 
that the researchers are associated with Satanists, and that they take blood from study 
participants to sell it abroad in order to prosper. Why, otherwise, would they need so much 
blood from participants, when an HIV test can be done with only one drop of blood? And why 
would people receive money just for coming to a clinic? Around this time, although not 
related directly to the project, an old woman is burnt alive in the street, accused of Satanism. 
When Rose is giving a talk about the study to a group of women in her neighbourhood, 
people start throwing stones at her. In the market when she is doing her shopping she hears 
people whisper, ‘There’s that lady who works with those Satanists. Her money is tainted.’ All this 
is very unsettling, and Rose’s husband wants her to quit her job.  
The newspapers also find out about the rumours, and a national columnist comments that the 
rumours merely demonstrate the people’s ignorance. Rose considers herself better educated 
than most, and so far, she has understood and identified with the information that her 
employers have offered her about the study procedures. On the other hand, she feels quite 
dizzy herself when blood is drawn from her arm for the study every three months. She wonders 
whether this has something to do with the fact that she had lost quite a lot of blood when she 
gave birth to her last child – or, on the other hand, it might indicate that something bad is 
indeed going on. Her doubts about the research are exacerbated by her memories of an 
older rumour about a batch of birth control pills from abroad, which had allegedly been 
contaminated by a sterilizing agent.  
To counter the rumours of Satanism, the research organization invites all staff to visit the 
laboratory where the blood samples are processed. Rose joins the visit, and is shown how all 
blood samples are incinerated. The research organization also arranges a community meeting 
where study participants explain to their relatives and neighbours what the research project is 
about.  
The rumours do lessen after this, but Rose is still asked occasionally why she works with the 
Satanists. When the preparation study is completed and the ‘real’ trial is about to begin, Rose 
is unsure about whether or not to join it.  
QUESTIONS 
 Do you think Rose discussed her concerns with her employers? If not, why not? How 
could her employers support her better? 
 
 What can rumours tell us about relations between researchers and community? In this 
case, what real concerns are being expressed? What historical truths are being 
reflected? 
 
 How can research organizations address the concerns that rumours raise? 
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REFLECTION ON YOUR OWN EXPERIENCES
 Have you come across rumours associated with medical research? 
 How did these rumours influence your work? 
 How were they addressed by your organization? 
 Can you think of other ways to address the concerns which the rumours express?  
ACTIVITY  
Divide into groups of four to six and discuss the ‘reflection’ questions. Try to formulate 
guidelines on how a research organization could handle concerns and rumours about 
research.  
FURTHER READING 
Fairhead, J., Leach, M., and Small, M. (2006) Where techno-science meets poverty: medical 
research and the economy of blood in The Gambia, West Africa. Social Science and 
Medicine, 63(4), 1109–1120. 
Feldman-Savelsberg, P., Ndonko, F.T., and Schmidt-Ehry, B. (2000) Sterilizing vaccines or the 
politics of the womb: retrospective study of a rumor in Cameroon. Medical Anthropology 
Quarterly 14, 159–179. 
Geissler, P.W. (2005) ‘Kachinja are coming!’: encounters around medical research work in a 
Kenyan village. Africa: Journal of the International African Institute 75, 173–202. 
Geissler, P.W. and Pool, R. (2006) Editorial: Popular concerns about medical research projects 
in sub-Saharan Africa – a critical voice in debates about medical research ethics. Tropical 
Medicine & International Health 11(7), 975–982. Available at: 
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2006.01682.x/pdf (accessed 25 October 
2015). 
Kingori, P. et al. (2010) ‘Rumours’ and clinical trials: a retrospective examination of a paediatric 
malnutrition study in Zambia, southern Africa. BMC Public Health 10(1), 556. 
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THE SHEEP STUDY: 
OLD MEMORIES OF FOOD, BLOOD 
AND DEATH 
FACILITATOR’S NOTES 
This story is designed to encourage you to think about how 
communities remember research. In some communities, 
research has been conducted for many years, sometimes by 
several different organizations. What effect does this have on 
how such communities perceive studies? Sometimes 
researchers complain that participants suffer from being ‘over 
researched’ or from ‘research fatigue’. This story asks your 
students to think more widely about how memories of past 
research might inform perceptions of current or future 
research. It also asks readers to consider what messages 
former research participants are left with. Dissemination of 
research findings is seen as a key aspect of good research, 
but what will participants remember several years down the 
line?  
In exploring this, the story also raises an important point about 
rumours around medical research. Other case studies in this 
collection stress that rumours should be understood more as a 
social commentary on living conditions, rather than as 
‘misinformation’. Here, we add an additional historical 
dimension. Rumours about current medical research may 
speak to collective memories of both past research, and 
rumours about it.
LEARNING 
OBJECTIVE 
To raise awareness 
of the impact of 
community 
memories of 
previous research on 
the success of future 
research 
 
 
 
 
 
 
 
KEYWORDS 
Inducements 
Rumour 
Adverse events 
Blood 
Long-term 
engagement 
Memories of past 
research 
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THE SHEEP STUDY: 
OLD MEMORIES OF FOOD, BLOOD AND DEATH 
 
 
THE CHILDREN WERE CURIOUS – WHAT KIND OF STRANGE PARTY WAS THIS? 
THE STORY 
n this rural part of a Central African country, transnational medical research has been 
conducted by a range of agencies for many years. One of the first studies in the region is 
collectively remembered as ‘the Sheep Study’. The actual purpose and routines of the 
research are long forgotten. What people do remember – or have heard about from their 
parents and grandparents – is that researchers came and cooked a feast for the research 
participants every single day. Villagers who were young children at the time remember 
standing at the research compound’s fence, and watching cooks prepare luxury foods like 
chapati, liver and, most importantly, roasted lamb. These were rare foods, normally reserved 
for funerals or Christmas. One young woman remembers her mother keeping her away from 
the compound for fear that she would be kidnapped by the researchers. Those who 
participated in the research remember visiting the compound every day to ‘take their drugs’, 
which they washed down with soda and the feast.  
Why did the researchers prepare this feast for the participants? The collective memory is that 
the drugs were very ‘harsh’. They couldn’t be taken on an empty stomach, and at that time of 
I
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national famine, stomachs were very empty. What happened to that research? The villagers 
recall it ended somewhat prematurely. People have heard that some participants died some 
years after the study, because the drugs were ‘too strong’. What happened to the 
researchers? They left. Very few people can remember the name of the research 
organization. Just that some of the people in charge were white.  
One of the former local research assistants has a better memory. He recalls that the British 
Principal Investigator had insisted on providing the good food. Some of the staff, he says, had 
told him that that’s what people would expect to eat. The research assistant also remembers 
that, at the time, he thought providing such festive food might make people suspicious. 
‘They’ll wonder what they have to exchange for such a good meal!’ But he didn’t say 
anything to the Principal Investigator. 
After the Sheep Study finished, the researchers left the area and a new research organization 
came in. Although most people today know the name of the newer organization, they aren’t 
clear that they weren’t also responsible for the Sheep Study. Occasionally, when rumours 
surface around new research projects, people remember and talk about the people who 
supposedly died after taking part in the Sheep Study.  
QUESTIONS  
 What does this case study tell us about the ways that participants might remember 
research studies? 
 
 Why do you think the villagers remember the food more than the research itself? 
 
 Do you think the memories of the Sheep Study matter, both practically (for the new 
project) and ethically? 
 
 What could the new research organization do to distance itself from the Sheep Study? 
REFLECTIONS ON YOUR OWN EXPERIENCES 
 What procedures are in place for governing collaboration between research 
organizations in your area?  
 
 Do organizations share their experiences with each other? Are there systems in place to 
streamline the way researchers communicate about what they are doing with the 
community? What is the role of research, and the role of the government, in promoting 
this? 
 
 Have you worked on a research project where former participants remember the 
‘wrong thing’ about the study? What kind of things do they tend to remember? What 
do they forget? What dissemination have you done or could you do to change this? 
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FURTHER READING 
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WILL THEY LEAVE US 
WHERE WE ARE?: 
EXPECTATIONS OF MEDICAL 
RESEARCH INTERVENTIONS 
FACILITATOR’S NOTES 
This story highlights the fact that medical research projects 
often share similarities with projects which try to create more 
immediate change in local communities. For example, when 
compared with NGOs and ‘development’ bodies which have 
a primary goal of improving current conditions, they may have 
a similar physical presence, comparable organizational 
structures and practices, and project activities which seem the 
same to local people. Such similarities may create 
expectations about the goals of the work, and hopes for 
immediate changes. 
The purpose of this story is not to discuss how research 
organizations and their staff should correct this 
‘misunderstanding’. Rather, the case aims to suggest that it 
might be more ethical for research organizations to adopt 
more ‘developmental’ goals, aiming to create both 
immediate and lasting change, as resource-rich and often 
long-term collaborators within both a local community and a 
national health system. 
LEARNING 
OBJECTIVE 
To consider 
similarities between 
medical research 
and other kinds of 
community 
interventions, the 
expectations that 
these similarities may 
create, and the 
possible ways that 
research 
organizations could 
address these issues 
this 
 
 
 
KEYWORDS 
Long-term 
engagement 
Community 
engagement 
Memories of past 
research 
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WILL THEY LEAVE US WHERE WE 
ARE?: 
EXPECTATIONS OF MEDICAL RESEARCH 
INTERVENTIONS 
 
 
 'YES, WHAT REALLY IS THIS ALL ABOUT?' WONDERED LINDA 
THE STORY 
inda has no formal job, but she and her husband have built some rooms to rent in the 
urban shanty town where they live. With her children grown up, and more time on her 
hands, she has become an experienced volunteer in a public health clinic, where she is 
elected a member of the Neighbourhood Health Committee. The sister-in-charge at the clinic 
often sends her to workshops and seminars on various health programmes because Linda is so 
good at communicating what she has learnt to her fellow volunteers. She is trained as a child 
health promoter, and helps distribute food donated by various international agencies among 
families with malnourished children. She is active in her church choir, which often receives 
visitors from abroad, and she also works in one of the local community schools. This school is 
L
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run by a local NGO which has strong connections to an international NGO with offices in the 
city. She likes the way that those involved with the school seem to gain training and 
opportunities. 
Linda is hardworking and very well connected. Because of these connections she is also very 
well informed about what is going on in the community – including what programmes are 
coming to the area. She does her best to share her knowledge and connections with people 
in her neighbourhood. To use a common local expression, she ‘has a heart for the 
community’.  
Because of her position, she is among the first to learn of a new project that is to start at the 
clinic. It is an HIV research project, run by an NGO working with the government to improve 
public health. Linda is ready at the clinic on the first day that local participant recruiters are 
being hired, and she is selected and joins the training. She learns about the purpose and the 
time-frame of the project, and the various activities that will take place. She then begins her 
job recruiting and retaining study participants, and entering various kinds of data into the 
project computers. She enjoys the project meetings, where she learns a great deal and meets 
many influential people. 
Linda can’t help noticing the different ways in which the research organization interacts with 
people’s lives and job prospects. She receives a salary for her work as long as the project lasts. 
It’s a relatively high and much more stable income than she usually gets. Community 
representatives on the liaison board established by the organization are not paid, but receive 
allowances for meetings, various local training opportunities, and access to computer and 
Internet facilities in the meeting room. As for medical personnel, a young doctor Linda knows 
from the clinic is also hired to work for the research organization, and receives a lot of training 
abroad, ending up with a degree from a foreign university. At the same time, nurses working in 
local public clinics are sometimes hired by the researchers, but when the project finally ends 
after several years, they find it difficult to get a position in their old organizations. 
When the project ends, Linda finds things are much the same as when it started. People are 
still getting sick with HIV and dying. All her years of effort have provided some extra income, 
but created little change in the community, and given her nothing to help her move into 
another similar job. Looking back, Linda feels less positive about overseas research projects 
than before. Talking about projects with her many contacts, she starts to express the opinion 
that the foreign researchers ‘come and take our information and then leave. They leave us 
where we are, without empowering us. If we volunteer for them we don’t get trained so that 
we can get a job afterwards.’  
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QUESTIONS  
 What are some of the similarities between medical research organizations and other 
projects which might operate in local communities? What are the differences? 
Consider the organizations’ structure, physical presence, employment and recruitment 
strategies, and goals. 
 
 What do you think about the way the research organization treats the different people 
who get involved? Do you think this might create problems? If so, for whom?  
 
 Why do you think it is difficult for local health workers to move between the public 
health system and the international research project? 
 
 What do you think about Linda’s expectations of the project? Do you think she should 
be satisfied with her experience? Or should the research organization do more to 
address immediate problems in the area? 
 
 Should the research organization start to pay all its participants? What might this mean 
in terms of practicalities on the ground, the quality of data, and research ethics? 
 
 Are there other ways the research organization could try to alleviate poverty in the 
area, in order to limit some of these problems? How far do you think a research 
organization should go in assisting the wider community? 
 
 Who do you think should be involved in deciding on the objectives of overseas projects 
in local areas?  
REFLECTION ON YOUR OWN EXPERIENCE 
 Have you come across expectations about medical research projects, which your 
organization had not planned for? 
 
 How did your organization respond? Could things have been done differently? 
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SEEING IS BELIEVING: 
TRIAL REGULATIONS VS. 
COMMUNITY ENGAGEMENT IN AN 
EBOLA VACCINE TRIAL 
FACILITATOR’S NOTES 
The story, set in the context of an Ebola outbreak, focuses on 
the difficulty of balancing internationally agreed protocols 
with demands in the field and the nature of social relationships 
between local staff and community members. Ethical 
guidelines can often feel detached from the realities of 
everyday interactions and can put staff working on clinical 
trials in difficult positions when the demands of the trial run 
counter to those of social relations on the ground. There are 
three key issues to be explored in this case study. 
The first has to do with the fact that employees in an Ebola 
vaccine trial are not allowed to take the trial vaccine. The 
study coordinator calls this the ‘conflict of interest rule.’ The 
idea behind this is that employees may feel pressured to take 
the vaccine that their employer is trialing, and this would put in 
question the voluntary nature of their participation. In the 
context of an outbreak, this restriction for local staff inevitably 
raises concerns that do not arise when clinical trials are being 
done outside of epidemic settings. The case study thus 
requires the reader to think about how standardised ethical 
protocols may present different questions depending on the 
context in which they are taking place. 
Secondly, the market trader’s insistence that ‘seeing is 
believing’, brings up the issue of trust and social relations. The 
fact that two trial staff, John and Jane, are from the 
community where the trial is taking place and that, Hawa the 
market trader, is Jane’s mother in law should lead us to reflect 
on the complexity of social relationships and the challenges 
faced by local staff when attempting to navigate the difficult 
terrains of community engagement in vaccine trials. 
LEARNING 
OBJECTIVE 
To explore the 
challenges of 
balancing the 
demands of 
internationally 
agreed protocols 
with demands in the 
field during an 
epidemic 
 
 
 
 
 
KEYWORDS 
Rumour 
Study rules 
Recruitment 
Community-based 
fieldworkers 
Community 
engagement 
Outbreak 
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Community members’ concerns with the fact that local trial staff cannot take the vaccine 
should also prompt the reader to think through motives for participating in vaccine trials and 
the prominent role played by social relations and trust in community members employed by 
the study - especially under conditions of an outbreak or emergency.  
Finally, the emergence of a rumour surrounding the potentially sinister motives of the vaccine 
trials depicts how anxieties surrounding vaccine trials - amplified by an epidemic – can be 
articulated through hearsay and how they can be understood as products of fears and 
mistrust. Furthermore, Jane’s difficult personal experiences and her suggestion that perhaps 
she ought to lie about her ability to take the vaccine also suggest the very real worries that 
rumours create amongst trial staff both in terms of their potential impact on the running of the 
trial itself but also, and more importantly, in terms of the damage that they may cause to 
social relationships that will outlive the presence of the trial in the community. 
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SEEING IS BELIEVING: 
TRIAL REGULATIONS VS. COMMUNITY ENGAGEMENT 
IN AN EBOLA VACCINE TRIAL 
 
 
‘WHEN WILL YOU TAKE THE VACINE MY CHILD?!’ 
THE STORY 
ohn and Jane are community liaison officers in an Ebola vaccine trial taking place in the 
middle of an Ebola epidemic. Because they are employed by the trial, John and Jane 
are told by their managers that they cannot receive the vaccine candidate, as it would 
constitute a conflict of interest’. They are not entirely sure what this means. Despite their 
concerns about contracting the disease and their disappointment about not being able to 
receive the vaccine, John and Jane decide that they really want to be involved in the fight 
against the virus in their own community, and continue to work for the project.  
As the trial gets underway, John and Jane are asked to organize community meetings to 
introduce the vaccine and to explain the modalities of the trial, including the fact that 
J
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participation is entirely voluntary. Their first meeting is with a group of market traders and is 
held in the hall of the town’s market. After having given a short presentation about the trial, 
John and Jane open up the floor for questions. The first to ask a question is Hawa, the leader of 
the market traders – and Jane’s mother in law. Hawa asks when the traders can expect to see 
Jane, John and all of their colleagues receiving the Ebola vaccine. “Seeing is believing”, she 
adds, and says that once they have seen them take the vaccine publicly, people in the town 
will feel more confident in taking part in the trial. Jane and John look towards their supervisor, 
who nods to suggest they must tell the audience about the conflict of interest rule that 
prevents them from taking the vaccine. Once they have finished explaining, Hawa asks: “But 
you are our children, how do you expect us to take this if you won’t?”  
A few days after the meeting, rumours begin spreading that the trial vaccine is a slow poison, 
which will infect those who take it with Ebola to cause another epidemic in a few years’ time. 
This, the rumour goes, is the reason why trial staff will not take the vaccine publicly. The study 
coordinator calls John and Jane to a meeting to discuss ways of addressing these concerns. 
At the meeting, Jane tells the coordinator about the market trader meeting, and that her 
mother in law has stopped talking to her and that people in her compound no longer trust her. 
She asks if they can tell the community that trial staff will in fact be allowed to take the 
vaccine in the near future.  
QUESTIONS  
 What are the ethical issues at stake?  
 
 What do you think is the ‘conflict of interest’ alluded to that excludes staff from 
receiving the trial vaccine?  
 
 What do you think about the decision of excluding staff from the trial during an 
epidemic?  Do you agree or disagree? Why? 
 
 Why do you think it was so important to Hawa that Jane and John take the vaccine in 
front of community members? Do you think it is fair of Hawa to expect Jane and John 
to take the vaccine? 
 
 How can we explain the rumours emerging in town after the meeting with the market 
traders? 
 
 What do you make of Jane’s suggestion that she tells the community staff will take the 
vaccine later? Why do you think it is important to her that the community thinks she will 
be taking the vaccine at a later stage? 
 
 What are the possible responses the study coordinator could give to Jane’s idea?  
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REFLECTIONS ON YOUR OWN EXPERIENCE 
 Have you experienced anything similar? How have you dealt with the possibility of 
losing community members’ trust?  
 
 Can you think of any other examples where the trial’s regulations come into conflict 
with local staff’s commitments to their communities? 
 
 What are the key ethical differences between a trial under outbreak conditions and a 
routine trial on prevention or treatment of endemic disease? 
ACTIVITY 
Divide into groups of 4 and devise a community liaison strategy for countering rumours that 
the vaccine is slow poison and a communication strategy around why trial staff are not 
allowed to take the vaccine. 
FURTHER READING 
Marsh, V., Kamuya, D., Mlamba, A., Williams, S., Molyneux, S. (2010) Experiences with 
community engagement and informed consent in a genetic cohort study of severe childhood 
diseases in Kenya.  BMC Medical Ethics, 11-13. 
Global Campaign for Microbicides (2004) Mobilization for Community Involvement in 
Microbicides Trials: A Report from a Dialogue in Southern Africa. Washington DC, USA. 
Accessed 27th June 2016: http://www.global-campaign.org/clientfiles/SA-community-
involvement.pdf  
Larson, H., Cooper, L., Eskola, J., Katz, S., Ratzan, S. (2011) Addressing the Vaccine Confidence 
Gap.  The Lancet 378:9790, 526–535. 
Hantel, A., Olopade, CO. (2015) Drug and Vaccine Access in the Ebola Epidemic: Advising 
Caution in Compassionate Use. Ann Intern Med 162, 141-142. 
ANTHROPOLOGY AND EBOLA WEB RESOURCES 
The Ebola Response Anthropology Platform: http://www.ebola-anthropology.net/ . Accessed 
27th June 2016.  
Series of anthropological blogs on Ebola:  http://somatosphere.net/series/ebola-fieldnotes . 
Accessed 27th June 2016.  
Anthropology and Ebola Communication page on the Ebola Communication Network 
website: http://ebolacommunicationnetwork.org/anthropology-and-ebola-communication/ 
Accessed 27th June 2016.  
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INSTITUTIONAL RELATIONSHIPS 
 
TRAINING CASE STUDIES 
 
 
‘DO TOO MANY COOKS SPOIL THE BROTH OR MAKE IT BETTER?’ WONDERED THE CHAIR OF THE RESEARCH 
STAKEHOLDERS FORUM
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INSTITUTIONAL RELATIONSHIPS 
CASE STUDIES 
 
Global health research relies on a series of 
collaborations: collaborations between 
countries, governments, institutions, funders and 
agencies – all with their own logics, agendas 
and staff. The institutions involved in 
collaborative research often have very different 
resources, connections and power; for example, 
a leading US teaching hospital and a medical 
faculty at an African state university have 
different access to technology and training.  
These imbalances are often but not always in favour of the Northern 
partner; in some situations, specific local knowledge or political and other connections can be 
decisive for the viability of research. Overall, however, more resources equal greater power. 
This is why collaboration between 
professionals from these different institutions 
is such challenging terrain. 
In addition to scientific institutions and 
universities, transnational collaborative 
medical research often involves working 
with, within, or in consultation with 
government health services. In this context, 
differences in training, expectations, 
resources and standards of care between 
medical research projects and local 
healthcare facilities can be sources of 
tension in official relationships. Many of the 
case studies in this section are stories about 
this. How can and should research handle 
these healthcare-related differences? How 
can we both conduct good research, and 
contribute to good public health in these 
circumstances?
FURTHER READING 
Lairumbi, G.M. et al. (2008) Promoting the 
social value of research in Kenya: examining 
the practical aspects of collaborative 
partnerships using an ethical frame. Social 
Science and Medicine 67(5), 734–47. 
Moyi Okwaro, F. and Geissler, P. W. (2015), 
In/dependent Collaborations: Perceptions 
and Experiences of African Scientists in 
Transnational HIV Research. Medical 
Anthropology Quarterly 29, 492–511 
Lachenal, G et al (2016) Neglected Actors in 
Neglected Tropical Diseases Research: 
Historical Perspectives on Health Workers and 
Contemporary Buruli Ulcer Research in Ayos, 
Cameroon. PLoS Neglected Tropical Disease 
10(4): e0004488 
MY DATA OR OUR DATA? 
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TOO MANY PEOPLE 
HAVE TURNED UP! 
ADDRESSING STAKEHOLDERS’ 
CONCERNS 
FACILITATOR’S NOTES 
This case study is about relationships between collaborative 
research programmes on the one hand, and government 
officials and other local stakeholders on the other. In the story, 
researchers aim to respond constructively to complaints about 
their work, but their efforts do not seem to solve the immediate 
problem. How can research organizations develop 
constructive and mutually beneficial collaborations in this type 
of setting, without placing themselves under unreasonable 
obligation, or going beyond their remit and responsibility?  
The story raises questions about divergent obligations and 
expectations, and also about power relations, including the 
sovereignty of both local officials and the researchers. 
Questions about power, transparency, communication, 
obligations, and expectations are at the heart of this story, 
and are likely to emerge in your discussion.  
You could also consider the main criticisms raised by the senior 
government official in the story, and discuss them one by one. 
Your discussion should acknowledge that some of these 
comments include an implicit appeal for access to resources 
and ‘fringe benefits’, and consider how the research 
organization could respond.
LEARNING 
OBJECTIVE 
To consider ways of 
developing 
constructive and 
mutually beneficial 
relationships with 
local collaborators, 
given differing 
priorities and the 
limits of a research 
organization’s 
responsibility and 
resources 
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TOO MANY PEOPLE  
HAVE TURNED UP!: 
ADDRESSING STAKEHOLDERS’ CONCERNS 
 
 
SUDDENLY THE ROOM FELT A LITTLE CROWDED! 
THE STORY 
arah is a community relations officer at a large international research centre which 
operates in a rural area of Malawi. The research at this field station includes demographic 
health surveillance, malaria research, and HIV treatment and prevention studies.  
In the course of Sarah’s work, she attends a ‘health stakeholders’ forum’ every three months, 
where she is frequently attacked with numerous questions. These are mostly about the way the 
research collaboration operates, how it is financed, why it does not collaborate more with 
local universities and NGOs, and why senior staff haven’t visited senior officials. At one 
meeting, the senior government officer who is acting as chair requests that the national and 
international directors of the research programme arrange to see him next week. By the time 
the meeting closes, it is late on Friday afternoon, and it takes Sarah another hour to return to 
the main research offices by Land Cruiser.  
S 
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On Monday morning Sarah informs the national and international director about the 
complaints voiced at the meeting. A large group of senior international and national 
researchers and administrators are immediately dispatched to visit the senior government 
officer in two Land Cruisers. En route, Sarah tries to ring his office to inform him that they are 
coming, but the mobile network is down and she cannot get through. During the journey the 
team try to understand what has led to this situation. One African scientist comments, ‘It is well 
within the senior government officer’s jurisdiction to close the research programme down.’  
It is about 10.30 when the team arrive at the governmental offices. The senior government 
officer is out at meetings, but due back shortly. His secretary tells the team to wait, and records 
everyone’s name in the appointments book. Before long, the senior officer arrives, and after 
greeting everyone his first comment is: ‘Too many people have turned up.’ With difficulty, his 
secretary finds enough chairs to accommodate everyone in his office.  
During the introductions the senior government officer stresses that he has been in post for 
several months, and this is the first time that he has received a formal visit from anybody from 
the research centre. He starts by summarising the complaints voiced at the meeting, 
specifically highlighting the need for researchers not to bypass senior council and 
governmental leaders. He also explains that stakeholders from NGOs and local universities feel 
excluded from contributing to health development in the areas where the research 
collaboration operates.  
The team reply that, since a lot of their research is community-based, they have primarily 
focused on establishing several community advisory boards, and consulting with local 
government officers. ‘This is good, but not good enough,’ the senior government officer 
responds. He sums up by saying, ‘If you work in isolation you will have people fighting against 
you. We need a new start. How should we proceed?’  
QUESTIONS  
 What were local stakeholders’ concerns about the research programme?  
 Why do you think the stakeholders raised these issues in the way they did?  
 Do you think Sarah should attend the stakeholder forum meetings alone? What do you 
think this says about how seriously the research organization takes stakeholder 
engagement? 
 Do you think the research organization should take the requests ‘at face value’, or do 
you think the comments may have contained underlying demands, which were not 
stated clearly? What do you think these might be? 
 What do you think the senior government officer expected to see happen after the 
stakeholders’ meeting, both immediately and in the longer term? Do you think things 
went as he expected?  
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 What do you think about the research organization’s response to the stakeholders’ 
complaints? Why were so many people from the research programme dispatched to 
see the senior government officer? Do you think this was a good idea? 
 Why do you think the senior government officer might have been concerned about the 
number of people who turned up? What does this tell you about his intentions? 
 What do you think about his comment about local healthcare provision in the area? 
 What were a) the researchers and b) the senior government officer trying to get across 
in the meeting?  
 How do you think the government official could ‘close down’ the programme if he 
decided to? 
 How should the director of the research collaboration respond to this situation now?  
 Do you think there is a need for ‘personal relationships’ even in community-led projects, 
and if so, how far do these extend?  
 Do you think research organizations should try to work with in-country institutions such as 
NGOs and universities? Why?  
 Do you think that local and national government officers should have a say over how 
research operates? If so, how do you think this should work? What kind of projects 
would this be more, and less, appropriate for? 
ACTIVITY 
Split into groups of four to six and try to develop a community engagement strategy, with a 
particular focus on how you will involve leaders from the local government administration. 
Think carefully about how to support collaboration, and how to negotiate explicit and implicit 
expectations.  
FURTHER READING 
Emanuel, E.J., Wendler, D., Killen, J., and Grady, C. (2004) What makes clinical research in 
developing countries ethical? The benchmarks of ethical research. Journal of Infectious 
Disease 189, 930–937. 
Meslin, E.M. (2008) Achieving global justice in health through global research ethics: 
supplementing Macklin’s ‘top-down’ approach with one from the ‘ground up’. In: Green, R.M., 
Donovan, A., and Jauss, S.A. (eds.) Global Bioethics: Issues of Conscience for the Twenty-First 
Century. Clarendon Press, Oxford, UK.
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DATA TROUBLES: 
COLLABORATION AND THE 
FUTURE OF PARTNERSHIP 
FACILITATOR’S NOTES 
This case study is about the nature of partnership in research 
collaborations, with a focus on equality and involvement in 
decision-making, and access to and use of patients’ health 
data. It raises questions about the ownership of patients’ 
health records, their purpose (clinical and scientific), how this 
data should be used, and who stands to benefit from this 
resource.  
The ethics of data sharing, and the development of policies 
and guidelines to support practice, are currently receiving 
much due attention from regulatory bodies, bioethics 
councils and medical institutes. You can access more 
information about this consensus work via the links provided 
under ‘Further Reading’. Please note, however, that this is an 
evolving discussion, so you may want to look into the most up-
to-date guidance from these bodies. The topics discussed in 
this consensus work are very relevant to this case study. They 
include rules of engagement, protecting patient 
confidentiality, and the need for frameworks that facilitate 
the responsible sharing of clinical and trial data in the interests 
of public health.  
Deciding on rules of engagement or drawing up memoranda 
of understanding is a critical process in research 
collaboration, and one that may need to be revisited and 
renegotiated over time. In the story below, the research 
relationship started informally and was established in a spirit of 
networking. Both parties benefited from this relationship: the 
doctor’s workplace was improved and could serve more 
patients, and the scientist accessed valuable data to further 
his research. Over time, however, the doctor begins to sense 
that his therapeutic expertise is being sidelined in favour of 
LEARNING 
OBJECTIVE 
To explore access 
to, use, and 
ownership of 
participants’ health 
data in 
collaborative 
medical research, 
and through this to 
reflect on 
collaboration 
between unequal 
partners 
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capturing research-quality data. He also starts to question the equality of the collaboration, 
given that the scientist assumes primary ownership of the data and fails to actively involve him 
in the dissemination of findings and plans for new studies. The fact that communication 
between both parties is very limited contributes to the deterioration of the relationship. In your 
session you could ask participants to think about how this situation could have been 
prevented, or rectified.  
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DATA TROUBLES: 
COLLABORATION AND THE FUTURE OF PARTNERSHIP 
 
 
DR SEKIDDE WAITED PATIENTLY FOR THE ACKNOWLEDGEMENT THAT NEVER CAME 
THE STORY 
usa Sekidde is a doctor in a local clinic. For about ten years, he has been keeping a 
register of his patients who are taking antiretroviral therapy. The ledger contains key 
information including each patient’s identity, address, therapeutic regimen and 
disease progression.  
About five years ago Dr Sekidde attended an HIV medicine training programme where he 
met Dr Martha Smith, a professor of medicine and epidemiology from a UK university. Dr Smith 
had been working in the capital but was looking for a clinic where she could conduct 
research among a rural population. She was very impressed with the detail and rigour of Dr 
Sekidde’s bookkeeping and, after visiting Dr Sekidde’s facility, Dr Smith proposed a research 
partnership. During the discussions, Dr Smith also promised to create and donate a computer 
database of patient records. Dr Sekidde accepted her proposal.  
M
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Initially, the collaboration worked well. Dr Smith’s study was well-funded and Dr Sekidde’s clinic 
was transformed from a basic facility to one that could accommodate several thousands of 
patients comfortably. However, despite these positive changes, a few things began to bother 
Dr Sekidde. For one thing, his clinical expertise was constantly being sidelined. Dr Smith was 
only interested in data that could be gathered through advanced diagnostic technologies 
(which she had also donated to the clinic), and she showed no interest in her colleague’s 
clinical observations. In addition, while the computer-generated clinical forms looked 
‘smarter’ then the exercise books that Dr Sekidde had used previously, they took considerable 
time to fill out, and missed out important information about the physical status of patients – 
details which were being carefully elaborated in the hand-written records. More troubling was 
that Dr Smith continued to refer to the patient database as ‘hers’ when presenting findings at 
a number of international conferences. While she always included Dr Sekidde as co-author, 
more often than not Dr Smith only shared the slides with him after they had been presented. Dr 
Smith had also mentioned to Dr Sekidde in passing that she was planning to apply for further 
funding to conduct studies with Dr Sekidde’s patients, but a full proposal had not been 
formally discussed.  
Things come to a head when a Norwegian research team approaches Dr Sekidde to 
collaborate on a project investigating patient adherence to treatment. Dr Smith expresses her 
concern that she was not approached for the permission to use the database. It had, after all, 
been set up with her grant money, which was continuing to provide training to the clinic’s 
staff. However, in Dr Sekidde’s view, the database constituted a donation to the clinic. He 
knew that the collaboration came with certain expectations, but felt that the clinic had more 
than compensated for this ‘gift’ by giving Dr Smith access to Dr Sekidde’s ‘valuable patients’.  
 
QUESTIONS  
 What makes Dr Sekidde feel uneasy about the collaboration? Are his anxieties justified? 
 What about Dr Smith’s concerns? In which ways is the database hers and in which ways 
is it not?  
 What do you think the implications might be for Dr Sekidde if he collaborates with the 
Norwegian team? What do you think he should do?  
 Should the Norwegian team have contacted Dr Smith first? 
 Who owns the computerized database and who has the right to use it for research? 
Who has priority?  
 In what ways are Dr Sekidde’s patients valuable? For whom, and in what ways?  
 What rights do the patients have with regard to their data? 
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 What does this story demonstrate about some of the advantages and disadvantages of 
international collaboration?  
 What measures could have been taken to prevent conflict between the collaborators? 
REFLECTION ON YOUR OWN EXPERIENCES 
 In your own research setting, are there guidelines for data sharing and management?  
 Whose interests do these guidelines protect?  
 What are the advantages and disadvantages of formalizing plans for access to data 
and ownership of patient information? What are the pros and cons of more informal 
agreements?  
ACTIVITY 
Divide participants into small groups of four to six and ask them either to critique any existing 
guidelines for data sharing used at your institution, or to agree on key components of data-
sharing agreements. Ask them to use the questions above to guide their discussions, and to 
consider the rights of patients concerning the use of their data in research.  
FURTHER READING  
Crane, J.T. (2011) Scrambling for Africa? Universities and global health. The Lancet 377(9775), 
1388–1390. 
Lang, T. (2011) Advancing global health research through digital technology and sharing 
data. Science 331(6018), 714–717.  
Petryna, A. (2007) Clinical trials offshored: on private sector science and public 
health. BioSocieties 2(1), 21–40. 
Ongoing consultations in the area of data sharing:  
Bioethics, Research Ethics & Review. The ethics of data sharing. Available at: 
https://globalhealthreviewers.tghn.org/community/blogs/post/988/2013/11/the-ethics-of-
data-sharing/ (accessed 25 October 2015).
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BETWEEN ENVY, 
SUSPICION AND 
DESIRE: 
EMBEDDING RESEARCH IN 
GOVERNMENT HEALTHCARE 
FACILITIES 
FACILITATOR’S NOTES 
This case study invites us to consider what can happen when 
research is embedded in regular state healthcare facilities. 
The story describes an intervention where extra equipment 
and staff training is provided to health facilities in the 
intervention arm of a trial. In addition to the trial, a sub-sample 
of children that attend the facility are followed closely to 
measure the impact of these additions on morbidity. In theory, 
anyone receiving services at the facilities in the intervention 
group should benefit from this research, as it should raise 
standards across the facility as a whole. In practice, however, 
children enrolled in the sub-study receive more attention than 
other patients, and receive travel reimbursements to reach 
the clinic. This special treatment distracts peoples’ attention 
away from the wider efforts to improve the quality of care 
provided across the whole facility, and gives rise to envy.  
Be careful to stress both the advantages and disadvantages 
of embedding research into routine healthcare settings, and 
encourage attendees to think about how to address some of 
the problems that can arise. As an example of a research 
project with multiple layers (a main intervention and a sub-
study) this story is also helpful for thinking through the 
challenges of describing complex research.  
LEARNING 
OBJECTIVE 
To consider how 
research can 
change the 
landscape of 
healthcare 
provision, and to 
discuss how 
researchers can 
promote 
constructive 
collaboration with 
routine healthcare 
staff and local 
communities 
 
 
KEYWORDS 
Government 
Standards of care 
Inducements 
Research versus 
care 
INSTITUTIONAL RELATIONSHIPS                                              HANDOUT Between envy, suspicion and desire 30 
 
157 
 
BETWEEN ENVY, SUSPICION AND 
DESIRE: 
EMBEDDING RESEARCH IN GOVERNMENT 
HEALTHCARE FACILITIES 
 
 ‘WHY IS HER CHILD GETTING SPECIAL TREATMENT?’ 
THE STORY  
 trial has taken place to improve the quality of services provided in lower-level 
government health facilities in a designated area. The intervention was funded by a 
Northern philanthropic foundation through a European university, collaborating with a 
major African teaching and referral hospital.  In half of the area’s health facilities, chosen by 
randomization, health workers were given extra training and the facilities were supplied with 
new diagnostic equipment. To test how well the project has worked, researchers compare 
comments from community members who attend the health facilities in the intervention arm 
with those who attend the facilities in the control group. 
In addition, researchers randomly select a cohort of children from households across the area, 
to measure the impact of the project on disease. The children are periodically visited in their 
A
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homes by members of the study team. They are also given a special card to present during 
their visits to the health centres, to record all treatments provided. For all such visits, the 
caregivers are provided with transport – either reimbursed in cash or picked up by the project 
car to get to and from the facility. The treatment records are collated as part of interviews 
conducted by fieldworkers in participants’ homes. As a ‘token of thanks’, participants and 
their families are given sugar and tea on these occasions. 
At the end of the study, a group discussion is called by the project’s social scientists, to talk 
about patients’ experiences of the project. This meeting is facilitated by two social scientists 
from the study team. Most of the people in the group say they have not noticed any 
improvements in the quality of the service at their health centre – even those who have been 
visiting clinics, which received the extra funding and training. But one participant, a lady in her 
early thirties, protests, stating that she always received excellent service at the health facility: 
‘For me, every time I visit I receive proper treatment – they examine my child and provide me 
with the required medication.’  
The other participants jeer and sharply disagree: ‘It is because her child is enrolled in this 
special group that she gets preferential treatment.’ The lady in question agrees. But another 
participant argues that enrolment in the sub-study was no guarantee of good service. Rather, 
she has found that healthcare providers actually discriminate against the children who are 
enrolled in the special group. She explains: ‘The staff at health centre, they tell you that you 
are just faking your illness so that you can get money from the study team. And when you try 
to explain the illness they tell you that you should not feel so special, and should stop telling 
them what to do’. 
In the course of the discussion there appears to be a consensus that services have not 
improved in any of the health centres, and that participating in the sub-study led to one or the 
other form of discrimination by nurses in the centres – with the exception of the one discussant 
who expressed satisfaction.  
Yet, despite the mainly negative comments about the treatment of children enrolled in the 
special study, and no one mentioning improvements in the intervention facilities, some of the 
participants raise some new questions as the discussion draws to a close: Why did the study 
team not visit their own village? Why hadn’t they enrolled any children from their village? ‘Ever 
since this study started, I have never seen any members of the study team in our village. Is it 
because they do not think we have problems, or what? Or is it because the study nurse prays 
together with the head mistress there?’ Addressing the moderator directly, one person adds: 
‘Please tell your people that we also have problems in our village and we need your help.’ 
The social scientists end the meeting at a loss as to what to respond or what to tell their 
colleagues.  
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QUESTIONS  
 What ethical and practical issues are raised by the somewhat contradictory positions 
expressed in this discussion?  
 How do research activities alter the landscape of healthcare, and what ethical issues 
emerge from inclusion and exclusion in research projects? 
 How can we explain the tension between suspicion and desire among research 
participants? 
 How can we explain the reported behaviour of the health facility staff?  
 How do you think this situation could be avoided or managed? 
REFLECTION ON YOUR OWN EXPERIENCES 
 From your experience, are research participants keen to enter new projects, or are they 
suspicious – or both? How are these emotions expressed? 
 What different kinds of reactions and behaviours have you observed among 
healthcare personnel, when engaging with medical research projects?  
FURTHER READING 
Street, A. (2012) Affective infrastructure: hospital landscapes of hope and failure. Space and 
Culture 15(1), 44–56. 
Sullivan, N. (2012) Enacting spaces of inequality: placing global/state governance within a 
Tanzanian hospital. Space and Culture 15(1), 57–67.
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THE END OF A TRIAL: 
POST-TRIAL RESPONSIBILITES AND 
RELATIONSHIPS 
FACILITATOR’S NOTES 
This case study raises difficult questions about the blurred lines 
between health research and medical care in places where 
access to routine healthcare is limited. In such settings, it is 
arguably unethical to conduct research without catering for 
study participants’ general healthcare needs. But what are 
the appropriate boundaries for this care? For whom are 
researchers responsible, and for how long?  
In this story, the research team agreed to a request from a 
village elder to extend the provision of free healthcare to all 
villagers, instead of just restricting it to study participants, and 
worked hard to establish a continuity of care for both 
participants and employees. This created a good rapport 
between the research programme and the community, and 
supported trial recruitment. Now, however, the research team 
leader faces a difficult situation: the trial has ended with no 
prospect of new research involving the same participants in 
the near future. This creates difficulties for both participants 
and staff, and might threaten other future projects. So how 
should research organizations prepare for such situations? How 
can they manage community expectations, and what can 
they do to mitigate negative effects?  
There are no easy answers, but you could get participants to 
think about the advantages and disadvantages of 
researchers’ working closely with routine healthcare providers; 
the need to make funders and research sponsors more aware 
of these challenges; and the need to be realistic and 
practical in managing community expectations. 
LEARNING 
OBJECTIVE 
To consider the 
problems of ending 
trials when research 
has become a 
major part of the 
healthcare 
landscape, and to 
identify solutions for 
managing these 
challenges 
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THE END OF THE TRIAL: 
POST-TRIAL RESPONSIBILITIES AND RELATIONSHIPS 
 
 
STAFF WERE NOT PLEASED TO RECEIVE THEIR END OF CONTRACT LETTERS 
THE STORY 
kono, the trial coordinator of a large-scale three-year vaccine trial which is ending, 
has called a final staff meeting. It is two weeks since the last blood samples were 
collected, and it’s essential to get everyone together before the staff leave for home 
for good. Sitting around a seminar table, he assures the 25 nurses, fieldworkers, and drivers that 
they will all be receiving reference letters from the trial, but that it is uncertain when a new 
research project might begin. It seems unlikely that he can retain most of the team on 
contract.  
Privately, Akono is frustrated. In the past, the projects that he has managed have followed on 
from each other quickly, allowing him to re-hire and extend staff contracts. There are 
fieldworkers in this group that he has worked with for over ten years – workers who know the 
A
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local communities, and are well known and accepted. The current gap after the end of this 
project means that if a new study starts, not only will he have to retrain a whole new group, 
but he’ll also need to rebuild the trust this team has worked so hard to establish with the 
community. ‘If it were up to me,’ he tells the group, ‘I would keep you all on staff. 
Unfortunately, it is not; funding decisions are outside of my scope. This is up to the donors and 
people up there. Does anyone have any questions?’ 
Ebrima, a project nurse who has been stationed in a remote village at the edge of the study 
area, raises his hand. ‘We have been living with them for almost three years, sharing meals, 
taking care of their families when they are sick. We are giving them the vaccine and then we 
are leaving. They worked hard with us and we are letting them down. It is not right.’ 
Akono has anticipated these concerns. With nurses living with communities for months on end, 
a number of close connections and friendships have formed between staff and their patients. 
Ebrima, he knows, took his job very seriously, and many of the participants from that village 
spoke very highly of him and the quality of his care. ‘Yes, I know they will not be happy,’ 
Akono responds. ‘But they knew this was a research project. It has a beginning and an end.’  
Ebrima is not convinced. ‘The station is still here and other projects will come in the future, 
perhaps even soon. We could continue working with them until the next one comes. At 
community level, it would help a great deal. If we leave just like that, the next time they will 
say “You people, we only see you when you want something from us and then we don’t see 
you again.”’ 
Akono is beginning to get irritated. He knows that bad community feelings could have serious 
repercussions for future research – and also for his own job success. To enrol the necessary 
numbers into this vaccine trial he spent weeks in discussions with village leaders, and worked 
hard to meet their demands. He even extended the provision of free healthcare from 
volunteers and their families to all residents within a participant village. A resentful nurse, 
especially one who has just lost his job, is exacerbating an already difficult meeting. ‘Like you,’ 
Akono replies abruptly, ‘participants are on a contract. Your job now is over.’  
As he leaves the meeting, Ebrima shakes his head. ‘I don’t know how they are going to tell 
them but it is going to be a big problem. We are from the same community and I will meet 
them, at festivals, in town. How can I look them in the eye?’  
QUESTIONS  
 What are Ebrima’s main concerns? What are Akono’s? And what are the research 
participants’? 
 In which ways do these concerns overlap, and in which ways do they not?  
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 What do you think about Ebrima’s suggestion? Is keeping a nurse posted in a study area 
after the end of a trial a good idea? Why, or why not? What about the practicalities? 
 While funding decisions are beyond Akono’s control, are there other things he could do 
to make things easier for staff and participants? How, and why, might the project 
planners support him in this? 
REFLECTION ON YOUR OWN EXPERIENCES 
 In your own research setting, what are the procedures when trials come to an end? 
 How do local people understand the timeframe of research, and what are their 
expectations of the relationship with staff?  
 How have you managed these expectations in the past? What are the risks – for 
participants and staff – of associating research with healthcare? What are the benefits? 
FURTHER READING 
Kelly, A.H., Pinder, M., Ameh, D., Majambere, S., and Lindsay, S. (2011) ‘Like Sugar and Honey’: 
the embedded ethics of a larval control project in The Gambia. Social Science & Medicine 70 
(12), 1912–1919. 
Lairumbi, G.M. et al. (2011) Ethics in practice: the state of the debate on promoting the social 
value of global health research in resource-poor settings, particularly Africa. BMC Medical 
Ethics 12(22), 1–8. 
Will, C.M. (2011) Mutual benefit, added value? Doing research in the National Health 
Service. Journal of Cultural Economy 4(1), 11–26. 
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HELPING HAND: 
WORKING WITH PUBLIC HOSPITALS 
 
FACILITATOR’S NOTES 
This case study describes the activities of a fieldworker who 
accompanies one of ‘his’ research participants through their 
treatment at a public hospital. The fieldworker wants to ensure 
that the participant receives the best possible treatment, but 
also to check that the data recorded is of the high quality 
needed to meet standards for reporting Serious Adverse 
Events (SAEs). In the process, this fieldworker experiences 
friction with hospital staff.  
This is a common medical research situation. As well as raising 
questions about the different resources available to research 
staff and government health workers, the story suggests 
differences in how the two groups perceive each other and 
how their communication styles differ, and points to cultural, 
gender, and generational differences. 
The group could be guided to distinguish between different 
levels of interactions in the story: the personal level 
(experienced by the fieldworker and hospital staff), the 
institutional level (the role of the research organization and the 
hospital), and the global level (the systemic resource gap 
between international research and national funding for 
healthcare). Possible solutions could emerge at any of these 
levels: changing personal styles of communication; more 
frequent engagement meetings and other shared activities 
between the hospital and researchers; or larger-scale 
structural interventions like long-term partnerships to address 
systemic inequality and improve hospital facilities. 
Ideally, the discussion would move beyond Jonah’s 
shortcomings as an individual, to consider institutional 
practices. This case invites practical solutions to improving 
LEARNING 
OBJECTIVE 
To explore different 
viewpoints and 
interests when 
government health 
facilities collaborate 
with transnational 
research bodies – 
and to explore the 
challenges facing 
individuals in an 
unequal system 
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communication and collaboration. The institutional practices in the study can be questioned: 
how was the research project introduced to healthcare personnel? What sort of agreement 
exists between the research programme and healthcare institution? Is this in writing, and 
accessible to staff? Does it specify particular practices and resources? How often do 
representatives and staff from the institutions meet, and at which level? What ownership does 
the hospital have in results and publications? Do hospital doctors receive any other benefits 
from the collaboration, such as training? What sorts of stereotypes exist with regard to the 
other group? The discussion could be guided towards improvements in any or all of these 
issues, perhaps through formal procedures, including complaints procedures on both sides.  
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HELPING HAND: 
WORKING WITH PUBLIC HOSPITALS 
 
 
BARRABAS ATE THE CHICKEN JONAH HAD BROUGHT HIM, WHILE JONAH CHECKED HIS CHART FOR MISTAKES 
THE STORY 
 multi-country malaria vaccine trial, following good clinical practice and international 
trial regulations, monitors all adverse events, and offers full in- and out-patient care for 
participants throughout the project. Sick participants are referred for in-patient care to 
the national hospital, where the research clinic is hosted. Costs for hospitalization, laboratory 
and other procedures, and drugs, are paid for directly by the trial. This collaboration has been 
in place for several decades, but without a detailed written memorandum. 
Barrabas, the oldest study participant, suffers from serious heart arrhythmia. Halfway through 
the trial his concerns worsen and he is admitted to the hospital. Jonah, a fieldworker who has 
become friendly with Barrabas after repeated home visits for data collection, visits him in the 
ward several times a day. 
A
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Jonah previously worked as a porter in the same public hospital and is familiar with hospital 
routines and procedures (as well as with their potential shortcomings). He begins each day by 
reading Barrabas’ medical file. If he does not find the file by the bedside, he goes to the 
nurses in charge, whom he knows, and runs through the file with them. 
Based on his on-the-job training as a fieldworker on this study, Jonah identifies gaps in both the 
treatment and the routine measurements that he needs for adverse event reporting. Today he 
sees that no respiratory rates were taken (or recorded); temperature values are missing; and it 
is not clear when the patient was last seen by the consultant. Jonah, who has been employed 
by the international research organization for several years, and has become very self-
confident, scolds the young hospital nurse, and explains (in somewhat politer terms) to the 
matron of the ward that proper routines had not been observed – but not why it matters for 
the trial. 
Jonah fills in some of the missing records himself after taking rates and measurements, and 
hands the file back to the clinician in charge who has arrived for his ward round. The clinician 
mentions that Barrabas’ heart rates are a bit low and that an ECG is needed. Seeing that this is 
in the best interest of ‘his’ patient, Jonah immediately assures the doctor that the research 
project will pay for the ECG and insists that a written request is immediately prepared. Aware 
of the complicated procedures of queueing, appointment-making, and payment for such 
procedures, Jonah goes and pays the small fee to the hospital cashier, and takes Barrabas 
straight through to the ECG nurse. Just 20 minutes later they are back on the ward. 
‘This ECG alone would have taken a few days, if I had not been there,’ Jonah comments to 
himself. ‘How can we work with this hospital if they can’t even take a pulse regularly? How can 
I fill my SAE form with this sort of data?’ 
When Jonah returns to the research clinic in a different building, the study coordinator tells him 
that he has had a call from the hospital, complaining about interference in clinical 
procedures. They both shrug it off as the sort of ‘inevitable’ friction which has to be ‘endured’ 
in order to procure adequate care and valid data. 
After work that day, Jonah passes by the supermarket, and buys half a roast chicken to bring 
to Barrabas on the hospital ward. He noticed earlier that Barrabas has lost weight whilst in 
hospital. Jonah has now known Barrabas for two years. He has visited him at home, discussed 
personal problems with him, and assisted in his treatment on occasion. Visiting him in hospital, 
Jonah feels like he is not just visiting a research participant, but caring for a friend.  
QUESTIONS 
 Why is Jonah’s intervention in the hospital setting relevant to the success of the 
research? How might it endanger it? 
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 What motivates Jonah’s detailed investigation and engagement with Barrabas’ care? 
 What expertise does Jonah draw upon, and how did he come by it?  
 
 What happens to the knowledge that Jonah brings to, and gains by, his work in helping 
Barrabas? What else might he have done with this knowledge – in relation to both the 
hospital, and the research team?  
 
 What do you think about Jonah’s relationship with the public hospital staff? What 
different factors shape this relationship? 
 
 Why did the hospital doctor call and complain about Jonah’s activity in the hospital? 
Could the doctor have done something else? What do you think about the reaction of 
Jonah and the study coordinator? Do you think such friction is ‘inevitable’ and must just 
be ‘endured’? Why do you think Jonah and his colleague view it this way? 
 
 How might knowledge of the way the local hospital works impact the findings of the 
research? Do you think this is helpful? What changes could be made in referral policies 
for the trial?  
 
 What might be done, at what levels, to avoid the situation repeating itself? (The 
facilitator’s notes have some suggestions.) 
 
 What do you think individuals can do when facing structural inequalities in healthcare?  
ACTIVITY 
Put yourself in Jonah’s shoes. What would your reaction be to the shortcomings of the 
hospital’s routines and provisions? What would you do about them? What care would you 
have to take when doing so? Then take the opposite perspective, of the different members of 
staff in the public hospital. How do they each perceive Jonah? How might they react next 
time?  
REFLECTION ON YOUR OWN EXPERIENCES 
 Can you think of contexts where research staff or clinicians at your workplace draw 
upon specific local knowledge or informal contacts in order to help research? 
 
 Are there similar situations where knowledge of your local health system is necessary in 
order to ‘make ends meet’ and facilitate successful collaboration? 
 
 How far should a research project go in addressing the shortcomings of local 
healthcare provision? What are the challenges of this? 
 
 Are there times when you have felt helpless in the face of global-level inequality? If so, 
how have you responded? 
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FURTHER READING 
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WHOSE CAPACITY?: 
COLLABORATION THROUGH 
CAPACITY BUILDING 
 
FACILITATOR’S NOTES 
Capacity building in the South is one of the key aspirations of 
collaborations in transnational biomedical research, especially 
in partnerships involving researchers and institutions from the 
North. Collaborations have been hailed as beneficial to all 
involved, and many collaborative agreements have capacity 
building as one of the core objectives and an indicator of 
good collaboration. Although the general consensus among 
African research scientists is that collaborations are good and 
must be encouraged, some disquiet is emerging regarding the 
actual benefits that emerge in different collaborative 
arrangements.  
This case study invites us to think about a range of issues which 
emerge within collaborations, especially between unequal 
partners. Most North-South collaborations involve the transfer 
of a substantial amount of resources (funds, technical 
expertise and organization) to the African institution, in 
exchange for access to desired patient populations and 
expert colleagues who can shepherd proposals through local 
ethical review. Collaborations imply equality, but can there be 
equality between unequal partners? This case study asks us to 
consider whether collaboration as a paradigm serves to 
create the desired equality or, rather, hinders open discussions 
of the same. Should collaborating partners strive for more 
‘equitable’ collaborations, or change the entire paradigm?  
LEARNING 
OBJECTIVE 
To consider the 
nature of scientific 
collaborations and 
the rhetoric of 
equality between 
Northern and 
Southern partners, 
especially around 
questions of 
capacity building of 
both human 
expertise and 
infrastructure 
 
 
 
 
KEYWORDS 
Capacity building 
North-South 
relationships 
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WHOSE CAPACITY?: 
COLLABORATION THROUGH CAPACITY BUILDING 
 
 
LUCY WAS PLEASED SHE HAD GOT HER CHANCE, BUT THE ISSUE OF SPONSORSHIP WAS A THORNY ONE 
THE STORY 
 group of African scientists are having a discussion over drinks in a pub, after a 
workshop on the role of collaboration in capacity building in their institutions. In their 
stories and experiences, various differing views emerge about the prospect, nature 
and outcome of capacity building initiatives in Africa. Through their different stories, 
told with lots of humour and laughter, three differing propositions emerge.  
Timothy, a senior scientist at an African national research institute, has this to say about 
collaborations and capacity building: ‘Collaborations are very good, because from them we 
are able to develop both the human and infrastructural capacity of our institutions. Everything 
you see in my institution here, which by the way is exemplary, has been acquired through 
collaborations. And if it were not for collaborations, the director and I would not be professors 
at the moment. In terms of relationships with our collaborators from the North, we are their 
equals. We are even allowed to be Principal Investigators in projects initiated by them.’  
A
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Musa, another scientist, however, disagrees. He counters that in reality collaborations may not 
be as equal as presented by his colleague. He argues that collaborations are by their very 
nature unequal and imbalanced. ‘You know us scientists! We “collaborate” in full knowledge 
of this inequality, and we are content with the little we get. Otherwise, we would stand to lose 
even this little support if we insisted on an equal share of everything.’ The group of scientists 
who support his position in this discussion maintain that the collaborations they are involved in 
have resulted in capacity building in favour of the North, but this does not bother them. They 
consider this to be normal – the way things should be. One of the scientists who manages a 
very successful research institution engaged in collaborative research explains it candidly: 
‘Collaborations do not necessarily imply a 50:50 stake in everything. Even 80:20 is acceptable. 
For example, when we have ten scholarships on a project, we know eight will go to 
candidates from our collaborator’s country, while we shall get two. That is normal. Even in your 
own family, you must first take care of your own children before your neighbours’ kids.’ 
A third position is put forward by other scientists, who observe that collaborations as 
constituted do provide more capacity building to the North than the South. But, unlike in their 
colleagues above, these scientists consider this to be a problem which ought to be addressed. 
One of the scientists, who has worked in collaborative research engagements for over ten 
years, has this to say: ‘When we talk about capacity building, we must now ask, whose 
capacity? You find nowadays when a project is funded from the North, most of the PhD 
students employed come from our collaborators in the North. Can we still talk about this as 
capacity building to the South?’ 
Lucy, who is a research director in her institution, observes: ‘We have now come to the end of 
a very long collaborative research programme which has been on for the last 14 years, and 
we are doing our reviews of the project. And to our astonishment, we have realized that 
human capacity building has been tilted in favour of the North. Most of those we have trained 
over the last 14 years have been students from the North – yet the whole programme was 
billed as capacity building initiative for Africa. This cannot be right. We need to do something 
new’.  
QUESTIONS: 
 The three groups of scientists disagree with each other about both the nature of North-
South collaboration and whether or not it should be changed. Which view do you think 
best sums up North-South collaborations? Why? 
 
 Why do you think Timothy, Musa and Lucy have different perspectives on 
collaboration? 
 
 Musa uses an analogy of a family ‘feeding their children first’ to justify unequal resource 
allocation between partners in terms of funding PhD scholarships. Do you agree or 
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disagree with this analogy, and why? What do you think the long-term consequences 
of such practices could be for both North and South partners? 
 
 This story only focuses on the opinion of the South partners. What do you imagine their 
Northern counterparts might say about collaboration? Do you think they would share 
the views of Timothy, Musa, or Lucy?  
 
 Lucy says, ‘We need to do something new.’ What kind of ‘new’ collaboration practices 
can you imagine? How would you like the future of collaboration to look? What barriers 
do you think might need to be overcome to reach this goal? 
 
 Short of changing global inequalities, are there any immediate, practical steps that 
could be put in place to create better collaborations? 
REFLECTIONS ON YOUR OWN EXPERIENCE: 
 How would you describe the type of collaboration your institution has with its partners? 
(For example, ‘contented’? ‘Equal’? ‘Awkward’?) 
 
 How do you feel about this collaboration? Does your perspective fit one of the three 
views described above or do you have another, different, view?  
 
 What are the strengths and weakness of the collaborations of your institution? 
 
 How do you think your institution’s collaborations could be improved? What are the 
barriers to this? Can you offer realistic solutions to how they can be overcome? 
 
 Has your institution faced a situation where collaboration has broken down? What 
happened? Why? What could have been done differently? 
FURTHER READING 
Chu, K.M., Jayaraman, S., Kyamanywa, P., Ntakiyiruta, G. (2014) Building research capacity in 
Africa: equity and global health collaborations. PloS Med 11(3), e1001612. 
Jentsch, B. and Pilley C. (2003) Research relationships between the South and the North: 
Cinderella and the ugly sisters? Social Science and Medicine 57, 1957–1967. 
Panitch, V. (2013) Exploitation, justice, and parity in international clinical research. Journal of 
Applied Philosophy 30(4), 304–31
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LIKE A MARKET: 
COMPETITIVE RECRUITMENT AND 
DOUBLE ENROLMENT 
FACILITATOR’S NOTES 
This case study is about recruitment procedures for two new 
research projects, what participants do in order to secure a 
place on a trial, and how researchers try to balance 
recruitment targets with study protocols and ethical 
standards. It also raises questions about collaboration 
between different research organizations operating in the 
same area, and the confidentiality of participants’ data. 
One key issue that this case highlights are the different 
material and immaterial interests which are important to 
different stakeholders, and how these shape practices. For 
example, the researchers have to change their recruitment 
practices in order to demonstrate their competence and 
maintain their reputation. Another issue arising from this is how 
these interests and practices might conflict or agree with 
fundamental ethical principles. 
  
LEARNING 
OBJECTIVE 
To reflect upon the 
challenges of 
institutional 
coordination, 
participant 
inducement, and 
competitive 
recruitment in 
intensely studied 
geographic areas, 
and to consider the 
role of research 
participation as a 
valuable resource 
for both researchers 
and participants 
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LIKE A MARKET: 
COMPETITIVE RECRUITMENT AND DOUBLE 
ENROLMENT 
 
 
 ‘SUDDENLY EVERYONE WANTS TO KNOW US!' 
THE STORY 
 multi-site trial of treatment-as-prevention (TAP) for HIV, conducted by an international 
consortium, tests the efficacy of new drugs. Participants on this trial have to be sexually 
active, HIV negative men-having-sex-with-men (MSM). 
Due to the massive stigma (and national legislation) against homosexuality, this type of 
research participant is in limited supply, and the researchers working in each location have to 
go outside their usual areas to find enough people. There is a particular pressure to recruit 
participants quickly, because the international consortium has directed each site to find a set 
number before a certain date, so nearby projects will have to compete for those who could 
join either study. The more participants each site can recruit, the more it can contribute to the 
overall sample, and thereby increase its share in the overall findings and its reputation.  
A
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To make things more complicated, similar participants are needed by other HIV prevention 
research projects in the area. Young, HIV negative male participants who have sex with men 
are in high demand – partly because of their high infection risk, and partly because this target 
group has recently gained a high profile globally, so there is lots of funding to reach them. 
Normally, each research organization operates in different rural districts. However, the new 
interest in MSM, and the pressure for high recruitment rates, leads two particular organizations 
to step into each other’s ‘territory’ in recruiting men from the whole region. 
These two organizations, which both operate in remote rural areas, have worked together to 
agree standard rates of ‘transport reimbursement’ for participants. These rates are usually 
based on protocols and consent forms. The ongoing HIV prevention trials, however, 
complicate this arrangement, partly because it requires people to travel much larger 
distances, needing larger, staggered reimbursements of travel cost. Therefore, reimbursement 
conditions are adjusted over the course of the trial. 
As a lead scientist privately admits regarding these payments, it is very important ‘not to fall 
behind what the other group is offering the participants’ in terms of transport reimbursement 
and other benefits such as lunches during clinic visits, so as not to lose out on recruitment. As 
he is well aware, ‘participants hear about many trials, and shop around and compare, it’s like 
a market’ – so one has to know what the others are doing. He cites several occasions when 
participants at public information meetings about the trial have asked for improved benefits, 
referring to what (they had heard that) the other trial was providing. ‘And yet,’ he adds, ‘we 
do not want to end up paying participants.’ 
Participants who consider themselves as MSM realize that this new trial, in spite of its awkward 
conditions, including coital diaries and regular physical examinations, entails particular 
benefits. These are not all material. People in this group are keen to learn more about the risk 
of HIV and possibilities to reduce it, and also, not insignificantly, are keen to meet people 
sharing similar problems. The confidential recruitment phone line is busy responding to large 
numbers of young men seeking to enrol. Staff who work on participant travel discuss reports 
that people are so keen that they travel over 100 miles, pretending to be residents of the wider 
study area, in order to take part.  
Staff also wonder whether actually all the men involved in this trial really do have sex with 
men, and surmise that some of the participants have registered for more than one trial 
simultaneously. Such double enrolment can have a serious negative impact on the health of 
the participants, and the ethics and validity of the research. Responding to these suspicions, 
staff from different research organizations meet, compare records, and identify several men 
participating in both trials – in some cases even using different names. In response to this 
severe medical, ethical and scientific challenge, the research organizations agree to jointly 
finance a costly joint biometric database, in order to prevent future double enrolment. 
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QUESTIONS  
 What are the key ethical issues at stake here? Try to identify several, related to very 
different areas of ethical consideration. 
 
 What are the risks of the pressure to recruit participants, and for whom? 
 
 What solutions could the research organizations try, in response to the pressures of 
competitive recruitment, and the other challenges of operating within the same region 
and population? 
 
 What ‘immaterial benefits’ do you think the research offers participants (including those 
who have lied in order to take part)? 
 
 What happens to informed consent, if participants are so keen to join the trial and work 
so hard to fit the criteria? Is the trial genuinely ‘voluntary’ now? What could project 
planners do about this? 
 
 Do you think it is realistic that most ethics guidelines insist that the flow of resources, 
medicines, specimens, and information in research is non-economic? Do you think this 
reflects reality on the ground? If not, how could guidelines be amended, or what should 
be done in order to reflect real-life experience whilst also ensuring that research is not 
exploitative?  
ACTIVITY 
 Try to write a short summary of standard operating procedures for recruitment, consent 
and data handling for an imaginary HIV prevention study. Then compare these 
procedures to the practices described in the story. What differences are there? 
 
 Based on the scenario in the case study, form three groups of equal size: trial staff 
including local Principal Investigators, monitors from the overseas consortium, and local 
research participants and the community. What does each of these groups make of 
the solutions described above? First, discuss this briefly in each group, then debate it 
between the groups. 
REFLECTION ON YOUR OWN EXPERIENCES 
 Have you ever experienced pressure to recruit participants? How was this pressure 
made clear to you? Discuss with others how this is felt by different people at different 
levels within your organization. 
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 Have you encountered populations who are very keen to be recruited into a particular 
trial, or research in general? Have you observed people striving to meet inclusion 
criteria, or even adapting to them? How did you cope with this challenge? 
FURTHER READING  
Caulfield, T. (2005) Legal and ethical issues associated with patient recruitment in clinical trials: 
the case of competitive enrolment. Health Law Review 13(2–3), 58–61. 
Kamuya, D., Marsh, V., and Molyneux, S. (2011) What we learned about voluntariness and 
consent: incorporating ‘background situations’ and understanding into analyses. The 
American Journal of Bioethics 11(8), 31–13. PubMed PMID: 21806436. 
Simon, C. and Mosavel, M. (2010) Community members as recruiters of human subjects: 
ethical considerations. American Journal of Bioethics 10(3), 3–11.
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UNDER ONE ROOF: 
SHARING RESOURCES IN A 
DISTRICT HOSPITAL 
 
FACILITATOR’S NOTES 
The main aim of this case study is to generate discussion about 
sharing resources when conducting research. It raises 
questions about how this should be regulated, who should be 
responsible for case-by-case decision-making, and how those 
responsible can be supported.  
It could be argued that the research leadership needs to 
support research nurses and doctors to act in accord with the 
Hippocratic Oath, and their professional codes of practice. 
This could imply that, when the same staff will be caring for 
patients who are both in a study and outside it, research 
budgets should extend to covering at least some of the costs 
of caring for those who are not within the study. On the other 
hand, should researchers have to assume responsibility for the 
failings of routine medical services to provide essential care?  
Or should research only take place in settings where there will 
not be obvious differences in access to resources and 
standards of caregiving?  
Or should health researchers assume an advocacy role in 
terms of quality of care, supporting patients and providers to 
lobby for improved healthcare structures, processes and 
outcomes? If yes, what effects (negative and positive) could 
this have in terms of the implementation of research?  
 
 
LEARNING 
OBJECTIVE 
Toconsider the 
challenges of 
conducting health 
research in resource-
limited health 
facilities, where 
differences in care-
giving between 
research and routine 
services can result in 
dilemmas about 
equitable access to 
resources and 
expertise 
 
 
 
KEYWORDS 
Clinical responsibility 
Standards of care 
Government 
Capacity building 
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UNDER ONE ROOF: 
SHARING RESOURCES IN A DISTRICT HOSPITAL 
 
 
AS THEY BATTLED OVER THE OXYGEN, BEATRICE WONDERED WHAT THEY WERE FIGHTING FOR 
THE STORY 
eatrice is a senior research nurse employed by a national health research organization, 
which collaborates with international researchers and medical research sponsors. She 
oversees the nursing care of paediatric study participants who become sick in the 
course of clinical trials taking place at a rural district hospital.  
Trial participants are recruited in buildings adjacent to the hospital’s main outpatient clinics. 
The hospital management board and medical superintendent have agreed to host trials, and 
entered into a memorandum of understanding (MOU) with the national research organization, 
which receives funding from international sponsors. The MOU outlines the points of agreement 
between the hospital and the research organization with regard to rent, use of hospital 
resources (space, water, electricity), and roles in patient care. Despite the hospital 
management’s requests, however, there are no provisions for infrastructural improvements, as 
the international sponsor’s funding regulations do not allow them to use funds to build lasting 
infrastructure. 
B 
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The paediatric ward where Beatrice works has 30 beds in total, often occupied by more than 
one patient. She and her team of three research nurses are based in a separate bay on this 
ward, containing six beds. Research clinicians (including a fully qualified paediatrician) review 
the sick trial participants in this separate bay regularly. Other patients on the ward are cared 
for by four hospital nurses, three auxiliaries, and two hospital interns (recent medical school 
graduates) who are also responsible for various other wards.  
Beatrice has quite a good relationship with the other ward nurses but they regularly ask to 
‘borrow’ cannula and other resources allocated to the research patients, as hospital supplies 
run short on a regular basis. Beatrice and her team have access to separate nursing supplies, 
and the research doctors have access to a well-stocked formulary.  
In the spirit of collaboration Beatrice is happy to share small items such as cannula, but less 
sure about medication. She talks to the trial coordinator and Principal Investigator about this 
and they meet with the ward staff and the medical superintendent to discuss how to move 
forward. They agree to share cheaper resources like analgesics fairly liberally, setting aside a 
budget to keep these in stock. But more expensive medications can only be given out in 
situations of emergency or particular need, on a case-to-case basis which will be judged by 
the trial paediatrician.  
They also agree with the hospital to take turns in paying for oxygen cylinders to be refilled, to 
ensure a ready supply is available for all sick patients. The latter arrangement works for a 
month, until the hospital has another shortfall of funds. The research organization foots the bill 
for oxygen refills for a while, but then decides they will purchase their own oxygen cylinders 
and pay to refill them separately. They are under pressure from research sponsors to keep 
within the budget allocated to the research projects running at the district hospital. 
Soon after that Beatrice receives a call from a junior nurse on night duty. The nurse tells her 
that an infant with severe pneumonia has been admitted to the ward and the hospital nurses 
need to ‘borrow’ the research oxygen cylinder in order to save the child. Beatrice is in two 
minds and does not know what to advise.  
QUESTIONS:  
 What are the key ethical issues at stake in this situation? Describe the challenges that 
this hospital-based research setting raises.  
 
 What would you do if you were Beatrice? Would you follow the new regulations, or let 
the hospital nurses use the oxygen cylinder?  
 
 What is the purpose of a Memorandum of Understanding (MOU) in these types of 
research collaborations, and what details should a MOU include?  
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 When research takes place in resource-limited health facilities, should research sponsors 
contribute financially to the care of patients who are not enrolled in research studies?  
 
 Should research take place in settings where it is difficult for hospital staff to provide the 
same standards of care for both research and routine patients? Would it be better for 
research participants to be looked after in a separate ward? Should this ward be within 
the hospital environment or in a separate research facility? What would be the 
advantages and disadvantages of this, for patients and staff? 
REFLECTION ON YOUR OWN EXPERIENCES 
 Have you any experience with hospital-based research, or with using public health 
facilities in research?  
 
 Have you ever been in a similar position to Beatrice? Share your experience, and 
explain what you did and why.  
 
 How feasible do you think it is to regulate such resource-sharing arrangements? Who 
should draw these up, and how should practitioners be supported to follow them?  
 
 How are project budgets drawn up in your place of work? Is allowance made for 
sharing resources? 
FURTHER READING 
Benatar, S.R. and Singer, P.A. (2010) Responsibilities in international research: a new look 
revisited. Journal of Medical Ethics 36(4), 194–197. 
Brown, H. (2015) Global health partnerships, governance, and sovereign responsibility in 
western Kenya. American Ethnologist 42, 340–355. doi:10.1111/amet.12134 
Street, A. (2014) Research in the clinic. In: Street, A. Biomedicine in an Unstable Place: 
Infrastructure and Personhood in a Papua New Guinean hospital. Duke University Press, 
Durham, North Carolina, 194–222. 
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WE WILL NOT DO 
YOUR WORK FOR FREE: 
INCENTIVES, PER DIEMS AND 
PROFESSIONAL CULTURE 
FACILITATOR’S NOTES 
The purpose of this case study is to encourage us to think 
critically about the use of per diems – especially in research 
which focuses on improving the quality of care, and does not 
directly involve patients. The participants in the story outlined 
below are healthcare workers who are required to make a 
change in their clinical practice for the purpose of a research 
project. This change involves some extra work, and although 
they are offered training and new skills in reward, they also 
request payment.  
In effect, the healthcare workers do not believe that the 
intervention brings its own rewards. The researchers, however, 
believe that the study is just part of their existing professional 
duties, simply raising these to a new level, so no further 
incentive is required. This argument falls on deaf ears, 
however, partly due to the pervasive use of per diems 
elsewhere in medical research.  
In your discussions, try to get participants to think critically 
about accepted practice, in order to develop objective 
arguments for or against the use of per diems in such 
instances.  
 

LEARNING 
OBJECTIVE 
To consider the 
advantages and 
disadvantages of 
using per diem 
payments in 
research, especially 
in research focusing 
on the quality of 
care rather than on 
new medical 
technologies 
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Standards of care 
Government 
Money 
Capacity building 
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WE WILL NOT DO YOUR WORK 
FOR FREE: 
INCENTIVES, PER DIEMS AND PROFESSIONAL 
CULTURE 
 
 
 ‘THANK YOU FOR THE TEA BUT WHERE IS OUR PAYMENT…?’ 
THE STORY 
 trial is being conducted to improve the quality of health services in lower-level 
government facilities in an African rural district. This involves retraining healthcare 
providers, and equipping them with skills to help them provide better care for their 
patients and to become better managers. This mostly involves reminding them of skills they 
learned in nursing and medical school, such as diagnosis and consultation skills for various 
medical conditions. However, some aspects, such as the use of new diagnostic equipment, 
are new to many of the participants. As well as these new practices, the intervention requires 
the healthcare workers to fill out four new columns in patients’ records in the regular 
outpatient department register.  
A
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Most of the care providers participating acknowledge that the retraining and new tools make 
them better at their jobs, and help them look more professional in the eyes of their clients. They 
complain, however, that the ‘retraining’ takes too long, and that the new systems increase 
their workload and lead to delays in caring for patients.  
The project’s overseas Principal Investigators are determined not to pay per diems for the 
activities. According to them, the project falls under participants’ routine duties; if anything, 
they should be grateful that the project retrains them and improves their skills for free. For their 
part, however, the participants consider the new duties involved in the trial as ‘project work’, 
over and above their ordinary tasks.  
For this, they expect to be ‘motivated’. They also state that extra columns in the registers 
‘consume too much of our ink’ and that they are ‘running out of ball pens’ because of this. In 
response, the project team provide two pens per month for each of the workers, and asks 
them to report to the project coordinators any time they run out of pens. The health workers 
then complain that the workload is too heavy, and that they are spending all the day in the 
facility without a lunch break. The project team respond by buying them sugar, tea leaves 
and biscuits to make tea during their work.  
Several weeks later the project team discovers that workers in some health centres are not 
carrying out most of the trial activities. They send one of the senior project leaders, a local 
medical doctor, to find out what is going on. When he arrives, the health workers inform him 
that their informed consent agreement allows them to withdraw from the project at any time, 
and that they are not required to give any reasons for their withdrawal. The project team 
therefore has no right to ask them to explain themselves. When pressed further to explain their 
reason, the workers declare that they will not ‘work for free’ for the project. They cite their 
experience with other projects where they were paid a per diem for any activity, even if the 
activity did not take long, and reiterate that they expect to be ‘motivated’ or they will not 
participate. 
The project team maintains that they will not pay a per diem, and sends other high-ranking 
Ministry of Health officials to implore the health workers to participate in the project. 
Meanwhile, over 15 other research projects are taking place locally at the same time, all 
organized by different institutions and all requiring the services of healthcare providers. Most of 
these institutions ‘motivate’ participants for taking part in the projects. 
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QUESTIONS  
 Why do you think that the research Principal Investigators did not want to pay per 
diems? What beliefs do they seem to have? Do you think they are right? 
 
 Can you sympathize with the healthcare providers’ position? Why? 
 
 What do you think about how both sides addressed the challenge? Do you think the 
study team understood what was behind the participants’ requests, or not? Why? What 
do you think each side could have done differently? 
 
 What do you think about the use of per diems in this kind of research? Is there a 
difference between reimbursing participants in clinical trials, and those in service 
improvement studies? What, if any, are the differences between projects like this one, 
and ones which conduct other kinds of research?  
 
 Can you think of other ways of motivating staff to support the research?  
 
 If you were the study coordinators, what would you do next?  
 
REFLECTION ON YOUR OWN EXPERIENCES 
 Present the case for or against reimbursing the healthcare workers for carrying out the 
study intervention.  
 
 Have you encountered similar situations in your work? What were these and how did 
you deal with them?  
FURTHER READING 
Conteh, L. and Kingori, P. (2010) Per diems in Africa: a counter-argument. Tropical Medicine & 
International Health 15(12), 1553–1555. 
Ridde, V. (2010) Per diems undermine health interventions systems and research in Africa: 
burying our heads in the sand. Tropical Medicine and International Health. Doi.10.1111/j.1365-
3156.2010.02607.x 
Vian, T., Miller, C., Themba, Z., and Bukuluki, P. (2012) Perceptions of per diems in the health 
sector: evidence and implications. Health Policy and Planning, 10(1093), 1–10. 
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IS IT A GIFT, REALLY?: 
DRUG DONATIONS, ACCESS AND 
SOCIAL BENEFIT 
FACILITATOR’S NOTES 
This story explores questions about the local benefits of 
transnational drug donations and related research. It presents 
the case of a donation programme which includes phase 4 
post-licensure evaluation activities for a new drug, aimed at 
providing information about long-term and rare side-effects. 
The drug being donated is an expensive, newly-licensed 
treatment aimed at preventing heart disease. Its current 
market price means that it is unlikely to be adopted as a 
recommended routine medication, or have any significant 
market, among the population where the programme takes 
place. Instead, the results of the evaluation are likely to 
increase the drug’s market share in high-income populations, 
mainly in the global North. Yet, in the short term, the donation 
programme provides substantial benefits to patients and 
doctors in the recipient population. 
Critics of the donation programme argue that it is a for-profit 
trial posing as charity. They are concerned that a vulnerable 
population is providing information for the longer-term benefit 
of wealthy patients elsewhere. Local clinicians, however, 
highlight the advantages of the programme for their patients – 
even if these are only temporary.  
This case study is designed to trigger reflections on the relative 
social benefit of experimental interventions. In some cases, this 
is straightforward. For example, if a trial involves risky 
experimentation on vulnerable volunteers, with the aim of 
developing a drug targeted mainly at high-income 
populations –for example, testing anti-obesity drugs in 
malnourished populations – this is obviously problematic. If, at 
the other end of the scale, a trial tests, for example, a low-cost 
alternative to imported ultrasound examination gel, produced 
LEARNING 
OBJECTIVE 
To consider the 
challenges and 
benefits of drug 
research projects 
that have few (but 
sometimes 
significant) local 
benefits 
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by local doctors and scientists, this seems much less problematic. Most cases, however, are 
less clear-cut, and require careful and detailed assessment of the potential benefits and 
disadvantages. This type of careful analysis might result in the conclusion that whilst a 
particular intervention makes unjust use of vulnerable study participants, it is also beneficial in 
some ways for these participants and other actors. The tension between knowing that 
something is unfair, for oneself or others, and yet feeling compelled to go along with it, is one 
of the most interesting aspects of this case study, as it relates to wider questions of ethical 
deliberation and personal conscience.  
This case encourages policymakers, researchers, study managers, and field staff to consider 
the social and long-term benefits of donation programmes carefully, and weigh these against 
immediate benefits. As researchers, we need to be keenly aware that our activities can be 
exploitative and can reinforce pre-existing injustices. We therefore we need to be careful that 
we do our best to address these health inequalities, rather than aggravate them.  
As part of the group activity exploring the benefits and disadvantages of this particular 
programme, training participants should think carefully about larger and smaller benefits to 
different actors, such as patients, relatives or healthcare personnel. For example, a clinic head 
might receive income from a trial; a district doctor or nurse might find her work eased by the 
availability of drugs and other tools; a family caretaker might be relieved of the high costs of a 
less efficient, locally available drug; and patients may be able be able to prevent heart 
disease.  A journalist or activist, on the other hand, might look to the wider context, relating the 
programme to wider discussions about multinational pharmaceutical companies, drug 
pricing, constraints on health systems, and global health inequalities. The discussion should 
explore the way these different levels of interest and engagement overlap. 
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IS IT A GIFT, REALLY?: 
DRUG DONATIONS, ACCESS AND SOCIAL BENEFIT 
 
 
'THERE IS A NEW DRUG IN TOWN. IT’S FREE AND IT’S GOOD FOR YOUR HEART!' 
THE STORY  
-22 is a novel prophylactic drug to prevent coronary heart disease. It has recently been 
licensed for use in North America and Europe, and is available in upmarket pharmacies 
in most African countries. But due to its cost of approximately US$90 per month, it is not 
widely used and there are no plans to include it in any national drug provision plans.  
The drug is becoming a huge success story for the UK-based pharmaceutical multinational 
that developed it but, as mandated by the licensing authorities, they still need to carry out 
post-licensure studies to update the drug safety profile by obtaining more information about 
rare and longer-term side-effects. With the support of a major Northern public health research 
agency, the pharmaceutical company decides to embark on an ambitious drug donation 
and evaluation programme in a West African country. The country in question is undergoing a 
rapid health transition characterized by an increase in chronic diseases, which is partly due to 
changes in smoking and dietary habits. The company and public health research agency 
discuss and agree their plans with leaders at the country’s National Research Institute, and as 
a result an X-22 drug evaluation group, including international and national investigators, is 
X
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established. After consultation and agreement with the Ministry of Health, the group decides 
to conduct the programme in a district with a population of 400,000, which has among the 
highest rates of coronary heart disease in the country.  
The pharmaceutical company commits to donating X-22 to all of the public health facilities 
based within this district for three years. Patients at high risk of coronary heart disease – as 
determined by age, cholesterol levels, blood pressure, family history, and lifestyle habits such 
as smoking – are offered X-22 as part of the programme. Participation involves patients visiting 
their local health facility every two months for two years. At each visit, the patient’s health 
status is checked, and they are asked to complete health and lifestyle questionnaires and 
provide blood samples for cholesterol monitoring. Blood tests are processed at district level 
and then transferred to a data server hosted by the National Research Institute, along with the 
other personal health information, where it is analyzed by investigators from the national and 
international evaluation group. To support patient care and help to process the blood 
samples, the pharmaceutical company funds the establishment of a small laboratory in every 
dispensary and a larger data-processing and laboratory facility in the district hospital.  
After just one year, over 5,000 patients have consented to take part in the programme. This 
sparks the interest of a local journalist, who finds out how much X-22 costs and asks the 
pharmaceutical company what they plan to do to ensure local patients can continue to 
access the drug once the programme is finished. It becomes evident X-22’s main target 
market is high-income customers, who are interested in a preventative medication to help 
offset high-risk behaviours such as a poor diet, smoking, and a lack of exercise. The drug has a 
statistically significant but relatively small effect on predicted morbidity and mortality, and is 
therefore not intended for populations which struggle with much more immediate, and more 
easily controlled, health issues. The company representative tells the local journalist that there 
are no immediate plans to market the drug at a lower price in his country. 
In response, the journalist publishes a major article headlined ‘African guinea pigs for Western 
lifestyle drug’, arguing that the programme abuses vulnerable patients and health systems to 
expand the market share of a high-cost drug which will benefit only patients in very different 
socio-economic conditions – and, of course, the drug company. According to his article, the 
drug donation and evaluation programme is just a way to camouflage a for-profit drug trial. 
The article causes major outrage, not just among patients, but also among doctors and nurses 
– especially those not involved with the donation programme. One year earlier than 
anticipated, and in the middle of discussions about an extension of the donation programme, 
the pharmaceutical company decides to terminate its commitment. In a commentary in the 
same newspaper, the national Principal Investigator of the programme regrets the closure of 
the project, and comments that this could lead to significant heart problems for those taking 
part, which could have been avoided.  
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QUESTIONS 
 What is your view of this programme? How would you describe it? What is the main 
purpose? Does it constitute research?  
 Why do you think the pharmaceutical company and Northern public health agency 
decided to conduct the drug donation and evaluation programme in West Africa? 
Why is it not being conducted among those who are more likely to be able to access 
the drug after the study?  
 What is your view of the benefits and disadvantages of making X-22 available via the 
programme?  
 What questions would you ask to get a clearer picture of the programme and its ethical 
implications? You may want to think about what you would ask 
1. the different members of the drug donation and evaluation programme,  
2. national policymakers,  
3. local health facility staff,  
4. staff directing the programme at district level, and  
5. participants. 
 
 How do you think these different stakeholders would respond? What might their views 
be on the relative benefits and disadvantages of the programme?  
 Do you agree with the journalist? Explain why, or why not. Was it right to publish the 
article? What were the consequences? What did the article not achieve? 
 Why did the drug company end the programme? Do you think this was right? Were 
there other options? 
 Do you know of similar cases, in which charitable and commercial interests are mixed? 
GROUP ACTIVITY  
Divide into two groups, one arguing for the programme, the other against it. Think about the 
benefits to particular individuals at different levels of the programme, as well as large groups 
of people. Next, discuss and aim to agree on a list of minimum requirements that you think 
should be met by any drug donation programme operating in your area of work.  
FURTHER READING 
Pinheiro, C.P. (2008) Drug donations: what lies beneath. Bulletin of the World Health 
Organization 86(8), 580. 
Saha, S. and Galper, A. (2013). The ethical basis of drug donation to third world countries. 
Ethics in Biology, Engineering and Medicine 4(1), 29–46.  
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Samsky, A. (2011) Since we are taking the drugs: Labor and value in two international drug 
donation programs. Journal of Cultural Economy 4(1), 27–43. 
Samsky, A. (2012) Scientific sovereignty: How international drug donation programs reshape 
health, disease, and the state. Cultural Anthropology 27(2), 310–332.  
Shretta, R., Walt, G., Brugha, R. and Snow, R.W. (2001) A political analysis of corporate drug 
donations: the example of Malarone in Kenya. Health Policy and Planning 16(2), 161–170. 
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TRAINING CASE STUDIES 
 
  
 
 
 THE STAFF TURNED IN THEIR BADGES SADLY. “ANOTHER SHORT TERM CONTRACT…” THEY SIGHED. 
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STAFF RELATIONSHIPS 
 
CASE STUDIES 
The majority of global health research in Africa is conducted 
through transnational organizations. These are collaborative 
partnerships between one or more in-country national research 
institutions, and the overseas arms of one or more government or 
academic institutions from other countries. The situation is further 
complicated by the involvement of global non-governmental 
bodies, usually through the provision of funding. Often, specific 
research projects are multi-sited, connecting institutions and staff in 
multiple sites and countries. Project-specific funding also means 
that whilst some staff are employed on a more permanent basis, 
others are employed on a contract or even daily basis.  
The nature of research and its requirements means that 
the staff population may include people with a wide 
range of educational backgrounds, from highly skilled 
and educated scientists to community mobilizers with less 
formal education, chosen for their knowledge of their 
local communities. 
Medical research, therefore, brings together staff from 
different national, cultural and educational 
backgrounds. It also means that in one research field-station there may be groups of staff 
employed under different salaries, conditions and regulations – and exposed to different 
opportunities for educational and professional development. The stories in this section look at 
some of the issues that might arise in these circumstances when staff from these different 
backgrounds relate to one another.  
Some of these stories explore the relationships between ‘expatriate’ researchers from the 
North with African researchers. The chance to experience different cultures is often a 
motivating factor in seeking employment in medical research on both sides. However, the 
differences between their socio-economic situations are difficult to avoid.  
Expats are often employed on short-term contracts, their children attend international schools, 
and they frequently travel to international meetings and conferences. Security issues can 
mean they are housed in gated communities, with special guards and secure vehicles. They 
FURTHER READING 
Redfield P. (2012) The unbearable 
lightness of expats: double binds 
of humanitarian mobility. Cultural 
Anthropology 27(2), 358–382. 
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may have to follow certain rules about where they can go 
and what they can do whilst living in Africa. What difficulties 
does this pose for relationships between expat and African 
staff? Other stories in this section look at experiences and 
allegations of nepotism and corruption in medical research 
institutions in Africa. Perceptions – and often realities – of 
corruption in the public sector in Africa are high. How do 
these perceptions affect employment issues and staff 
relationships in medical research, when held by staff and 
communities? 
MEETING BY THE CLUB POOL 
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PER DIEM: 
PRACTICAL INEQUALITIES IN 
SCIENTIFIC COLLABORATION 
FACILITATOR’S NOTES 
This case study demonstrates how the economic 
circumstances of different staff shape their professional 
positions, and determine the practical choices they make. In 
this story, economic inequalities affect staff participation at a 
national conference. Some effects are subtle, like authorship 
positions, and others are more evident, like differences in 
accommodation and levels of physical presence at the 
conference. Different actors experience this situation very 
differently, and draw different conclusions from it.  
The main aim of this case study is to think about how these 
inequalities emerge, sometimes in unanticipated ways; how 
this might affect collaboration; and how a more equitable 
situation could be achieved. It is important to remember that 
some inequalities have historical, political and economic roots, 
and that trying to redress the balance is not straightforward. 
Nonetheless it is important to engage with and discuss these 
inequalities in a constructive manner, to work towards lasting 
change. In this particular case, the discussion might lead to 
both simple practical changes in the way the conference is 
organized, and a more general consideration of long-term 
issues like discrepancies in salaries. 
In exploring this story, students could reflect on the ways that 
equality is often taken for granted in professional scientific 
engagements. Inequality, however, persists in many ways, 
material and immaterial – and inequalities are perceived in 
various ways, filtered through different stakeholders’ everyday 
life experience and historical memory. The ways in which we 
see or don’t see, and engage or don’t engage with, material 
inequalities shape how we live and work together. 
LEARNING 
OBJECTIVE 
To think about the 
various practical 
effects of 
inequalities between 
different types of 
staff, and to 
brainstorm both 
short-term and long-
term solutions 
towards equality in 
the workplace 
 
 
 
 
 
KEYWORDS 
Employment issues 
Money 
North-South 
relationships 
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PER DIEM: 
PRACTICAL INEQUALITIES IN SCIENTIFIC 
COLLABORATION 
 
 ‘AFTER A LONG DAY AT THE CONFERENCE, I THINK I’LL HAVE A DIP IN THE POOL…' 
THE STORY 
 workshop on HIV care is held in an international 4-star hotel, which offers well-
equipped conference rooms, excellent catering, and pleasant garden and pool 
areas around which scientists can meet and talk between sessions. Rooms and meal 
prices are expensive, but the delegates’ employers – international NGOs and their 
collaborators – pay a substantial per diem which covers all the costs incurred in attending the 
workshop, so this does not affect participation. Delegates include international policy advisors, 
scientists, local civil servants, and health facility personnel. 
Most workshop presentations – well-prepared slide sets embossed with the relevant 
organizational logos – are given by African clinicians, policymakers and scientists, on behalf of 
co-authors who are predominantly overseas colleagues. Proceedings are carefully timed, 
A
STAFF RELATIONSHIPS                                                                                      HANDOUT Per diem 38 
 
198 
 
allowing for animated and friendly discussions after each paper. The conference chairs seek 
to involve and elicit views from all participants, regardless of their status. 
Over dinner, a leading international NGO representative states how impressed she is by the 
large number of African presenters at this workshop, but wonders why so few of the local 
healthcare staff attend dinner and evening activities. The director of a large NGO consortium 
which sent many staff to the conference points out that all his staff, irrespective of their 
nationality or seniority, receive the same per diem for their conference visit, and that it is up to 
individuals to decide where they stay. But, he adds, ‘Maybe next time we should just pay for 
the hotel for everybody.’ 
While international visitors and most managers from larger international NGOs (local and 
expatriate), as well as some Northern HIV care volunteers, stay at the conference hotel, most 
Department of Health staff, local clinicians and civil society representatives have chosen to 
stay elsewhere in town, in cheaper accommodation or with relatives. Due to traffic and long 
commuting times, many arrive late and leave immediately after the last presentation. They 
receive the same per diem regardless. The same evening, some delegates including a group 
of local HIV activists and junior health professionals from the regional hospital have gathered 
at a popular music venue. Over a drink they start to discuss their respective per diem rates, 
and jokingly compare how much they can save from this three-day conference. Based on her 
US$70 per diem, one nurse calculates that she will be able to take home almost her monthly 
salary after tax – just at the right time, before the school fees are due. She stays with a relative, 
and her two hours’ local transport costs less than US$2.  
Two Scandinavian student volunteers tagged along on this outing, preferring the lively music 
venue to the hotel pool. The evening gets late, and when everybody leaves, their new friends, 
who are familiar with the city and its dangers, take great care to find a safe taxi driver to take 
them back to the hotel. The volunteers depart, slightly embarrassed, as their friends jokingly 
point out, ‘We must take care to get you safely back home from the ghetto!’  
The next morning, everybody is assembled to listen to an honorary address given by one of the 
host country’s most eminent doctors, who is well known for his advocacy of traditional 
medicine. Looking at his young colleagues, he praises the progress African medicine has 
made since the 1960s, a time when he had to leave Africa to obtain his degree. He starts by 
acknowledging the achievements of the international organization hosting the conference, 
and then recounts his research into herbal medicines, drawing attention to the achievements 
of African traditional doctors. Finally, he calls for more emphasis to be placed on local 
resources to tackle HIV/AIDs, warning against dependency on drugs manufactured by 
powerful global pharmaceutical companies. After that, a young woman from the 
international organization which sponsored the workshop thanks the speaker, joins in his praise 
of African doctors, thanks the sponsors, and closes the meeting. 
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QUESTIONS 
 Inequality appears at many different points in this account. Try to identify different forms 
of inequality, taking note of who is involved and how the power differences become 
apparent.  
 Equality, as a value and intention, is also present throughout the observations presented 
above. Explore where and in what ways equality is emphasized. 
 Why is the manager of the expatriate NGO proud of their policy regarding per diem 
rates? What is made equal by them (and what is not)? 
 What do you think junior local doctors would say if next year their hotel bill was paid for 
and they received no further per diem? Would this be more equitable? Why? 
 Why are the two expatriate volunteers embarrassed by their friends’ joke? 
 What concerns over equality and inequality are expressed in the senior doctor’s 
honorary speech? How might this be perceived by different members of the audience? 
 How does the way we engage or don’t engage with material inequalities shape 
working relationships and research practice? Why is it difficult to talk about hidden 
inequalities in a situation like this? What do you think should be done?  
REFLECTION ON YOUR OWN EXPERIENCES 
 Which inequalities are present among staff and collaborators in your own research 
setting? 
 Which of these inequalities are spoken about and directly addressed, and which are 
not? 
 Are there social settings or groupings in which inequalities can be discussed, and others 
where one does not take them up? 
 Are there practices or situations in which equality, as a moral value, is emphasized or 
followed through on, within your research organization?  
FURTHER READING 
Geissler, P. W. (2014). What future remains? Remembering an African place of science. In: 
Geissler, W. (ed.) Para-states and Medical Science: Making Global Health in Africa. Duke 
University Press, Durham, North Carolina, 142-178. 
Redfield P. (2012) The unbearable lightness of expats: double binds of humanitarian mobility. 
Cultural Anthropology 27(2), 358–382. 
Simon, C. and Mosavel, M. (2011) Getting personal: ethics and identity in global health 
research. Developing World Bioethics 11(2), 82–92.  
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DO ANTHROPOLOGISTS 
KNOW BEST?: 
RELATIONSHIPS BETWEEN SOCIAL 
SCIENTISTS AND MEDICAL 
RESEARCHERS 
FACILITATOR’S NOTES 
This story is about misunderstandings which can occur around 
the role of social scientists working in collaboration with 
medical researchers. Through the discussion, participants will 
hopefully come to appreciate the anthropologist’s 
understanding of her role as critic, and as a representative of 
community views. They should also understand the sensitivities 
of the medical scientists, who hold managerial and budgetary 
responsibilities as well as being concerned with the public 
image of their research, and try their best to do good and 
useful science. In particular, the story exposes different views 
of the concepts of validity and data in the different disciplines. 
Discussing the study should leave participants with a sense of 
the opportunities for social science to bring difficult issues ‘to 
the fore’ and thereby respond to problems and promote 
improvements – but also a sense of the challenges and 
sensitivities which arise from practising social science in 
medical research. 
LEARNING 
OBJECTIVE 
To reflect on the 
critical role, and 
limitations and 
responsibilities, of 
social scientists 
involved in medical 
research 
 
 
 
 
 
 
 
KEYWORDS 
Social science 
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DO ANTHROPOLOGISTS KNOW 
BEST?: 
RELATIONSHIPS BETWEEN SOCIAL SCIENTISTS AND 
MEDICAL RESEARCHERS 
 
 
ELISE FOUND THE RESEARCH PARTICIPANTS WERE KEEN TO HAVE THEIR VOICES HEARD 
THE STORY 
lise is an anthropology graduate student from a leading North American university. To 
bridge an employment gap before embarking on her PhD, on ‘Poverty, child-death and 
resistance in Brazilian slums', she finds short-term employment with her university’s 
teaching hospital, which has a long-term overseas collaborative programme conducting 
health research in Africa. Her task is to support a planned malaria vaccine trial, by examining 
how ready the community seems to be for the new study and providing social science insights. 
The contract also requires her to submit social science academic papers before the end of 
her one-year contract. 
E 
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Elise sets out to conduct fieldwork among the communities from which trial participants are 
soon to be recruited. Working together with a local translator, she interviews people from all 
walks of life, and different generations and gender, about expectations and experiences of 
research. She expected that people would be somewhat skeptical about international 
research, but she very quickly learns that while former research participants and their families 
hold diverse views of research – some negative, most positive – they are overall extremely 
keen to participate in research projects.  
However, people’s ideas about what research is about are often far from the actual aims and 
practices of the studies that they have participated in. They seem to know little about which 
diseases actually were studied, and for what purposes blood specimens were collected. There 
is little awareness of the use of placebos and of unproven study vaccines and drugs; instead, 
the prevalent understanding is that the research programme provides top healthcare and 
better drugs, and people are therefore keen to sign up. 
Elise finds this fascinating, partly because she is overwhelmed by how much people want to 
be part of research projects, and partly because her findings point to potential weaknesses in 
the informed consent process. It seems that a more thorough assessment is needed of how 
much actual information is passed on to communities about the studies. She thinks that these 
findings could be useful to the future trial, but also that they speak to the anthropological 
literature on global justice and inequality, which are subjects close to her heart. 
Halfway through her fieldwork, she presents a draft manuscript at the research station’s weekly 
seminar, entitled: ‘“Bring more research” – why people are so keen to join clinical trials’. In the 
paper, she describes the sometimes comical, sometimes worrying misunderstandings about 
research that she has found, and as a background she examines differences between the 
excellent healthcare provided by the research centre and the weaknesses of local health 
facilities. She argues that under overall conditions of poverty, information is ultimately less 
important to local people than good healthcare. She concludes with specific 
recommendations for improved consent procedures. 
The discussion at the seminar is lively. Front-line fieldworkers, especially, confirm and expand on 
the misunderstandings that Elise described, underlining that, as one of them puts it, 
‘Participants don’t really care what the research is about, as long as they get good 
healthcare’. 
Elise’s Principal Investigator is slightly critical about the paper, however, and asks: ‘How 
representative is this?’, ‘How many people have you asked?’, and, eventually ‘So, you are 
saying that we completely failed to inform people about what our research is about? That 
their consent is essentially worthless? Have you actually done statistics on this? Do 
anthropologists know best?’ 
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In a subsequent conversation between the Principal Investigator, Elise, and the overall 
programme director, Elise is told that the paper as it stands has scientific weaknesses and is 
potentially damaging to the site – also on account of the ‘offensive’ description of local 
healthcare institutions and practices. Elise, who has spent weeks writing this first paper, is sad 
and offended, because, as she interjects, she is supportive of global health research, and 
thinks these findings are important to improve the work. She convinces her Principal 
Investigator to allow her to rewrite the paper; eventually it is submitted, but Elise is left with the 
feeling that she did not say things quite as clearly as she wanted to.  
QUESTIONS  
 Why do you think Elise was so interested in this subject and made it her first paper? 
 Why did her line managers react negatively to her material and analysis?  
 What different ideas about ‘data’ and ‘validity’ might play into this discussion? 
 Who do you think cares more about the wellbeing of local people, and in what ways? 
Does the problem lie in different disciplines, or different personal commitments?  
 How would Elise have justified that her findings are relevant for medical research? 
REFLECTION ON YOUR OWN EXPERIENCES 
 In what way do you think anthropology could make a useful contribution to health 
research? 
 What do anthropologists have to look out for when writing about such issues?  
 What is required from medical scientists to allow for fruitful collaboration with social 
scientists? 
FURTHER READING 
Lederman, R. (2007) Comparative "research": A modest proposal concerning the object of 
ethics regulation. PoLAR: Political and Legal Anthropology Review 30(2): 305-327. 
Bell, K. and Elliott, D. (2014) Censorship in the name of ethics: critical public health research in 
the age of human subjects regulation. Critical Public Health 24(4): 385-391. 
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WHO ARE YOU?:  
EMPLOYMENT ISSUES AND NORTH-
SOUTH RELATIONSHIPS 
FACILITATOR’S NOTES 
This case study is about the relationship between local 
scientific staff and expatriates, and the experiences and 
perceptions of employment status which might affect these 
relations. Specifically, it tells the story of a Northern PhD 
student who temporarily works as a well-paid consultant, and 
the way in which this negatively affects his previously good 
relations with local colleagues and advisors. In a post-colonial 
context of transnational medical research, staff at local host 
institutions and expatriates are often employed on different 
terms and through different mechanisms – often holding 
contracts with different institutions in different places.  
The story invites us to think about an issue which can be very 
sensitive for everyone involved – who gets jobs and why in 
transnational medical research. And the most difficult question 
– what role does a person’s skin colour or country of origin play 
in this? Following on from the central tenet of this workbook – 
that we believe it is important to talk about concerns that 
might otherwise remain unvoiced – the facilitator should use 
this case study as a chance to address these sensitive issues.  
The first key relationship to explore here is between the PhD 
student and the fieldwork supervisor, which changes when the 
student turns into a well-paid consultant. You can imagine the 
fieldwork supervisor thinking, ‘How did this happen? How did 
he gain the ear of the European director so quickly? Why was I 
not given the same opportunity?’ His subsequent refusal to 
engage with the project could be read as a way to regain 
some power in the situation. The story then becomes a lesson 
in how to properly handle employment issues, in order to 
render decisions transparent.
LEARNING 
OBJECTIVE 
To reflect upon 
unspoken 
assumptions and 
challenges in 
relation to personal 
economic 
circumstances and 
professional roles, 
when Northern 
scientists and 
students work in 
Southern medical 
research sites 
 
 
 
 
 
KEYWORDS 
Employment issues 
North-South 
relationships 
Capacity building 
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WHO ARE YOU?:  
EMPLOYMENT ISSUES AND NORTH-SOUTH 
RELATIONSHIPS 
 
 
MOHAMMED SAW ANTONIS THE PI TALKING TO JAMES AT THE CLUB…. 
THE STORY  
ames is a 35-year-old German PhD student at Hamburg University, with a background in 
computer science and developing digital health technologies for projects in Germany 
and overseas. In his PhD he wants to assess how electronic systems and digital devices 
are being used to collect demographic and health-related data at household level, and help 
develop more sophisticated and user-friendly systems for use in resource-limited settings. One 
of James’ PhD supervisors has international contacts with a Tanzanian research station, which 
is mainly funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). 
He puts James in contact with the directors and they agree that he can come for a 
preliminary visit to explore the feasibility of conducting his research at the station. 
J
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During his visit James is shown around the research facilities, and introduced to Tanzanian 
members of staff who work in the IT and demographic surveillance offices. They are 
welcoming and the demographic surveillance fieldwork supervisor, Mohammed, who is 
completing a Masters in health informatics, is particularly interested in James’ ideas. James 
decides to include him as a co-investigator on his protocol.  
During his visit, James also meets Antonis, the European Senior Scientist, who is responsible for 
the conduct of research funded by EDCTP. They meet formally at the station to discuss James’ 
proposed PhD project and also socially for dinner at one of the restaurants frequented by 
expatriates in the city. Antonis knows that James has a background in computer science and 
digital health and so asks him to help draw up the job description for an e-health research 
coordinator. He also asks James if he knows anyone from his past work who would be willing to 
apply for the position as a short-term consultancy, with a view to training a Tanzanian 
researcher to take it over.  
On his return to Hamburg James prepares his research protocol for ethics review. His new 
Tanzanian collaborators tell him that obtaining Tanzanian ethics clearance will take a long 
time and is easier to work on in-country. James is keen to get started on things in Tanzania as 
his PhD funding is time-limited. So he decides to apply for the e-health research coordinator 
position himself. The consultancy fees will augment his research funds, cover his living expenses 
and enable him to move to Tanzania earlier. James is invited for interview and returns to 
Tanzania where he is interviewed by four national and international researchers based at the 
medical research station.  
James is offered the job and starts to juggle pushing through the national and European ethics 
clearance for his PhD research, with mentoring a Tanzanian IT graduate and working closely 
with other IT staff and health researchers. Once he has settled in he asks Mohammed, the 
demographic surveillance fieldwork supervisor, if he could spend some time with him in the 
field observing how fieldworkers collect data. Mohammed responds negatively and advises 
his team not to let him join them in any fieldwork activities. James is baffled – and a little hurt –
and does not know what to do. Mohammed had initially seemed so supportive of his PhD 
plans. Now, his resistance to James’ work could be very detrimental to both his PhD fieldwork 
and his good relations with his new colleagues. 
QUESTIONS 
 Why does James decide to take up the consultancy work? Why is he offered it? 
 Consider how this work might affect his PhD research both positively and negatively.  
 Why does Mohammed’s attitude towards James’ PhD research change?  
 What should James do?  
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REFLECTION ON YOUR OWN EXPERIENCES 
 Have you ever witnessed or been in a similar situation? Who do you identify with in this 
story and why? 
 What processes could be put in place to mitigate potential tensions as a result of 
James’s employment? 
FURTHER READING 
Redfield P. (2012) The unbearable lightness of expats: double binds of humanitarian mobility. 
Cultural Anthropology 27(2), 358–382. 
Okwaro, F.M. and Geissler, P.W. (2015). In/dependent Collaborations: Perceptions and 
experiences of African scientists in transnational HIV research. Medical Anthropology Quarterly 
http://dx.doi.org/10.1111/maq.12206 
Prince, R.J. (2013) “Tarmacking” in the millennium city: spatial and temporal trajectories of 
empowerment and development in Kisumu, Kenya. Africa: Journal of the International African 
Institute 83, 582–605. 
Nordling, L. (2014) Kenyan doctors win landmark discrimination case, Nature 22 July 2014 
Irikefe, V. et al (2011) Science in Africa: The view from the front line. Published online 29 June 
2011, Nature 474, 556-559 doi:10.1038/474556a.  
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SNOT FOR SALE: 
STAFF’S HANDLING OF TRANSPORT 
REIMBURSEMENT AND RUMOURS 
FACILITATOR’S NOTES 
The main aim of this story is to encourage reflection on the 
way rumours arise and are dealt with in a medical research 
setting. It focuses particularly on the role of money in rumours, 
as well as how junior staff deal with such rumours and why, 
sometimes, they may not feel comfortable discussing their 
experiences with senior colleagues. It concerns a rumour, 
heard by village health workers working on the study, that 
researchers are buying and reselling children’s snot.  
There is often a great deal of concern in the medical research 
world about rumours which associate research in Africa with 
blood stealing, Satanism and witchcraft. Narratives about 
blood stealing are found all over sub-Saharan Africa; blood 
has both literal and metaphorical power in many settings and 
most research stations will be implicated in such rumours at 
some point. This story deals with a more mundane bodily 
substance for rumour: snot. This also allows the training group 
to focus on the fact that the cause of rumours is related not 
only to what medical researchers do in medical procedural 
terms (like taking blood), but also what they are doing in social 
and economic terms.  
This story is useful for thinking about the practice of providing 
transport reimbursement in medical research, and how 
something seemingly straightforward may prove complex in 
practice. Some of the mothers whose children are 
participating in the study perceive their transport 
reimbursement as payment for services or products rendered. 
Are they right? How does this practice feature in and 
contribute to the rumour? This story shows how certain ‘micro’ 
issues, such as the specific study procedures for disseminating 
results, and the timing of the distribution of money allocated 
LEARNING 
OBJECTIVE 
To reflect on the role 
of money in rumours 
about medical 
research, and the 
challenges facing 
field staff around 
dealing with rumours 
and discussing them 
with senior 
colleagues 
 
 
 
 
 
 
KEYWORDS 
Money 
Employment issues 
Rumour 
Informed consent 
Inducements 
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for transport reimbursements, contribute to the rumour. But you might also want to think about 
the role of ‘macro’ issues or relations, such as historical social and economic relationships 
between the West African country and the countries of its research collaborators.  
Whilst rumours can sometimes be very damaging to medical research activities, it is important 
to remember that rumours are not fixed ideas. They are unstable, open-ended, and often 
debated and reframed in face-to-face contact. In this story the rumour ultimately did not 
affect research participation. Invite your group to think about why this might be so. 
Rumours can teach us about the dynamics of social relationships. Both the rumour itself and 
the way it is discussed amongst the medical researchers can tell us something about the social 
relationships operating here – not only between the villagers and the researchers, but also 
between the study coordinator and the village health workers. The village reporters described 
below do not feel able to raise the issue of the rumour with the study coordinator. They keep 
quiet. Encourage the group to discuss why. This story can also be used, therefore, to enable 
staff to ‘deliberate’ how best to encourage junior and senior colleagues to engage in open 
discussion about challenges and understandings of study procedures.  
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SNOT FOR SALE: 
STAFF’S HANDLING OF TRANSPORT REIMBURSEMENT 
AND RUMOURS 
 
 
 “DID YOU HEAR? THOSE STRANGE RESEARCHERS ARE BUYING CHILDREN’S SNOT!”
THE STORY 
n some villages in a West African country, mothers are asked to bring their children to a 
clinic so researchers can collect nasal swab samples to check for certain viruses. Each 
village has its own village health worker who is employed by the transnational research 
station. The village health workers are respected locally, know the people well, and act as a 
link between the villagers and the researchers. The study pays them to invite the mothers to 
come to the clinic. They walk door to door visiting the mothers and telling them about the 
study. Each mother who decides to takes her child is told she will be given a small sum of 
money to cover her transport costs. She is also told that she won’t be given her child’s 
individual results because they will not be able to tell if the presence of the viruses mean the 
child is sick. But at the end of the study the researchers will give a presentation about the 
overall findings.  
I
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Halfway through recruitment, the study coordinator calls a meeting with the village health 
workers. A similar study was conducted in this area last year, but so far, the number of children 
recruited is lower this year, despite the researchers being able to offer more transport 
reimbursement. The study coordinator wants to know why. He asks the village health workers 
for their opinions. The village health workers are non-committal. It has been raining a lot lately 
so perhaps the mothers are too busy farming, they offer. Or perhaps it is because the 
swabbing hurts the children? Another suggests that increasing the transport reimbursement 
might help. The study coordinator tells the village health workers that increasing the 
reimbursements is impossible. ‘We have to give everybody the same amounts,’ he tells them, 
‘and some of your participants are able to walk to the clinic anyway.’ 
A social scientist, Joe, who has been working and living in the village, is also at the meeting. He 
has heard a rumour that some mothers don’t want to take part, because they suspect that if 
researchers are prepared to buy something strange like snot, there must be a sinister reason. 
Perhaps, they wonder, it is what Americans use in witchcraft instead of blood.  
‘Buy the snot?’ Joe says to the mothers when he hears this. ‘What makes you think they are 
buying it?’ The mothers explain that after the samples are taken from their children, they are 
given some money. To them this was a clear commercial transaction. ‘Isn’t that money for 
your transport?’ Joe asks. ‘How could it be?’ the mothers reply. ‘Most of us live within walking 
distance to the clinic, and anyway we are given the money afterwards, not before.’  
‘Also,’ one of the mothers says, ‘a friend of mine who lives a bit far did ask the researchers to 
pay the motorbike driver who carried her to the clinic. They refused. They told her she had to 
wait to get her payment until the sample was taken. And the driver was waiting right there for 
the money. He charged her waiting fees!’ 
Joe wonders if he should say anything in the meeting about this rumour. In the break he asks 
some of the village health workers if they have heard it too. ‘Oh yes,’ they reply, ‘everyone is 
talking about it, and part of the problem is that it is very hard to explain to the mothers why 
they don’t get their child’s individual results. To be honest, we don’t really understand either.’  
Joe asks them how they explain the transport reimbursement to those mothers who live within 
walking distance of the clinic. Anna, a village health worker famous for her sense of humour, 
tells him, ‘Oh, I say, “You know, you could take a motorbike to the clinic. Or you could walk like 
this and this [miming a winding route with her hand] and cut through your neighbour’s 
compound like this, and through the market like this, where you buy some refreshing soda to 
keep you going!”’ 
Joe tells them it might be helpful for the study coordinator to know about the rumour and the 
challenges. He asks the village health workers to bring it up after the break. But they don’t. At 
the end of the meeting Joe raises his hand and tells the study coordinator about the rumour. 
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The study coordinator asks the village health workers if they have heard it. The room is quiet. 
Eventually, one of the health workers says they have heard the rumour, but it is just coming 
from one or two people; they have explained the study to them and now they are satisfied. 
The study coordinator sternly tells the group that the research station does not buy and sell 
samples. The matter is considered dealt with and the meeting ends.  
Joe feels a little bit embarrassed and annoyed with the village health workers. ‘Hey,’ he says, 
‘why didn’t you back me up in the meeting?’ ‘Well,’ they tell him, ‘researchers don’t like to 
hear about rumours. It’s our job to explain the study properly to the mothers.’ 
Recruitment for the study continues. The rumours also continue but don’t seem to have a 
significant effect on the study. By the end of the study the numbers recruited are sufficient and 
the researchers are pleased.  
QUESTIONS  
 Were the researchers buying the snot? 
 
 What might be the reasons behind the rumours? Do these have any relationship to 
‘reality’? You may want to think about specific local issues, and also wider historical 
issues. 
 
 What does the situation tell you about how well the researchers seem to understand the 
local environment? 
 
 Why do you think the village health workers were reluctant to discuss the rumours with 
the study coordinator? Would it have been helpful for him to know about them? What 
do you think he might say? 
 
 The issue of how to administer transport reimbursement is often tricky. Are there any 
different ways it could have been organized here? What are the pros and cons of these 
ways? 
 
 What else do you think the researchers could have done differently here to help the 
study run more smoothly? 
 
 Why do you think the rumour didn’t seem to have a negative effect on the study 
outcomes? 
REFLECTIONS ON YOUR OWN EXPERIENCE 
Have you experienced a particular rumour in your medical research? What conclusions can 
you come to if you try to ‘read’ it as a message to be translated? What can it tell you about 
social relationships? What were the specific local and wider issues contributing to it? 
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FURTHER READING 
Fairhead, J., Leach, M., and Small, M. (2006) Where techno-science meets poverty: medical 
research and the economy of blood in The Gambia, West Africa. Social Science and 
Medicine, 63(4), 1109–1120. 
Geissler, P.W. (2005) ‘Kachinja are coming!’: encounters around medical research work in a 
Kenyan village. Africa: Journal of the International African Institute 75, 173–202. 
Geissler, W. (2011b) ‘Transport to where?’: reflections on the problem of value and time à 
propos an awkward practice in medical research.Journal of Cultural Economy4(1), 45–64. 
Geissler, P.W. and Pool, R. (2006) Editorial: Popular concerns about medical research projects 
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I’M SURE YOU’LL GIVE 
HER A CHANCE: 
EMPLOYMENT AND CORRUPTION 
FACILITATOR’S NOTES 
Transnational medical research organizations, operating in 
countries with limited employment opportunities, are often 
perceived as highly desirable places to work. Competition for 
employment is usually fierce. In addition, such research is 
heavily dependent on maintaining the goodwill of key 
stakeholders and target communities. In this story, one of the 
local government officials pressurizes a study coordinator to 
employ a family member. It is often difficult for research 
coordinators to know how to respond to this kind of situation.  
It may be difficult to encourage staff to open up about this 
topic in a group discussion. Care should be taken to set up 
ground rules. For example, you might choose to ask 
participants to talk only about ‘hypothetical’ cases when 
reflecting on their own experiences, or examples from other 
organizations they have worked with. If you aim to use this 
case study to support your human resources policy, it would 
be important to have this to hand, and to encourage 
participants to talk about possible challenges they may face 
in following these rules.  
LEARNING 
OBJECTIVE 
To acknowledge the 
difficult issue of 
corruption in the 
employment 
processes of 
medical research 
organizations, and 
to discuss how to 
address this 
 
 
 
 
 
 
 
KEYWORDS 
Money 
Employment issues 
Corruption 
Government 
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I’M SURE YOU’LL GIVE HER A 
CHANCE: 
EMPLOYMENT AND CORRUPTION 
 
 
DAVID JUST COULD NOT GET THE CHIEF OFF THE PHONE. 'FINE,' HE SAID EVENTUALLY, 'I’LL GIVE HER A CHANCE.' 
THE STORY 
avid is the on-site Principal Investigator for a study looking at diarrheal disease in 
Southern Africa. The overseas Principal Investigators have entrusted him with 
employing staff for the study, and ensuring smooth relations with the local 
administration, which is particularly important as the study involves working with primary 
schools. The first step is to get the local government administrators on board, as people in this 
region will look to them for permission to participate in any research.  
The first local government meeting goes well, but after the meeting David gets a phone call 
from one of the officials. The official, Willis, tells him that he has a sister-in-law who would like to 
work on the project. David tells Willis that the application process is open to all qualified 
candidates, and if she has the relevant certificates she is welcome to apply. Willis replies that 
he is ‘sure my sister-in-law will get a chance’.  
D
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When the applications come into Human Resources, Willis’ sister-in-law is not shortlisted. She 
doesn’t have the required certificates. David receives another phone call from Willis. He is very 
angry that the research study has ‘failed to give her a chance’. He threatens to withdraw his 
support for the study. Panicking, David suggests that Willis’ sister-in-law should apply for the 
next round of jobs, which have less stringent requirements. This time the sister-in-law is 
successful. However, Willis calls again to complain, this time about the salary which is lower 
than the previous position. Again he threatens to withdraw his support. David doesn’t know 
what to do. In the end, he agrees to appoint her as a ‘team leader’ in her job category, and 
adjusts the salary a little. 
A few weeks later Willis’ sister-in-law is caught falsifying data and dismissed.  
QUESTIONS  
 What do you think will happen next? 
 
 What beliefs lie behind the opinion that all applicants must be treated ‘equally’?  
 
 Can you see the situation from Willis’ point of view? What beliefs might lie behind his 
behaviour? 
 
 Do you think David was right to do what he did? What could he have done differently?  
 
 Do you think the study would have suffered if David had not employed Willis’ sister-in-
law? 
 
REFLECTIONS ON YOUR OWN EXPERIENCES 
 Do you think such situations are a common occurrence in your organization? 
 
 Can you identify similar situations, where people may be hired for reasons other than 
their specific skills? What reasons can you think of?  
 
 What do you think the long-term consequences of employment practices like these 
might be? 
ACTIVITY 
Look together at your organization’s hiring policy. Can you make any suggestions about how it 
could be improved?
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GUIDANCE FOR FACILITATORS 
 
This resource has been designed as a flexible tool for training and development. The collection 
of training case studies can be used by individuals or in groups.  
INDIVIDUAL USE 
Individual readers might find it useful to read through the entire 
collection, or to pick stories at random, in order to draw parallels to 
their own experience and reflect on these. As such, this book can 
be read like any other. Recommended journal articles on the main 
themes (keywords) of each case study are provided for further 
reading. 
 
GROUP USE 
However, the workbook is mainly directed at groups of people 
involved in transnational medical research – either in research sites, 
or in academic institutions and universities – who can use the cases 
to elicit group discussions. This could happen during a dedicated 
training event, such as an ethics workshop or seminar over one or 
more days, involving a professional group or interested staff. If this 
involves many participants, smaller groups could work through single 
cases and report their experiences back to the larger group. 
Gradually, the group would in this way acquire deliberation skills and 
identify key issues that are of concern to them. We provide more practical information for 
facilitators below. 
Given the pressure on time, and the difficulty of gathering staff for longer periods of time, a 
more efficient way of using this material might be to have short, but regular, sessions of 15 to 60 
minutes to discuss one case at a time in relevant local groups. Such sessions can be added to 
existing meetings. For example, the members of an ethics review board, or an institutional 
scientific committee, could pick and discuss one case for 20 minutes before or after their 
monthly meetings. Here, one group member could introduce each case, and/or prepare 
questions and guide the debate. Similarly, a group of fieldworkers, or a Community Advisory 
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Board might use a relevant case to start off their regular meetings, in order to help people to 
think jointly through issues they confront in their daily work.  
CHOICE OF TRAINING MATERIALS  
In some cases, virtually any of the case stories might be relevant for a particular group (for 
example, scientists who as Principal Investigators bridge between academia and the field). In 
other cases the table of contents, keywords and summaries will help to identify particularly 
interesting or relevant cases relative to a particular site, target group or issue.  
TRAINING GROUND RULES 
In any of these cases of group deliberation, facilitators who engender sufficient respect and 
authority are needed to guide the discussion and encourage openness. At the same time, it is 
important that facilitators are not direct line managers, who might be seen as evaluating 
participants’ responses. For example, at collaborative research sites, the local social scientist 
might be a good facilitator. Or, members of a group of peers might decide to rotate the role 
of facilitator, giving each of them an opportunity to develop their skills. Overall, it is crucial that 
all participants are aware that the cases are not meant to lead to definite ‘correct’ answers, 
but to create a space to voice doubts, and to admit lack of clarity and even antagonism. The 
aim of deliberation is to elicit different opinions and to negotiate these. Moreover, ethical 
deliberation has the potential to open dormant controversies among staff – indeed, this could 
be seen as one of its purposes. But this needs to be carefully managed to avoid negative 
effects on collaboration and morale (see below).  
If the facilitator decides to suggest ground rules, such as confidentiality around any 
experiences or views discussed, it is important to ensure that all members of the group fully 
agree to these, and understand why an open discussion is important. The difference between 
apparent compliance and real commitment may be subtle, but the consequences for 
individual staff members might be severe. 
FACILITATOR’S ROLE AND PREPARATION 
The facilitator of ethical deliberation sessions, and to a certain extent the training attendees 
and their managers, are responsible for ensuring that discussions are underpinned by mutual 
respect even where differences in option emerge. Facilitators also need to manage the 
deliberation carefully so that the process leads to greater openness and to agreement, rather 
than to entrenched conflicts and disagreements.  
We have provided some guidance for facilitators at the start of each case study to support 
constructive deliberation. However, the strength of this approach, and of the stories that we 
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have selected, is that each of them elicits a variety of concerns and can lead to very different 
discussions in interaction with particular participants, or in the context of specific situations. 
Therefore, we cannot – and do not want – to provide exhaustive guidance. Instead, it is 
crucial that the facilitator thoroughly prepares for her/his task. Below, we provide some 
generic guidance for this. 
In the most practical terms, we envisage that deliberation sessions would consist of a brief 
introduction by the facilitator, perhaps explaining any ‘ground rules’ or the fact that no ‘easy 
answers’ are to be expected. This would be followed by a period of individual reading (or 
reading out loud) to familiarize participants with the case. The facilitator would then 
encourage the participants to address the guiding questions in turn. To make it easier for 
participants to talk, the facilitator might ask some open questions like, ‘What is happening 
here?’ or ‘What are the key ethical issues at stake here?’ Later on, they could try to help 
participants draw upon their own experiences in relation to the case: ‘Has anyone 
experienced similar situations?’ This may, however, just arise naturally in the course of 
discussions.  
The conversation might diverge far from the original questions; this is desirable, if it brings out 
local moral debates and applications. The discussion is likely to generate local comparisons 
and related anecdotes. Such concrete examples will enhance the discussion, but facilitators 
need to be mindful of the potential of underlying disagreements and conflicts to erupt (such 
as between field staff and scientists), which may need to be mediated. This moderation will 
require some skill from the facilitator, so it may be advisable to begin working with this book by 
starting with more general and less contentious issues.  
Some advance consideration of the following questions is essential:  
What is the learning objective? 
When preparing for her/his task, the facilitator should first stipulate specific ‘learning 
objectives’, bearing in mind the needs of the institution, the task at hand, and the specific 
group selected for training. What questions should be raised, and what insights be gained? 
What is it reasonable to expect as an outcome to the debate? It may also be important to 
manage the expectations of other, senior colleagues in this regard. 
What are the potential risks of using this story? 
The facilitator must also think carefully about the ‘risks’ involved in discussing a particular story: 
is this the right audience, the right time, the right place for this debate? Can the target 
audience understand the ethical or technical dimensions of this case? Could the discussion 
exacerbate existing tensions, either between members of the target group, or between the 
group and others (managers, participants)? 
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What is the best training method for my group? 
Once the learning objectives have been formulated and case stories chosen, taking potential 
risks into account, the facilitator must decide on suitable methods. Should the story be told or 
read? Should it be distributed during the session, or emailed beforehand? Should illustrations 
be used? Does the group invite smaller group work, or plenary discussion? How should smaller 
groups be composed, and what feedback asked for? Should one draw parallels with ongoing 
discussions on site, or not? 
What directions might the discussion take? 
Then, the facilitator should go through the case on their own, identifying the various multiple 
directions the discussion might take. From this, possible secondary learning aims can be 
derived, as well as, importantly, identifying ‘dead ends’ and ‘detrimental controversies’ to 
avoid. If possible, understanding something about the background of ethical dilemmas your 
participants have faced will be very important in this. 
Our goal is for ethical deliberations on these case studies to touch on three distinct arenas of 
debate and action: debate over individual choices and behaviour, debate over institutional 
practices, and debate over wider ‘structural’ issues. An awareness of all three of these ‘levels’ 
operating in global medical research is, in our view, essential for participants to move forward 
with a wider and more empowered understanding of ethical dilemmas. See the example of 
the discussion of the case of ‘Helping hand’ below for an example of these three ethical 
arenas. 
What is my desired outcome of the training? 
Finally, it is helpful to imagine the desired endpoint of the discussion, and to prepare a 
‘destination’ which can help the facilitator to draw together the discussion and reflect the 
learning aims. The facilitator might plan for this point of arrival to be reached via 1-3 points 
covered in the discussion, which they will want to reiterate in conclusion. Even though this 
‘endpoint’ may contain diverse or divergent ethical views, these should be ‘held’ and 
acknowledged by all in the final summing-up, rather than participants departing in major 
disagreement.  
All this will inevitably imply some didactic imposition on the part of the facilitator, but it avoids 
participants’ leaving the session feeling frustrated. Good skills in facilitation are important at 
every point in discussing the cases, but especially in the ending of the sessions. On the one 
hand there is a risk that participants will leave with an overwhelming sense of futility: ‘We have 
talked and talked, but what can be done?’ Or, ‘The underlying issues are so big that we can’t 
really do anything’. On the other, they might depart with a sense of too much certainty, be it 
about the perceived right course of action, or, worse, about already doing things right: ‘This 
would never have happened to us.’ ‘That nurse was really useless.’ ‘What was that PI thinking 
of?’  
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Once again it is important to reiterate that, when carefully balanced, ethical deliberation 
should lead to greater awareness of underlying fundamental challenges – and the 
impossibility of doing away with or avoiding them – combined with some ideas about key 
areas of practice where improvements are possible. 
EXAMPLE: ‘HELPING HAND’  
Imagine you are preparing a session drawing on the case story Helping hand. Let us say the 
target group are locally trained nurses and doctors who have been employed by the 
research organization for between one and ten years, and work on clinical trials which recruit 
participants from public health facilities, and refer them for in-patient care. The seminar is 
originally planned for up to 20 participants. 
The overall learning aim is: ‘For participants to achieve a greater awareness of the diversity of 
viewpoints and interests, and potential for friction – among healthcare personnel, research 
staff and patients – involved in collaborations between government medical facilities and 
transnational medical research collaborations’. This could further be split up into specific aims 
related to: mutual perception of professional status and role (how people see each other); 
styles of communication (culture, gender and generation); diverging ethics of patient care, 
data collection and cooperation (potentially different priorities); reflection on material 
differences and resource use (e.g. what drugs and technologies are available or not 
available, and what can be done about it); etc. 
Once some learning aims have been chosen, taking into account the current needs of the 
target population and institution, the facilitator might reflect in advance on the risks of 
discussing the case. Have there been any events in the recent past which might make 
individual participants feel uncomfortable with this discussion – e.g. conflicts between 
supervisors and staff, or between research staff and care staff – or which could open up 
undesirable conflicts among participants? 
Along with the risks, you might consider the potential advantages of extending the group 
beyond its original constituency – for example, including local health facility staff among the 
deliberation participants. How would you make use of this opportunity to involve more 
people? How would you mitigate potential risks of doing so? Let’s assume that on this 
occasion, you go back and invite personnel from the local health facilities, increasing the 
seminar size to 30+. 
Then, you would design methods and an overall schedule. First, a suitable introduction needs 
to be sketched: Why should we discuss this topic? What are our experiences in this area? What 
is our overall aim (formulating this positively and inclusively, e.g. in terms of good collaboration 
of mutual benefit)? You decide that following the brief introduction, the participants, whom 
you decide will be happy with written information, will be given the case story, and suitable 
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time to read. Given the size of the seminar group, it will then be split up into five groups of six 
people to discuss the case. Each group will choose a representative who will feed back to the 
plenary, before opening up the general discussion. You might decide that, in order to 
facilitate mutual understanding, the smaller groups will mix research staff and healthcare 
personnel. 
Before the actual session, you would go through the case story carefully and identify potential 
directions which the discussion might take, as well as different levels of deliberation. You might 
write these down, as leading questions which you can raise later to help you to guide the 
discussion if needed. Thus, you might expect the discussion to focus on the actors’ individual 
behaviour: Why did the research nurse behave the way she did? Could she not have done X? 
How is her behaviour perceived by the matron? Was his supervisor reacting correctly? How 
could the research nurse and the supervisor have dealt with the situation differently? Why 
don’t the healthcare personnel do their job properly? Is the research nurse not obliged to 
produce good data? What interest does the local nurse have in data production? These 
questions point to learning aims on the level of individual behaviour and communication, 
enhancing awareness about the role of language, specific actions, and interactions. 
One could also imagine that the discussion might turn to institutional practices: how was the 
research project introduced to healthcare personnel? What sort of agreement exists between 
the research and the healthcare institution? Is this in writing and accessible to staff? Does it 
specify particular practices and resources? How often do representatives and staff from the 
institutions formally meet, and at which level? What ownership in research results (and 
publications) is there on the health facility side? Are doctors included among authors, or have 
access to academic training? What sorts of stereotypes exist with regard to the other group?  
These types of questions point to learning aims on an intermediary level, pertaining to 
institutional practices and structures. Awareness of these constraints and possibilities is equally 
important as awareness of the role of personal behaviours and choices. But it is also important 
that the facilitator helps the participants to think of the two areas as distinct arenas of 
reflection and action. 
Questions and debates relative to these individual and institutional levels of the case story can 
be guided towards improved practice. You might anticipate that your group might decide 
that research nurses working within public healthcare institutions need adequate training 
about formal procedures and communication; they also need procedures, if necessary, to 
complain about practices which negatively affect data collection. Transnational research 
organizations implementing clinical trials in public hospitals, on the other hand, might need to 
respect the ‘ownership’ of local healthcare personnel, and institutionalize regular exchanges, 
as well as material support. While it does not serve the purpose of the deliberation seminar to 
identify definite solutions, it is possible here to collect propositions towards best practice, and 
even to ask whether any particular measures should be taken in the particular site. 
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Finally, it is hoped that the discussion will not only touch on these arenas of personal and 
institutional arrangements, but also reach a different level altogether: that of ‘structural’ 
political-economic relations of inequality. How can a research organization improve 
healthcare, if the state is unable to do so? Isn’t this a bottomless pit? Must the research 
organization not protect its resources, in order to produce good data? Or: Why has the 
research organization worked in this hospital for two decades, without significantly improving 
hospital practices? Shouldn’t transnational researchers contribute to local healthcare, or train 
local doctors? But also: Isn’t good data an important contribution to improved local 
healthcare? If not, why do scientific research findings not always translate into local 
healthcare benefits?  
These questions point towards global inequalities at the global level. As such, it is much more 
difficult to find clear-cut ways forward. You can expect some participants to propose 
unequivocal ‘solutions’: the mandate of research organizations is only to do research; besides, 
they should not alter local healthcare realities, because this would affect the validity and local 
relevance of their findings. Moreover, it would be unethical to improve healthcare and thus 
induce patients and hospitals to agree to research. Other participants might argue the 
opposite: to act ethically, large international research organizations should significantly 
improve or even build the hospitals they research in. Here, the facilitator’s skill is required to 
steer away from a polarization, and to avoid simple solutions. On this ‘macro’ of deliberation, 
rather, the learning aim should be to recognise the inevitable fact that transnational medical 
research is situated within what may be termed ‘structural violence’ related to the distribution 
of power and resources, and this has a direct effect on human lives.  
Thinking about how this plays out in any given situation will, hopefully, not simply raise but also 
help to answer the question of ‘what’s the point?’ Touching on this area is challenging, but it 
can also be energizing; it provides the underlying motivation of many thousands of people 
from all backgrounds working in global medical research around the world. A logical end 
point of your group’s deliberation process might be that they decide both individuals and 
institutions have an ongoing and continuous responsibility to work for improvements, to strive 
to ‘make things better’, without being able to resolve the underlying contradictions. In this 
sense, the authors of this workbook believe that the overall take-home message of discussing 
these cases could be formulated as: ‘we can all do more, and we must keep trying’. This, 
then, would be the ‘destination’ to be aimed for by the facilitator. A case like ‘Helping hand’ 
raises ethical concerns pertaining to three major levels: individual, institutional, and global-
structural. While the first two arenas provide opportunities to do things a little better – improving 
patient care, enhancing data quality, and addressing health system failures – the third 
constitutes the inevitable backdrop to transnational medical research under current global 
economic-political conditions: one of inequality and injustice. Although this level of challenge 
is beyond simple solutions, an awareness of it – and understanding of its contradictions – is 
crucial to provide orientation, direction, and thrust to ethical action.  
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FACILITATOR’S PREPARATION 
TEMPLATE: 
 
1. Choose a training case study (TCS) suited to your context. 
2. What is the key take-home message or learning aim I want to convey to my training 
participants? 
3. What are my secondary learning objectives? Do these include any potential action 
points?  
4. What is the desired outcome of this training exercise, what do I want to achieve? 
5. Are there any risks that might jeopardize our discussions? What can I do to avoid 
potential bottlenecks, or red herrings? Are there possible dead ends in the discussion?  
6. What format will the training exercise take? 
 
Key message/Learning objectives:  
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________ 
Potential action points:  
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________ 
Steps I need to take to achieve the learning outcome and potential action 
points:  
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
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FIRST EXPERIENCES OF PILOTING 
THIS TOOL IN AFRICA AND EUROPE 
 
When we piloted selected case studies and related stories from this workbook with audiences 
in a number of collaborative African research sites, they were met with astonishing resonance, 
triggering animated discussions and conversations, and more than one participant remarked 
plainly how good it was to talk. Supportive remarks and requests for copies of PowerPoint slides 
went well beyond reactions to ordinary social science presentations.  
During piloting, cases were selected after consultation with local scientists. For example, a 
case on per diems during conferences was removed from the presentation in a site where 
such per diem rates were under controversial revision. At another site, however, this case study 
proved to be very constructive: diverse solutions were discussed and dismissed – should 
employers simply pay hotel bills and not pay per diems? (Laughter; ‘No!’); should the 
conference next time be held in a cheap rural guesthouse? (Hesitation; some acknowledge 
enjoying ‘posh’ hotels, others call for ‘African’ conferences). Discussing the ‘Helping hand’ 
case on researchers working in a public hospital with a gathering of healthcare professionals 
yielded suggestions for improved communication and organization, provoked the formulation 
of concrete claims to address lack of specific resources in the hospital, and initiated the first 
ever discussion between the hospital and the wider community about external research in a 
site that collaborated for two decades. Discussing the story about a Northern graduate 
student who took on extra consultancy work, on the other hand, gave some expatriate junior 
researchers a chance to acknowledge and reflect on their co-operation with senior African 
colleagues, and question their assumptions and role.  
While the case studies helped to articulate experiences and release tensions in African 
research sites, when we piloted them among students and academics in Northern research 
institutions, they also provided concrete information about how ethical issues play out in real-
life situations. This helped those present to understand the challenges arising when ‘ethics hit 
the ground’, and served as a source of knowledge about real-life dimensions of global health 
research, which many of the participants had not yet had a chance to engage with, and 
which senior academics did not encounter during their short visits to the field. As such, the 
cases also served as ‘ethnographic’ data of sorts. 
The discussions triggered by the cases did not solve problems, but made it possible to talk 
about ‘awkwardness’ in a safe space, giving room to consider potential solutions. Speaking 
out about inequality can be embarrassing or confrontational, depending on one’s position 
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and interlocutors, but it helps those working together across inequality to avoid a sense of 
merely ‘performing’ equality, and can build trust, shared visions of collaboration, and joint 
scientific aims. The greatest danger we identified during the piloting, however, was not 
confrontation; tensions are not generated by discussion, but ultimately released. Instead, what 
has to be avoided is participants going away with a sense of futility. At least some elements of 
steps forward should be identified for further consideration, even if radical and definite 
solutions do not gain consensus or might seem unrealistic. It is thus important that facilitators 
consider some possible practical steps in their preparation. 
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RESOURCES 
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Beskow, L.M. and McCall, J. (Eds). Informed Consent. Rethinking clinical trials: a living textbook 
of pragmatic clinical trials. NIH Health Care Systems Research Collaboratory. Available at: 
http://sites.duke.edu/rethinkingclinicaltrials/informed-consent-in-pragmatic-clinical-trials 
(accessed 25 October 2015).  
Council for International Organizations of Medical Sciences (2002) CIOMS Guidelines. 
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ACADEMIC 
BACKGROUND:  
ETHICAL DELIBERATION, ENGAGED CONSCIENCE, 
AND CONSCIOUS CHOICE  
This workbook is the outcome of a decade of anthropological 
studies into how transnational medical research in Africa is 
carried out. It aims to extend insights from academic research 
to as wide an audience as possible. We hope that we can 
thereby support anyone involved in transnational medical 
research to think about and act on ethical challenges.  
Our workbook draws impetus from a growing interest among 
the qualitative social sciences in research ethics, and 
increasing attention from anthropologists in particular (for 
example Marshall and Koenig 2000; Hedgecoe 2004; Fairhead 
et al 2005, 2006; Parker 2007; Molyneux and Geissler 2008; 
Simpson 2009; Bandewar et al 2010; Graboyes 2010; Geissler 
2011; Whyte 2014).  
Anthropological approaches to research ethics share several 
key ideas:  
Ethics happen in practice  
While research ethics are (and should be) framed by 
international guidelines and principles, crucial ethical 
decisions are made in situated engagements and 
face-to-face encounters, giving rise to what can be 
called a ‘relational ethics’. These relational ethics 
cannot replace, but complement and interact with, 
formal regulatory guidelines and rules.  
(See, for example, Kleinman 1999; Molyneux et al 2005; Geissler et al 2008; 
Gikonyo et al 2008) 
 
KEY LESSONS 
Ethics happen in 
practice. 
Ethical situations 
involve a diversity of 
actors and arenas. 
Research ethics 
cannot be 
separated from the 
economic context 
of global health 
research. 
There are blind spots 
and public secrets in 
research. 
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Ethical situations involve a diversity of actors and arenas 
While research ethics must be guaranteed by public scientific institutions, and hold 
investigators accountable, many important ethical decisions are taken by technicians 
and fieldworkers. These ‘interface’ actors are often considered unproblematic quasi-
technical staff; they do not feature prominently in academic publications, nor in 
research ethics debates. We believe this is a major oversight. 
(See, for example, Fairhead et al 2005; Kelly 2011; Benatar and Brock 2011; Molyneux et al  2013; Kamuya 2013; 
Molyneux, Kamuya et al 2013) 
Research ethics cannot be separated from the economic context of 
global research 
Under conditions of widespread deprivation and increasing economic inequality, 
ethics, economics and politics cannot be separated. Material realities dictate ethical 
possibilities, and ethics are political. Ethical challenges in transnational research arise 
not only in relation to vulnerable participants, but also from collaborative and 
institutional engagements. 
(See, for example, Rajan 2005; Petryna 2009; Seth 2009; Rottenburg 2009) 
There are blind spots and ‘public secrets’ in transnational medical 
research 
Due to institutional structures and procedures, everyday ethical challenges 
experienced by individual actors often receive no attention in research planning and 
implementation, nor in reporting and publication. 
(See, for example, Farmer and Gastineau Campos 2004; Wendland 2010Geissler 2013) 
 
Ethics and structural violence 
The authors of this book relate to ongoing discussions among professional bioethicists, 
especially the concept of ‘structural violence’1 – the idea that the unequal distribution of 
people’s chances to survive, attain or maintain health, develop desirable life courses, or 
pursue better futures constitutes an underlying injustice (Pogge 2002; Lavery et al 2007; Panitch 
2013). In our view, practitioners who daily confront the suffering caused by such inequality 
have an obligation to try to make a difference, not necessarily to solve entrenched problems 
but to aim for some sort of improvement (Pogge 2002). In transnational medical research, 
                                                 
1 This term, borrowed from political science, refers to social structures or institutions which prevent 
people from meeting their basic needs, and thus harm them without necessarily deploying outright 
force (see Farmer 2004; Farmer et al. 2006). 
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which operates across major differences in health, wealth and opportunity, both these 
injustices and the resulting responsibilities can be particularly painful to deal with.  
A systemic perspective   
Our position resonates with what ethicists have referred to as ‘systemic’ perspective: one 
which situates medical concerns within wider questions of justice, rather than relying on 
individual doctor-patient relationships to seek improvements. This means viewing the entire 
field of inequality surrounding transnational research as a ‘skandalon’ – not a ‘scandal’ which 
calls for clamour and exposition (although there is a place for that, too), but, in the literal sense 
of the ancient Greek word, a ‘stumbling stone’ which helps us to stop, seek orientation, and 
redirect our efforts. This implies an ethics of opening, rather than of regulatory closure. Contrary 
to ethical arguments which seek to delimit ethical responsibility as a simple matter of scientific 
‘good practice’ – what some critics refer to as a ‘minimalist’ position (London 2006) – we 
believe that global inequalities should, indeed, worry transnational medical researchers 
persistently (Emanuel et al 2005). The first step in any attempt to address system-level 
inequalities must be to engage one’s ‘conscience’, taking note of larger and smaller 
stumbling-blocks and the personal challenge which these pose to each of us. 
Ethical deliberation 
At the same time, research ethics is, for us, less about ‘doing the right thing’ than about 
coming to grips with what is wrong. To do this, individuals and groups must develop an ability 
to express and confront overarching conditions and contradictions, to negotiate agreements 
about direction and purpose, to seek allies and identify obstacles, and to be open to 
disagreement and failure. Such debate, which has no easy solutions but encompasses 
multiple perspectives, has been called ‘deliberation’. We follow the argument made by, 
among others, Gracia (2003), that moral decisions must take into account not only principles 
and ideas, but also emotions, values and beliefs.  
Deliberation is the process in which everyone concerned by the decision is considered a valid 
moral agent, obliged to give reasons for their own points of view, and to listen to the reasons 
of others. The goal of this process is not the reaching of a consensus but the enrichment of 
one’s own point of view with that of the others, increasing in this way the maturity of one’s own 
decision, in order to make it wiser or prudent. The people involved in deliberating the case 
may have different opinions as to how the issues should be resolved, but debating the issues 
will help change their perceptions of the problem.  This is the benefit of the deliberation 
process.   
The case stories in this book invite such deliberation, by prompting positioned and engaged 
conversation about ethical challenges in context. This, we believe, will enhance our 
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awareness of how global inequalities translate into the minutiae of transnational medical 
research. 
Conscious choices and possibilities 
We also hope it will also create awareness of the possibilities which concrete situations and 
resources provide. Negotiating these possibilities is a matter of making conscious choices, 
which take into account the inevitable overlapping ethical demands, the limits of catch-all 
guidelines, any particular resource constraints, and the persistence of wider areas of doubt. 
This, hopefully, will help practitioners attain the best possible outcome in a given situation.  
Seeking the ‘best possible’ outcome does not, however, mean abandoning ambition. For 
example, the most radical demands put forth in the late 1990s discussion about standards of 
HIV care in transnational HIV research in Africa have still not been met; yet the articulation of 
claims, which many denounced as utopian pipe dreams at the time, has very effectively 
raised ethical standards. This has meant concrete, material improvements in the treatment of 
people with HIV, as well as a greater sensitivity to medical justice across the North/South divide 
across the board. The HIV treatment debate demonstrates that demands which critics 
denounce as ‘impossible’ may, in fact, reflect only mundane obstacles such as funding 
limitations, time constraints, or a lack of political will. If, therefore, activists today demand that 
research organizations help to establish functioning in-country public healthcare systems, we 
cannot simply dismiss such claims offhand as ‘unrealistic’ (de Cenival 2008).  
While such radical demands (which call, in effect, for public health research to act as a tool in 
overarching social transformation) must be taken seriously, they are not always directly useful 
on the ground. The focus of this book is not to make any such case. Rather, we seek to 
empower specific agents to create small-scale improvements, making the most of contextual 
opportunities and alliances. At the same time, if working with this book prompts the collective 
insight that we can do more – indeed, that we persistently must do more, rather than sit 
comfortably with minimal ethical arrangements – new directions might take hold in research 
culture. This may, eventually, lead to a wider engagement of medical research with the 
political context of systemic problems. This, we believe, is a goal worth striving for.
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THE CONTEXT OF GLOBAL HEALTH INEQUALITY 
Due to the particular experience of the authors of this book, our starting-point is medical 
research conducted by African, European and North American institutions in Africa, but we 
hope that the book will be useful in relation to research in other economically deprived 
societies (Rajan 2005; Petryna 2009; Abadie, 2010; Meyers and Hunt 2014). The main 
challenges to health and wellbeing is global political, economic, and epidemiological 
inequality, as well as unequal possibilities. While these issues recur in many contexts, the African 
continent offers some particularly stark patterns of difference (e.g. Prince and Marsland 2013; 
Geissler 2013, 2014b). 
Adverse medical, economic and political conditions in Africa are historically produced, and 
shaped by the legacy of colonialism. This is evident in the many echoes of ‘imperial science’ 
(e.g. Clarke 2007; Giles-Vernick and Webb 2013; Manton 2013) which persist in today’s 
research. Like the research conducted in Africa by imperial regimes, transnational research 
today operates across huge differentials in power, resources, and knowledge, and involves 
global circulations and transfers of personnel and expertise, apparatus and techniques, and 
data. Expressions such as ‘overseas research’, or ‘going out’ or ‘going down’ to African sites 
(even when these units are located in major capital cities), continue to express hierarchical 
centre-periphery geographies, implying secluded islands of civilization in the wilderness.  
Using such language sends a clear message to African scientific colleagues about their 
subservient relationship to Northern institutions, despite any claims in other contexts to ‘equal 
collaboration’, and it suggests that conceptual maps of power have altered little in the 
transition from colonialism to post-colonialism. It is all too easy for apparently extinct ethical 
positions to creep in alongside such world-views.  
The persistence of these terms also highlights that ill health and poverty are not simply 
technical problems, but are grounded in historically shaped inequality – the deprivation of 
large groups of people, in relation to others, through ongoing global processes. While the 
actual geography of deprivation has changed somewhat, so that inequality appears 
increasingly between a global middle class and the vast majority, rather than between 
countries, the basic problem remains. Relative ill health is not a remediable accident, but a 
direct outcome of the relationships between more and less affluent people. 
With this in view, this workbook aims to support ‘public’ transnational health research – 
scientific work which is predominantly funded by public institutions, is conducted by publicly 
employed scientists, shares its results in the public domain, and aims at public health 
improvements. It is important to differentiate such public research from rapidly growing for-
profit medical research, such as that conducted by pharmaceutical and genomics 
institutions, often through transnational ‘contract research organizations’ (Petryna 2007; Foster  
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and Malik 2012). In many cases, such research views global inequality as a condition for profit 
maximization rather than social good. Public medical research, by contrast, is at least partly 
directed towards social justice, with its actors motivated by the struggle against the effects of 
inequality on health and wellbeing.  
Public medical research is, like science and academia more generally, under threat from 
particular economic and political interests. For example, pharmaceutical companies 
influence research agendas in order to open up markets for new vaccines, to gain knowledge 
for drugs directed at Northern customers, or to gain public trust and tax relief. And research 
funded by Northern governments into the ‘tropical’ diseases of the poor also usefully protects 
the military in overseas operations. Northern ‘security’ agendas, for example those related to 
emergent viral diseases, can overwrite an older public health impetus grounded in 
international solidarity and basic needs.  
At the same time, consortia and public-private partnerships such as the HIV Prevention Trials 
Network (HPTN) or the GAVI alliance, which emphasize technical fixes like vaccines and drugs, 
make use of private funding and expertise. On the one hand this can enhance the speed and 
scope of public health interventions, but on the other it can jeopardize scientific 
independence and introduce industry influences into the public domain (Jain 2013). In the 
face of these threats to public medical research, it is of particular importance to retain the 
analytic distinction between public and private science. 
Transnational medical research has been expanding over the past few decades (Petryna 
2009). Global institutions and consortia are conducting growing numbers of trials, connecting 
more and more researchers through collaborations across geographic, cultural, and 
economic divides. Such work is often conducted under the remit of fairly durable institutional 
agreements, and in sites which attract substantial investment in infrastructure and human 
resources (Gerrets 2014; Okwaro and Geissler 2015). Many of these powerful and well-
endowed collaborations have achieved a quasi-permanent existence through consecutive 
funding, with a lasting physical presence. Personnel, too, often look to running employment, 
even if on renewable annual contracts.  
These highly productive research sites harbour particular challenges, because they juxtapose 
the radically different medical and scientific possibilities of local and international actors, and 
bring into confrontation diverse personal motivations and lifestyles. But because of the quality 
of scientific work they permit, and because of their size and long-term prospects, they also 
offer opportunities to lay the foundations for more sustainable national and regional scientific 
institutions, and continuous public health improvements. Successful collaborations create a 
wide range of relations which evolve over time, allowing not only for scientific discovery and 
progress, but also for the growth and development of personal relationships. In turn, hopefully, 
this can produce even better science. It is especially this process of long-term scientific 
engagement across difference to which our workbook hopes to make a modest contribution. 
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INEQUALITY AND DISCOMFORT 
Inequality shapes the field of transnational medical research in at least three key ways:  
Firstly, unequal economic conditions result in exposure to pathogens and cause malnutrition; 
the resulting infectious diseases remain the focus of transnational medical research. The entire 
field depends upon the fight against such ‘diseases of poverty’ for its legitimizing discourse.  
Secondly, underfunded and weak post-colonial healthcare infrastructures, and a 
concomitant lack of drugs, diagnostics, qualified staff, and technology, are a crucial factor in 
most transnational projects. They drive researchers to come up with new interventions, but 
they also limit research in that they require tools which can operate alongside malfunctioning 
healthcare systems (Redfield 2008; Lancet 2009; Biehl and Petryna 2013; Geissler 2014b). Weak 
public health systems also have an impact on informed consent in recruitment, and on data 
validity; and they shape the experience and motivations of health practitioners and scientists 
working in research (Crane 2010).  
Thirdly, inequality in transnational medical research pertains to scientific knowledge itself, 
and the conditions of its production. Neglected for decades by national governments and 
overseas agencies, universities and scientific institutions in many Southern countries have fallen 
far behind Northern institutions in terms of scientific expertise, output, and recognition. Their 
ability to produce innovative and generalizable scientific knowledge has been severely 
limited.  
These domains of gross inequality, pertaining to health and wellbeing and to education and 
knowledge, remain a persistent provocation to public health science. Even advocates of free-
market policies usually find it difficult to contest the fundamental human right to health and to 
knowledge. Since the ethics of transnational medical research is centred around inequality, it 
is hard to differentiate it from the politics of medical research: the legitimate interests, contests 
and struggles which occur within and around medical research settings – between 
researchers and research participants, funders and scientists, or institutions and researchers of 
different origins. This is why we chose to include the notion of ‘political’ deliberation into the 
remit of this book, to retain a prominent place for reflections on power, structural violence and 
contested interests. It is one of the premises of our work that ethical reflection which aims to 
steer free of political-economic questions, externalizing these as being ‘beyond research’, 
ultimately leaves unaddressed the most central choices which have to be taken in the pursuit 
of medical science and public health progress (see Kleinman 1999; Farmer and Gastineau 
Campos 2004; Geissler 2013). 
The ethics of transnational medical research, then, can only ever aim to ‘do the right thing’ 
within a wrong global and local order; and under such conditions, in fact, it is impossible to 
identify beyond doubt and for once and for all, what is ‘right’. As illustrated by the conundra 
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presented in this book, this makes for an essentially ‘uncomfortable’ position (Lavery et al 2010, 
2013), which rarely allows for stable settlements, fixed rules, or even obvious good practice. 
Such discomfort should lead neither to nihilism, nor to over-ambitious demands which can 
have a paralysing or divisive effect if lacking a basis in current political realities. A sense of 
discomfort, instead, could provoke ongoing critical reflection, helping practitioners to figure 
out the best options in a particular situation and to create incremental improvements – while 
remaining aware of the fragility of such attempts. This workbook, therefore, does not aim to 
prevent its readers from feeling uncomfortable.  
EMERGENT DEBATES 
The less-than-straightforward nature of the ethical challenges, the lack of clear and lasting 
solutions, and the indeterminate mode of progress driven by the type of critical engagement 
we are advocating, is evident in the history of transnational medical research ethics over the 
past two decades. 
The ‘standards of care’ controversy 
To many, this history starts with the late 1990s ‘standards of care’ controversy around HIV 
research in Africa (Angell 1997, 2000; Lurie and Wolf 1997; Wendland 2008). At the core of this 
acrimonious debate was outrage about the fact that African research participants in trials of 
a cheap and simple (though presumably less efficacious) drug regime to prevent HIV 
transmission from mother to child, received a placebo as comparison rather than the standard 
North American treatment, which relied on expensive drugs and health facilities, and was at 
the time unavailable in Africa. When these concerns were first raised around 1997, some of our 
colleagues involved in these attempts to develop effective, low-cost interventions against the 
spread of HIV in Africa were aggrieved. What did the critics hope to achieve? How could 
time-limited individual projects be asked to fill gaps in the public health system? What funder 
would be willing to pay additional costs of US-standard treatment and monitoring? How could 
one develop ‘adapted’ healthcare interventions, feasible under prevalent conditions in 
Africa, if ethicists insisted in applying global standards of care (Bhutta et al 2004)? 
Both sides in this debate grew heated. Some did not shy away from evocative comparisons 
with the US experiments at Tuskegee, or even Nazi experimentation. Others, in turn, accused 
the critics of killing HIV positive Africans by preventing the timely development of appropriate 
and realistic treatment and prevention. The controversy was fueled by the combatants’ 
personal stakes in HIV research, while Northern HIV activism framed HIV as a rights issue rather 
than a public health emergency (see Fisher et al, 2009). Some measures were taken which 
now seem mistaken, including the closure of important trials.  
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In one sense the debate fell far too short: 15 years later, no consensus has been reached 
about how to bridge the standards of care in the Northern medical institutions, in which trials 
are often designed, and the Southern healthcare systems in which they are conducted 
(Feierman 2011). Yet while this affair did not bring about the dramatic change which radical 
critics had hoped for, it did engender momentous shifts. For one, the confrontations raised 
awareness about the deficiency of regulations at the time, leading to innovations such as the 
concept of ‘good clinical practice’ and the establishment of ethical review boards.  
The regulatory turn 
The introduction of improved regulation was an important step in the development of 
transnational medical research ethics. Yet some critics have pointed out that these changes 
have had their own negative consequences (see e.g. Farmer and Gastineau Campos 2004). 
Taking into perspective the issues of wider injustice described above, regulation can appear 
to proclaim overly simply solutions, ignoring local entanglements. The regulatory emphasis on 
informed consent can seem to focus too much on research participants’ autonomy, instead 
of on mutual obligations between researchers and participants. In emphasizing participants’ 
individual, discrete choices, without exploring the wider context, some accuse the consent 
process of intentionally obscuring the wider conditions which create ill health.  
Ethical rulebooks can also foster a culture of superficial compliance, behind which nihilism can 
persist (Lachenal 2015). As illustrated in some of the case studies in this workbook, ‘ethics’ in this 
particular sense can silence debate, rather than foster it: if ‘consent’ is taken to be a 
participant’s signature, obtained as quickly as possible, then consensual engagement fades 
from view. If guidelines forbid material remuneration, then payments to research participants 
may be knowingly mislabelled as ‘transport reimbursement’ (Geissler 2011b). If an ethics 
review board chairman uses the ironic question ‘So you want to change the African health 
system?’ to silence board members’ questions about post-trial care, then the whole process 
risks becoming a rubberstamping procedure.  
And yet, some hard and fast rules are needed. The ‘ethical minimalism’ of relying solely on 
regulation constitutes a universal ethical baseline which can hold to account more ‘relational 
practices’ based on individual conscience. Under conditions of marked inequality, without 
regulation personal relations can easily be manipulated to serve specific interests. Even if 
these support a scientific goal, this would compromise informed consent and data validity. 
Moreover, in the absence of definite rules, ad-hoc decisions can more easily be taken by 
senior Principal Investigators and grant holders than by local frontline staff, which is both 
inequitable and reduces efficiency. Regulation has a role in granting agency and a certain 
form of transparency to all involved. Its overall value must depend, of course, on how it is 
implemented. 
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Overall, the overseas bioethics discussion has opened a new space for deliberation, ranging 
all the way from issues of individual patient care to structural questions of institutional 
inequality. On the one hand, regulatory minimalists seek to prevent abuse through general 
and enforceable rules, while on the other, activists articulate ambitious demands, seeking to 
make public health research a tool in overarching social transformation. This debate has 
continued to develop precisely because simple and lasting solutions are not easily found. It 
has led to more nuanced reflections on what constitutes a legitimate ethical concern: for 
example, the initial outrage about HIV treatment has led on to questions over participants’ 
rights to sustained antiretroviral treatment after projects end. Increasing numbers of trials now 
provide this, as well as healthcare beyond the immediate focus of their research. Even where 
provision is more basic, the debates have provided a vocabulary of claims for trial participants 
and their advocates. The reliance of HIV prevention trials on continued exposure, too – most 
notably in so-called ‘high-risk’ groups – has come under scrutiny. Here, the intimate relation 
between medical research and the social context on which it is predicated is particularly 
evident. 
A changing ethical landscape in medical research 
Increased ethical sensitivity in transnational medical research has widened beyond HIV. For 
example, the Neglected Disease Initiative promotes research into treatments for diseases of 
the poor which do not promise profits for the pharmaceutical industry (Allen and Parker 2012). 
Bioethics debates have also emerged around the ownership of value generated from 
biological specimens, for example in genomics research, the storage of specimens, and the 
distribution of benefits (Chokshi et al 2006). Discussion around bioethics in research has led to 
renewed emphasis on capacity building, and obliged Northern initiatives to invest further in 
involving African people in research, sometimes as a funding requirement (Chu et al 2014).2 
While all these provisions can be circumvented or used as ‘fig leaves’, they nonetheless point 
in the right direction. 
Gradually, and with inevitable setbacks, wrong turns and conflicts, bioethics discussions have 
changed the landscape of medical research. In 1994 Geissler could, as a PhD student, collect 
blood from schoolchildren without individual or parental consent, legitimized purely by the 
national government’s Ministries of Health and Education. Six years later, a major research 
project in the same area was closed prematurely after the United States-based evaluators 
found that no individual written consent had been obtained. Again, many of these moves risk 
becoming atrophied and turned into meaningless rituals; they can be kept vital only through 
continuous debate. We believe that these deliberations will, little by little, change the daily 
practices of transnational medical research for the better. 
                                                 
2 At the end of colonialism such efforts were labelled ‘Africanization’. The persistence of the term in 
discussions of research provides yet another point of continuity between the past, present, and 
suggested future of medical research in Africa. 
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WE NEED TO TALK MORE; WE NEED TO DO MORE 
This workbook was initially titled ‘We need to talk more’ – a phrase that came up during a 
public discussion with staff at a large health research station in Africa about the challenges of 
everyday scientific fieldwork. The speaker meant that staff would benefit from talking more 
about issues that seemingly were either too obvious, too personal or contentious, or too 
irresolvable, to be spoken about in professional conversations across divides in disciplinary 
training, hierarchical position, and origin. Talking remains, however, just the first step: when we 
more recently presented a draft of this workbook in an African research laboratory, somebody 
suggested that we change the title to ‘We need to do more’.  
We hope this workbook might be a small catalyst for translating talk into action. Discussing the 
tensions which arise from the endeavours of public health actors to ‘do the right thing’, and to 
combat some of the effects of entrenched global injustice, will not make the latter go away. 
But it might help to sharpen the tools here and there, allowing us to identify what we need to 
do in order to make improvements in our individual settings. Inspired by all those engaged in 
transnational medical research who believe that their efforts will eventually lead to better 
global health, the social scientists behind this book hope to empower practitioners to develop 
their own, relationally engaged approaches to ethical practice, which may one day, in turn, 
contribute to increased social justice. 
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LEARNING OBJECTIVES 
Researcher/participant relationships 
1. FIELDWORK AND FRIENDSHIP: WORKING IN YOUR OWN COMMUNITY   21  
To consider the challenges of working for research programmes in one’s own community, 
especially when competing for limited employment opportunities, and to identify possible 
solutions. 
2. SOAP AND PERSUASION: RECRUITING AND CARING FOR PARTICIPANTS  24  
To recognise that the balance between professional involvement and personal relationships is 
both a practical and a moral challenge for staff who interact directly with research 
participants, and to consider various possible views of the role of medical research in 
communities. 
3. GEL AND/OR CONDOMS: SAFETY IN A MICROBICIDE TRIAL    28  
To move beyond a simplistic understanding of informed consent (in terms of simple 
comprehension of facts), and to reflect on the extent of researchers’ responsibility towards 
reducing risk for vulnerable participants. 
4. FRIENDS LIKE HOW?: GETTING PERSONALLY INVOLVED WITH PARTICIPANTS   33 
To explore personal closeness and boundaries in research relationships, especially at the end 
of trials. 
5. READABILITY AND SWEET TALK: THE TRANSLATION AND COMPREHENSION OF STUDY 
DOCUMENTS           37   
To think more widely about the translation of study documents, considering local variations in 
language, the different ways participants interpret terms and facts, and the role of social 
relations in the information process. 
6. WE DON’T PAY: ‘BUS FARES’ AND OTHER GIFTS IN RESEARCH    42 
To reflect on the meaning and value of monetary payments in research among poor 
populations. 
7. YOUR FRIEND HAS NICE CLOTHES: CONFIDENTIALITY AND STAFF IDENTIY IN HIV HOME 
FOLLOW-UP           47 
To raise awareness of potential challenges – especially regarding confidentiality – when 
conducting home visits with HIV positive participants, and to discuss the role and personal 
involvement of research staff in relation to participants. 
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8. TRUTH AND LIES: DOING FIELDWORK IN YOUR OWN COMMUNITY    52  
To consider the challenges and dilemmas community-based field assistants can experience as 
a result of their dual allegiance to their home communities and their employers, and discuss 
how these could be better addressed. 
9. I COULD BE A SEX WORKER: MEANINGS OF EXCLUSION AND INCLUSION CRITERIA TO 
PARTICIPANTS           57 
To reflect on differences between how research participants and study coordinators may view 
inclusion criteria, and to appreciate the reasons behind this. 
10. THEY JUST COME AND ASK QUESTIONS: PARTICIPANTS’ UNDERSTANDING OF THE PURPOSE 
OF RESEARCH           63  
To consider challenges that can arise in the conduct of long-term research projects which 
involve health and demographic surveillance and do not result in short-term benefits. 
11. RESPONSIBILITY FOR WHAT AND FOR WHOM?: END-OF-TRIAL AND LONG-TERM 
HEALTHCARE            66  
To explore researchers’ responsibility towards study participants beyond the course of a trial, 
and to discuss differences between organizational responsibility, personal obligation and legal 
liability. 
12. HUNGER IS NOT OUR MANDATE: DEALING WITH POVERTY AMONG RESEARCH 
PARTICIPANTS           71 
To reflect upon poverty among research participants and how far medical research can and 
should address this. 
13. THEY JUST WANT TO SIGN QUICKLY: DIFFERENT INTERPRETATIONS OF INFORMED     
CONSENT            75 
To understand different interpretations of the informed consent process among researchers, 
social scientists, and participants, and to reflect on how to deal with withdrawals, silent 
refusals, and avoidance ethically. 
14. MARTHA’S DILEMMA: FOREIGN MEDICAL RESEARCH AS PUBLIC GOOD OR     
EXPLOITATION?            81 
To recognise how and why participants may feel conflicted about the value of foreign-funded 
medical research, and that these differing views can co-exist and create dilemmas. 
15. ROUTINE HEALTHCARE: WHOSE OBLIGATION?       85 
To discuss best practice when providing routine medical care for trial participants, and to 
consider the limits of ‘informed’ consent. 
Community and family relationships 
16. EVERYBODY’S CORRUPT: UNDERSTANDING SUSPICION IN MEDICAL RESEARCH   92 
To reflect on situations where simple administrative practices in research may lead to suspicion 
in the community. 
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17. BAD PRESS: ORIGINS AND IMPACT OF ‘BLOOD STEALING’ RUMOURS    98 
To consider the origins and spread of rumours about medical research programmes, and to 
discuss how researchers could seek to manage these more proactively. 
18. PEOPLE WILL ALWAYS TALK: PROTECTING PARTICIPANTS FROM STIGMA IN AN                  
HIV STUDY           102 
To reflect on some of the social and economic problems associated with researching HIV 
among ‘at risk’ communities, and to consider how far and in what ways researchers on this 
type of project are responsible for addressing these issues. 
19. LOST IN TRANSLATION: PUBLIC COMMUNICATION AND POWER RELATIONS  106  
To explore best practices and challenges in initiating community entry and creating 
community advisory boards, and to reflect on the importance of staff unity when engaging 
with the community. 
20. HUSBAND OUT OF TOWN: GENDER RELATIONS AND DECISION-MAKING  111 
To reflect upon the informed consent process, especially in relation to involving both parents 
of children involved in trials in decision-making. 
21. CHOP YOUR MONEY!: CHALLENGES IN RECRUITMENT AND ENFORCING STUDY             
RULES             116 
To consider challenges in recruiting participants and ensuring they follow study rules. 
22. MY HUSBAND DOESN’T KNOW: INVOLVING MALE PARTNERS IN MICROBICIDE       
RESEARCH           120  
To understand that although informed consent is often individual, participants have 
relationships (such as marriage) which may be affected by involvement in research. 
23. OF COURSE WE SPEAK ENGLISH: COMMUNITY ENGAGEMENT AND DISSEMINATING 
INFORMATION          124 
To appreciate the challenges involved in communicating with people of different cultural, 
linguistic, educational, and socio-economic backgrounds, and to consider how these could 
be addressed in your context. 
24. SATANISTS OR SCIENTISTS?: DEALING WITH NEGATIVE ASSOCIATIONS   128 
To appreciate the importance of taking rumours seriously as expressions of genuine concern 
about the purpose of medical research, and a starting-point for debate – rather than 
dismissing them as naïve misunderstandings which obscure scientific ‘truth’..  
25. THE SHEEP STUDY: OLD MEMORIES OF FOOD, BLOOD AND DEATH   132 
To raise awareness of the impact of community memories of previous research on the success 
of future research. 
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26. WILL THEY LEAVE US WHERE WE ARE?: EXPECTATIONS OF MEDICAL RESEARCH 
INTERVENTIONS          136 
To consider similarities between medical research and other kinds of community interventions, 
the expectations that these similarities may create, and the possible ways that research 
organizations could address this confusion. 
27. SEEING IS BELIEVING: TRIAL REGULATIONS VS. COMMUNITY ENGAGEMENT IN AN EBOLA 
VACCINE TRIAL          140 
To explore the challenges of balancing the demands of internationally agreed protocols with 
demands in the field during an epidemic. 
 
Institutional relationships 
28. TOO MANY PEOPLE HAVE TURNED UP!: ADDRESSING STAKEHOLDERS’ CONCERNS  147 
To consider ways of developing constructive and mutually beneficial relationships with local 
collaborators, given differing priorities and the limits of a research organization’s responsibility 
and resources. 
29. DATA TROUBLES: COLLABORATION AND THE FUTURE OF PARTNERSHIP   151 
To explore access to, use, and ownership of participants’ health data in collaborative medical 
research, and through this to reflect on collaboration between unequal partners. 
30. BETWEEN ENVY, SUSPICION AND DESIRE: EMBEDDING RESEARCH IN GOVERNMENT 
HEALTHCARE FACILITIES         156 
To consider how research can change the landscape of healthcare provision, and to discuss 
how researchers can promote constructive collaboration with routine healthcare staff and 
local communities. 
31. THE END OF A TRIAL: POST-TRIAL RESPONSIBILITIES AND RELATIONSHIPS  160 
To consider the problems of ending trials when research has become a major part of the 
healthcare landscape, and to identify solutions for managing these challenges. 
32. HELPING HAND: WORKING WITH PUBLIC HOSPITALS     164 
To explore different viewpoints and interests when government health facilities collaborate 
with transnational research bodies – and to explore the challenges facing individuals in an 
unequal system. 
33. WHOSE CAPACITY?: COLLABORATION THROUGH CAPACITY BUILDING  170 
To consider the nature of scientific collaborations and the rhetoric of equality between 
Northern and Southern partners, especially around questions of capacity building of both 
human expertise and infrastructure. 
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34. LIKE A MARKET: COMPETITIVE RECRUITMENT AND DOUBLE ENROLMENT  174 
To reflect upon the challenges of institutional coordination, participant inducement, and 
competitive recruitment in intensely studied geographic areas, and to consider the role of 
research participation as a valuable resource for both researchers and participants. 
35. UNDER ONE ROOF: SHARING RESOURCES IN A DISTRICT HOSPITAL   179 
To consider the challenges of conducting health research in resource-limited health facilities, 
where differentials in caregiving between research and routine services can result in dilemmas 
about equitable access to resources and expertise. 
36. WE WILL NOT DO YOUR WORK FOR FREE: INCENTIVES, PER DIEMS AND PROFESSIONAL 
CULTURE           183 
To consider the advantages and disadvantages of using per diem payments in research, 
especially in research focusing on the quality of care rather than on new medical 
technologies. 
37. IS IT A GIFT, REALLY?: DRUG DONATIONS, ACCESS AND SOCIAL BENEFIT  187 
To consider the challenges and benefits of drug research projects that have few (but 
sometimes significant) local benefits. 
 
Staff relationships 
38. PER DIEM: PRACTICAL INEQUALITIES IN SCIENTIFIC COLLABORATION   196 
To think about the various practical effects of inequalities between different types of staff, and 
to brainstorm both short-term and long-term solutions towards equality in the workplace. 
39. DO ANTHROPOLOGISTS KNOW BEST?: RELATIONSHIPS BETWEEN SOCIAL SCIENCE AND 
MEDICAL RESEARCHERS          200 
To reflect on the critical role, and limitations and responsibilities, of social scientists involved in 
medical research. 
40. WHO ARE YOU?: EMPLOYMENT ISSUES AND NORTH-SOUTH RELATIONSHIPS  204 
To reflect upon unspoken assumptions and challenges in relation to personal economic 
circumstances and professional roles, when Northern scientists and students work in Southern 
medical research sites. 
41. SNOT FOR SALE: STAFF’S HANDLING OF TRANSPORT REIMBURSEMENT AND              
RUMOURS            208  
To reflect on the role of money in rumours about medical research, and the challenges facing 
field staff around dealing with rumours and discussing them with senior colleagues. 
42. I’M SURE YOU’LL GIVE HER A CHANCE: EMPLOYMENT AND CORRUPTION  214 
To acknowledge the difficult issue of corruption in the employment processes of medical 
research organizations, and to discuss how to address this.
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